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ABSTRACT
Centrosomes are the only non-membranous organelles in most vertebrate cells
and their major function is to nucleate microtubules, hence often recognized as the
microtubule-organizing center (MTOC). Much like chromosome centrosome duplicates
only once during the S phase of each cell cycle. The fidelity and timing of this
duplication event will ensure equal division of duplicated chromosomes into the daughter
cells. As a consequence, numerical and/or structural centrosome abnormalities will cause
chromosome missegregation and lead to the generation of multiple mitosis and ultimately
chromosomal instability, which typify many cancers.
The molecular mechanism of centrosome duplication remains unclear. Previous
studies found that a fraction of human proline-directed phosphatase Cdc14B associates
with centrosomes. However, Cdc14B’s involvement in centrosome cycle control has
never been explored. In this study, we identify Cdc14B as a negative regulator in
centrosome cycle control: depletion of Cdc14B by RNA interference leads to centriole
amplification in both HeLa and normal human fibroblast BJ and MRC-5 cells; ectopic
expression of Cdc14B leads to stepwise loss of centrioles and attenuates centriole
amplification in HU/APH arrested S phase cells and cells treated with proteasome
inhibitor Z-L3VS. This inhibitory function requires centriole-associated Cdc14B catalytic
activity. In addition, our data suggests counterbalancing effects between Cdc14B
phosphatase and kinases such as Plk4, Cdk2/Cyclin-E/A in centrosome duplication
control potentially through modulating phosphorylation status of their common
downstream effectors, HsSas-6 and B23 respectively. Taken together, these results
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suggest a potential function for Cdc14B phosphatase in maintaining the fidelity of
centrosome duplication cycle.
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Chapter 1

Introduction to Centrosome Biology

1.1 Introduction:
Since its discovery in 1876, centrosome has attracted the attention of many
scientists from various backgrounds to study its structure, function and reproduction.
However, after more than 100 years of extensive studies, many aspects of this fascinating
organelle still remain a mystery (Rustem and Claude, 2007).

The term of “centrosome” was first coined by Theodor Boveri during the late 19th century
based on the observation that they are small phase-dense bodies located at the center of
the cells, surrounded by a relatively larger region of less dense materials (Nigg, 2002).
Theodor Boveri was a pioneer of centrosome biology who during his studies addressed
many of the fundamental problems in this field, notably the mode of centrosome
duplication and its relevance to human development and cancer. However, throughout the
early decades of the 20th century, the centrosome had proven refractory to molecular
analysis mainly due to its low abundance and tiny size. With the revolutionizing
technological advances in biology in the late 20th century such as forward and reverse
genetics, mass spectrometry, and the combination of live-cell imaging and laser
microsurgery, electron microscopy, molecular cloning and etc, we have gained detailed
insights into how centrosome is structurally organized, its detailed composition and how
1

it functions. These results also open up doors for new studies into the role of the
centrosome in the origin of cancer and other human diseases, its impact on stem cell and
developmental biology, human reproduction, and last but not least, its relevance to the
propagation of intracellular parasites (Nigg, 2004).

Centrosome is unique in that it is the only organelle in most animal cells that doesn’t
have a membrane. It is usually in close proximity to the nucleus. Centrosome functions
primarily as the major microtubule organizing centers (MTOC) of animal cells. It
governs most microtubule related functions: In the interphase cell, it facilitates the
nucleation of microtubules in the cytoplasm which in turn regulate cell polarity, shape,
mobility, adhesion and intracellular transportation; at the onset of mitosis, centrosome
helps to instruct the formation of a biopolar spindle which is indispensable for the
separation of sister chromatids during cell division (Nigg, 2002).

During S-phase of each cell cycle, cells make exactly two copies of its DNA, and during
mitosis the equal segregation of all duplicated chromosomes to the two daughter cells
depends upon the formation of a bipolar mitotic spindle. Since spindle polarity in higher
animal cells is usually dependent on the number of centrosomes serving as major
MTOCs, the cell must have exactly a pair of centrosomes by the onset of mitosis,
therefore much like chromosome centrosome duplicates only once during the S phase of
each cell cycle. The fidelity and timing of this duplication event will ensure equal
division of duplicated chromosomes into the daughter cells. As a consequence, numerical
and/or structural centrosome abnormalities will cause chromosome missegregation and
2

lead to the generation of multiple mitosis and ultimately chromosomal instability, which
typify many cancers (Erich, 2006). In fact, numerical and structural centrosome
aberrations have been implicated in virtually almost all types of cancer cells (Badano et
al., 2005; Saunders, 2005).

1.2 Centrosome Structure
Centrosome’s ultrastructure was investigated as early as the middle 1960s by
electron microscopy. As a result, a detailed description of many aspects of centrosome
composition was already available (de Harven, 1968; Fulton, 1971; Rustem and Claude,
2007; Stubblefield, 1967). Structurally, centrosome is comprised of a pair of barrelshaped centrioles situated at the core of the centrosome and surrounded by an electrondense proteineous matrix, the pericentriolar material (PCM) (Fig 1.1). Centriole is among
the most highly conserved structures in animal cells. It possesses a remarkable nine-fold
radial symmetry, consisting of an array of parallel microtubule triplets arranged like
blades of a turbine (Azimzadeh and Bornens, 2007; Marshall, 2007). It is a cylindrical
structure about 500nm in length and 200nm in diameter (Bornens, 2002; Paintrand et al.,
1992). However, there are variations of this structure among different species. In
vertebrates, typical nine triplet microtubules are found; whereas in D.melanogaster and
C.elegans they mostly are consist of doublet and singlet microtubules. Each centriole is
polarized along the proximal-distal axis with two functional different ends: The proximal
end (“minus” end of the centriolar MTs) where the new centriole usually starts to grow
and the distal end (“plus” end of the centriolar MTs) which can be the site of cilia origin

3

Figure 1.1: Centrosome structure. Centrosome structure in an animal cell at the end
of G1-phase, beginning of S-phase. From “a” to “j”, electron microscopy images (top
line – serial sections of daughter centriole, second line – selected sections of mother
centriole, scale bar 200 nm) illustrating different centrosome structures shown on the
centrosome scheme – “k”. MC – mother (mature) centriole, DC – daughter centriole;
PC – procentriole; PCM – pericentriolar material (pericentriolar matrix); A –
microtubule of triplet; B – microtubule of triplet; C – microtubule of triplet; H – hook
of C microtubule; MTD – A–B microtubule duplex (in distal part of centriolar
cylinder); ITC – internal triplets connections system; CS – cartwheel structure (axis
with spokes); PCS – pericentriolar satellite (=sub-distal appendage); HPCS – head of
pericentriolar satellite; SPCS – stem of pericentriolar satellite (connected to three
triplets in this case); SS – striated structure of pericentriolar satellite stem; MT –
microtubule; AP – appendage (=distal appendage); HAP – head of appendage; R – rib.
(Image courtesy of Uzbekov R and Prigent C., 2007).

4
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(Azimzadeh and Bornens, 2007). The two centrioles within each centrosome, however,
differ in their structures. Only the mature centriole (The maternal, or mother centriole)
has appendages close to its distal end (“AP” in Fig 1.1) as well as sub-distal appendages;
the immature centriole (The daughter centriole) has only electron dense ribs along the
microtubule triplets (“R” in Fig 1.1). The two sets of appendages on mother centriole are
thought to be required for anchoring microtubules. Mother and daughter centrioles are
linked through their proximal ends in part by large coiled-coil linker proteins of the
pericentrin family (Azimzadeh and Bornens, 2007; Rustem and Claude, 2007).

Under the electron microscope, the PCM surrounding the centrioles appears as an
amorphous, electron-dense fibrous lattice (Dictenberg et al., 1998; Nigg, 2002). Even
though a complete inventory of PCM components has not been established, in a typical
human centrosome, the PCM contains over one hundred proteins (Andersen et al., 2003).
Most of the components responsible for the major centrosomal functions, for example,
the γ-tubulin ring complexes that play indispensable role in microtubule nucleation,
reside in the PCM. Other PCM components are less well conserved although many
contain predicted coiled-coil domains, suggesting their structural functions to act as
scaffolds for the recruitment of cell cycle regulatory proteins, such as protein kinases,
phosphatases, components of the ubiquitin-dependent proteolytic machinery and etc
(Doxsey et al., 2005; Fry, 2004; Jackman et al., 2003; Kramer et al., 2004).
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1.3 The Centrosome Cycle
Traditionally, the centrosome–centriole duplication–segregation cycle has been
broken down into four consecutive steps: centriole disengagement, centriole duplication,
centrosome elongation and maturation, and sister centrosome separation (Fig 1.2). These
steps have been defined morphologically by detailed light and electron microscopy
studies following the progression of the cell cycle.

1.3.1 Centriole Disengagement
In a metaphase cell, each of the two spindle poles is characterized by the presence of one
centrosome comprising a mother-daughter centriole pair. They are tightly associated with
each other through an inter-centriolar linking structure and typically arranged in an
orthogonal configuration. Upon exit from M phase (or during early G1 phase) the tight
link between the two centrioles is lost, in a process now referred to as ‘disengagement’
(formerly ‘disorientation’) in which there is slight separation and loss of orthogonal
relationship between the pair of centrioles (Nigg, 2007b). This process has been reported
as a potential licensing mechanism for the two centrioles to undergo a new round of
duplication. Also, this process was suggested to be requiring the activity of separase, a
caspase related protease that also drives the separation of sister chromatids prior to
anaphase by cleavage of cohesion (Tsou and Stearns, 2006a). During G1, a different,
highly dynamic linker structure is formed between the two disengaged centrioles that
involves the tethering of filaments associated with the proximal ends of the two centrioles
(Bahe et al., 2005; Yang et al., 2006).
7

Figure 1.2: Schematic view of the centrosome cycle. (Image courtesy of Nigg EA,
2006)
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1.3.2 Centriole Duplication
Careful temporal analysis of CHO cells expressing green fluorescent protein GFPlabelled Centrin-1 led to the conclusion that daughter centriole assembly initiates around
the time of the transition between the G1 and S phases of the cell cycle (Thomas M.
Durcan, 2008). During this period new daughter centrioles, also referred to as
procentrioles, begin to grow at an orthogonal angle next to each maternal centriole close
to their proximal ends, establishing again the tight ‘base-to-side’ connections between
mother and daughter centrioles. Thus, duplication is semi-conservative in nature from the
perspective of the whole centrosome, but conservative from the perspective of the
centriole alone (Hartwell and Kastan, 1994).

Although daughter centriole biogenesis in vetebrate cells remains poorly understood,
substantial progress has recently been made in other organisms. In particular, the ease of
functional screening of genes using RNA interference (RNAi) has proven to be effective
in the identification of molecules that are involved in centriole assembly in C. elegans.
And as a result, the molecular mechanisms underlying centriole duplication have been
best studied in this organism. C.elegans centrioles are smaller and simpler compared with
the human ones, harboring a central tubule surrounded by 9 singlet rather than triplet
microtubules (MTs) (Pelletier et al., 2006). Despite differences in the structure, the
centriole/centrosome duplication cycle seems to be conserved. Like human centrosome,
generation of new daughter centrioles also happens in S phase in C.elegans. Five
essential proteins for centriole reproduction have been identified in C. elegans. These
proteins are recognized as a conserved centriole-assembly protein module including a
9

protein kinase, Zyg-1 (O'Connell et al., 2001a), and four putative structural proteins: Spd2, Sas-4, Sas-5, and Sas-6 ((Delattre et al., 2004; Kemp et al., 2004; Leidel et al., 2005;
Leidel and Gˆnczy, 2003; Pelletier et al., 2004). With the exception of SPD-2, which also
functions in centrosome maturation, reportedly, the rest of the molecules are exclusively
required for centriole duplication. Through elegant electron tomographic reconstruction
of early C.elegans embryos, the initial stages of procentriole assembly have been
revealed. In brief, there are two distinct steps as illustrated in Fig 1.3: First, a central tube
forms and elongates next to the base of the mother centriole which requires the function
of Spd-2, Zyg-1, Sas-5 and Sas-6; second, singlet microtubules assemble around the
peripherals of the central tube which is dependent upon Sas-4. Moreover, systematic
kinetic analysis and epistasis experiments indicates that the five proteins mentioned are
assembled sequentially onto nascent procentrioles (Delattre et al., 2006; Pelletier et al.,
2006): the initial recruitment of Spd-2 to the mother centriole mediated by cyclindependent kinase 2 (Cdk2) is required for the subsequent centriolar recruitment of the
kinase Zyg-1 onto procentrioles; Zyg-1 in turn enables the remaining three proteins to
localize to the centrioles; Coiled-coil molecules Sas-6 and Sas-5 are recruited next to
form the inner centriole tube that is essential for the binding of Sas-4; Sas-4 is important
for subsequent production of the surrounding MTs (Delattre et al., 2006; Pelletier et al.,
2006). Also, Sas-4 has been suggested to play an important role in recruiting PCM
components such as Spd-5 and γ-tubulin (Dammermann et al., 2004).

10

Figure 1.3: Procentriole assembly in C. elegans. (Image courtesy of Bettencourt-Dias M and Glover DM, 2007)
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Recent studies in other organisms, such as D.melanogaster and human, have shed lights
on the counterparts of these molecules in centriole duplication. Except for Sas-5 of which
orthologs have yet to be found, the rest four proteins all have orthologs in both human
and D.melanogaster. Thus the centriole assembly pathway is most likely to be conserved
during evolution. Cep192, the mammalian Spd-2 ortholog, is a major regulator of PCM
recruitment, centrosome maturation, and centriole duplication (Zhu et al., 2008); Sak,
also known as Plk4 (C Fode, 1994; Swallow et al., 2005), has been identified as a key
regulator of centriole duplication in both D.melanogaster (Bettencourt-Dias et al., 2005)
and human cells (Habedanck et al., 2005a). Although lacking sequence homology, it is
possible that Sak/Plk4 represents a functional homolog of C.elegans Zyg-1. Human Sas-6
(HsSas-6) localizes to the centrosome. Its absence leads to a lack of centriole duplication
whereas overexpression triggers centrosome amplification, suggesting a crucial role of
HsSas-6 in centriole assembly. Homolog of nematode Sas-4 is also essential in centriole
duplication in D.melanogaster (Peel et al., 2007; Rodrigues-Martins et al., 2007)
Recently, through siRNA screening and immunoelectron microscopy studies, a centriole
assembly pathway in human cells has also been delineated (Kleylein-Sohn et al., 2007a).
The depletion of nearly 30 candidate proteins (Andersen et al., 2003) by siRNA has
identified HsSas-6, Cpap (the putative homolog of C.elegans Sas-4), Cep135, and Cp110
as being indispensable for centriole biogenesis. Following activation of Plk4 on the
surface of the parental centriole, HsSas-6, Cpap, Cep135, and γ-tubulin are rapidly
recruited to the procentrioles. γ-tubulin is potentially responsible for centriolar
microtubules nucleation while Cpap and Cep135 probably play scaffolding roles. Finally,
Cp110 will be recruited and form a cap like structure underneath which the α-/β-tubulin
12

will be inserted for the growth of the centrioles. This study strengthens the concept that
centriole biogenesis is governed by an evolutionarily conserved mechanism (Delattre et
al., 2006).

1.3.3 Centriole elongation
Elongation of newly formed procentriole spans from late S phase until it reaches
the maximal length during the following cell cycle. The mechanisms underlying centriole
elongation are poorly understood. It was suggested that rare tubulin isoforms were
involved in the elongation of centrioles (Dutcher, 2003). For example, in
Chlamydomonas, the tubulin isoform ε-tubulin mutant Bld-2 forms short centrioles made
of singlet MTs instead of triplets implicating its role in centriole elongation. ε-tubulin is
conserved in mammals and has been proposed to be needed for both centriole duplication
and elongation (Azimzadeh and Bornens, 2007; Dutcher, 2003). Another interesting
observation is that in the presence of low Cdk1 activity D.melanogaster wing imaginal
discs had cells in which the daughter centriole was surprisingly longer than the mother
centriole. This suggests that the levels of CDKs are likely to regulate centriole elongation
(Bettencourt-Dias and Glover, 2007).

1.3.4 Centrosome Maturation and Separation
Maturation and separation of the two centrosomes start around the G2 to M
transition marked by acquisition of several maturation markers, recruitment of
pericentriolar material as well as an increase in MTOC activity.
13

Disassembly of the fibrous linker between the two centrosomes at the onset of mitosis is
thought to be necessary for centrosome separation. C-Nap1, found at the proximal end of
each parental centrioles but not procentrioles, is proposed to serve as the docking site for
the formation of this linker. C-Nap1 interacts with another coiled- coil protein called
rootletin, a fiber-forming molecule that emanates from the proximal ends of centrioles.
However, electron microscopy studies showed that C-Nap1 and rootletin do not seem to
account for the continuous linker between the parental centrioles suggesting other
proteins are also participating in the formation of the fibrous linker required for
centrosome cohesion. The disjunction of the two centrosomes is regulated in part by
phosphorylation of C-Nap1 by a centriole-associated NIMA-related kinase (Nek2) during
G2 phase of the cell cycle. This phosphorylation release C-Nap1 from the centrioles and
leads to the disconnection between the two centrosomes thereby allowing them to
separate. The activities of Nek2 kinases are counteracted by protein phosphatase 1 (PP1)
which is inactivated at the onset of mitosis (Bahe et al., 2005; Fry et al., 1998; N R Helps,
2000; Yang et al., 2006). Also, Mailand and co-workers have reported that another
phosphatase Cdc14A is also involved in centrosome separation (Mailand et al., 2002d).
This centrosome-associated phosphatase must act at a different level than protein PP1
because its overexpression leads to precocious centrosome separation and down
regulation of which leads to a failure in centrosome separation. The maturation of the
procentrioles extends about one and a half cell cycles including two successive mitoses
and completed with the acquisition of distal and sub-distal appendages (Azimzadeh and
Bornens, 2007).
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1.4 Centrosome Functions
1.4.1 Centrosome Mediated MT Events.
Microtubules are made up of two tubulins: α- and β-tubulin whose orientation
gives microtubules an intrinsic polarity. Microtubules are involved in many cellular
processes, including intracellular protein transportation, cell polarity, mobility, and
maintenance of cell shape, cell division and the formation of both meiotic and mitotic
spindles. Centrosome is recognized as the major MTOC of most animal cells. The PCM
is a key structure that promotes the formation and organization of cytoplasmic
microtubules during interphase and mitosis and is responsible for nucleating, anchoring
and releasing microtubules. Although many protein components of the PCM have been
described, only a subset of these are involved in nucleating microtubules: Pericentrin
plays a role in the formation of a lattice-like structure along with several other proteins
(Bettencourt-Dias and Glover, 2007; Bornens, 2002) that docks proteins such as γ-tubulin
(Zheng et al., 1995) to mediate the nucleation of microtubules. γ-tubulin is a highly
conserved protein in eukaryotes and exists in the γ-tubulin small complex (γ-TuSC), a
core tetrameric complex composed of two γ-tubulin molecules. A ring structure
comprising four or so these γ-TuSC sub-complexes known as the γ-tubulin ring complex
(γ-TuRC) was found to be responsible for nucleating microtubules in all cells studied so
far (Hannak et al., 2002). γ-TuRC is subjected to cell cycle dependent regulation and as a
result conformation and activities are different between interphase and mitotic
microtubules. In interphase, γ-TuRC nucleates fewer but longer microtubules while
mitotic microtubules are shorter, larger in number, and highly dynamic. This difference
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in the MT-nucleating ability of the centrosome between interphase and mitosis seem to
be controlled by a balance of factors that either restrict or promote the recruitment of MT
organizing molecules. Notably, protein phosphorylation and dephosphorylation play an
important part in maintaining this balance: among other protein kinases, Plk1 (Polo-like
kinase-1) and Aurora A promote MT nucleation, and this is counteracted by phosphatases
such as protein phosphatase-1 (PP1), protein phosphatase-4 (PP4) and etc (Blagden and
Glover, 2003; Trinkle-Mulcahy and Lamond, 2006).

Following their nucleation by the γ-TuRC, MTs are either released into the cytoplasm or
recaptured and anchored at the centrosome. MT nucleation and MT anchoring are two
separate processes that require different classes of molecules. Several different MT
anchoring mechanisms have been proposed. The subdistal appendages of the mother
centriole are thought to be a major site for anchoring MTs; PCM also has been proposed
to perform this function. The MT anchoring activity of subdistal appendages requires
ninein, as well as other molecules including centriolin, dynactin and EB1 (Badano et al.,
2005; Bornens, 2002; Mogensen et al., 2000). Ninein is a component of the subdistal
appendages of the mother centriole. It connects the centriole via its C terminus, whereas
its N terminus interacts with the γ-TuRC (Delgehyr et al., 2005). MT release from
centrosomes requires the activities of MT severing proteins, such as katanin, which has
been shown to sever MTs in vitro and in vivo (Ahmad et al., 1999; Doxsey, 2001;
Hartman et al., 1998).
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1.4.2 Organization of Cilia and Flagella
In postmitotic cells, the centrosome migrates to the cell surface, and one of the
centrioles differentiates into a basal body that nucleates microtubules to form a cilium
(Dawe et al., 2007). Cilia and flagella are highly conserved structures that consist of
microtubule axonemes that most commonly in the configuration of either (9+0) or (9+2):
nine outer doublet microtubules and two (or none) central pair microtubules. The term
cilia and flagella are sometimes used interchangeably despite minor differences such as
number, different modes of movement and etc. Cilia are found on virtually all cells
within the human body. They protrude from the cell surface and can either enable
movement of the cell itself, or facilitate the sensing of chemical and mechanical signals
surrounding the cells. A growing body of data suggests that cilia and flagella are
indispensable for various cellular and developmental processes that include cell motility,
propagation of morphogenetic signals in embryogenesis and sensory perception (Badano
et al., 2005).

1.4.3 Centrosome in Cell Cycle Regulation
In addition, the centrosome also plays a crucial role in cell cycle regulation. It has
been suggested that centrosomes can serve as multiplatform scaffolds for the binding of
many regulatory complexes including many checkpoint proteins. And these proteins have
been reported to participate in cytokinesis as well as G1 to S-phase (G1–S), G2 to Mphase (G2–M), metaphase to anaphase (M–A) transitions (Jackman et al., 2003; Mikule
et al., 2007; Uetake et al., 2007).
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1.4.3.1 Centrosome in Cytokinesis Control
Cytokinesis is the final stage of the cell cycle and is the process that two daughter
cells are generated from one mother cell. As shown in Fig 1.4, the general processes
involved in cytokinesis in eukaryotes are (Guertin et al., 2002):
•

Division site is first chosen, most commonly at the cell equator, and the
subsequent assembly of the cleavage furrow is assembled at the division
site.

•

Formation of contractile ring (also referred to as the actomyosin ring) that
contains actin, myosin, and other proteins.

•

Ingression or contraction of the actomyosin ring, generating a membrane
barrier between the cytoplasmic contents of each daughter cell.

•

Formation of a structu re called midbody when the ingressing furrow
constricts the components of the spindle midzone

•

Abscission, the final event of cytokinesis marked by the sealing of the
furrow, generating two completely separate cells.

One of recent studies showed that when centrosomes were removed from mitotic cells by
laser ablation, mitotic spindles were still assembled but about 30% to 50% of the mitotic
cells failed to complete cytokinesis (Khodjakov et al., 2000). Cells appeared to either
remain attached by intercellular bridges or abort cytokinesis, forming binucleate cells. In
another study in which centrioles were labeled with Centrin-GFP, the final events of
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Fig 1.4: General mechanisms of cytokinesis in animal cells. (Image courtesy of Guertin, D.A. et al, 2002)
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cytokinesis correlated with movement of the maternal centriole to the intercellular bridge.
However, the abscission, final step of cytokinesis, didn’t finish until the mother centriole
moved from the intercellular bridge back to the center of the cell. These observations
highly suggest that centrosomes were involved in the activation of the final stages of
cytokinesis.

1.4.3.2 Centrosome in G1/S Progression
Recent studies have proposed an intriguing possibility that G1/S transition is
dependent on centrosomes. The same techniques used to reveal centrosome function in
controlling cytokinesis have also identified a centrosome requirement for S-phase entry
(Hinchcliffe et al., 2001; Khodjakov and Rieder, 2001). When the centrosomes are
removed by either microsurgery or laser ablation, cells that do make it through
cytokinesis tend to arrest in G1 phase and never progress into the subsequent S phase.
More interestingly, if only one of the centrosomes is removed during prophase: the
acentrosomal daughter cell becomes arrested in G1 phase; however the centrosomecontaining daughter cell progresses to the next mitosis without any delay (Khodjakov and
Rieder, 2001). One attractive possibility is that these cells simply did not go through
cytokinesis completely which led to the activation of a checkpoint that monitors aberrant
centrosome numbers or maybe the presence of excessive DNA (Andreassen et al., 2001).
Alternatively, centrosomes may be required in a positive fashion to promote processes
required for G1/S transition. This may occur through recruitment or concentration of
molecules that are essential for the initiation of DNA synthesis (Hinchcliffe et al., 1999;
Lacey, 1999). Even though there is still ongoing debate of whether centrosomes directly
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participate in G1/S transition or centrosome defects trigger checkpoints that monitor the
completion of mitosis, one obvious outcome of having a centrosomal requirement for
G1/S progression is to ensure proliferating cells receive appropriate number of functional
centrosomes after each cell cycle.

1.4.3.3 Centrosome in G2/M Progression
Early research suggested that centrosome plays a role in progression into mitosis.
The evidence came from experiments when injected with centrosomes, G2-arreasted
starfish oocytes started progressing into mitosis and mitotic entry in Xenopus eggs were
also accelerated (Perez-Mongiovi et al., 2000; Picard et al., 1987). More recent studies
have started to reveal the role for the centrosome in the G2/M transition in mammalian
cells. It is widely known that the G2/M transition requires activation of Cdk1/cyclin B.
Although cyclin B1 is present throughout the cytoplasm before prophase, active
Cdk1/cyclin B1 was first detected at the centrosome during prophase before its
appearance in the nucleus (Jackman et al., 2003). This observation implicated that
centrosome might function as docking station where regulatory proteins such as
Cdk1/cyclin B are accumulated for triggering mitosis (Doxsey et al., 2005; Hames,
2004).

1.4.3.4 Centrosome in Metaphase-to-Anaphase Transition
After mitotic entry, the next critical transition point in the cell cycle is the
metaphase to anaphase transition. This is in part under the control of the spindle assembly
checkpoint which prevents the initiation of anaphase until all successful attachment of
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spindle microtubules to the kinetochores of chromosomes have been achieved (Hames,
2004; Musacchio and Hardwick, 2002). The main target of the spindle assembly
checkpoint is the multi-subunit ubiquitin ligase known as the anaphase promoting
complex or cyclosome (APC/C) (Hames, 2004; Page and Hieter, 1999). Securin and
Cyclin B are among the many substrates of APC/C that will be polyubiquitylated and
targeted for proteasome-mediated degradation. Destruction of securin promotes the onset
of anaphase by releasing separase which in turn cleaves the centromeric cohesin
molecules that hold the sister chromatids together (Nasmyth, 2002); Degradation of
Cyclin B, on the other hand, promotes mitotic exit. In order for APC/C to recognize its
substrates, an additional adaptor subunit is required: During metaphase to anaphase
transition, the adaptor needed is the Cdc20 (Fizzy/Fzy) protein; and at the time of mitotic
exit, the adaptor protein is the Cdh1 (Fizzy-related/Fzr) (Morgan, 1999). The current
view on how the spindle assembly checkpoint prevents anaphase onset is that checkpoint
proteins, notably Mad2, Bub3 and BubR1, form a mitotic checkpoint complex (MCC)
with Cdc20 preventing it from interacting with and activating the APC/C (Hames, 2004;
Hwang et al., 1998; Kim et al., 1998; Sudakin et al., 2001; Tang et al., 2001).

Kinetochores, as have already been extensively documented and well accepted, play an
essential role in regulating the metaphase to anaphase transition (Agnes L. C. Tan, 2005);
How centrosomes function as a molecular scaffold for sensing and regulating this
transition hasn’t been studied in details. It is interesting to know where exactly the
APC/C-Cdc20 gets activated: is it mainly activated at the kinetochores or possibly can it
first be activated at centrosome/spindle pole. Early evidence showed that some APC/C
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components such as Cdc16 and Cdc27 as well as Cdc20 localized to the centrosome in
fixed cells, however, these observations were circumstantial and other studies have
shown these proteins to be highly dynamic and existed in a number of other locations.
The first clear indication that centrosome/spindle pole was responsible for the metaphase
to anaphase transition came from live cell imaging of GFP-tagged cyclin B destruction in
Drosophila embryos (Raff, 1999). The loss of GFP-Cyclin B starts at the spindle pole
before spreading up the spindle to the chromosome. Other reports in HeLa cells (Clute
and Pines, 1999) and yeast cells (M Yanagida, 1999) confirmed this result. Even more
convincing is the finding that in a particular Drosophila mutant (‘centrosomes fall off ’,
cfo), cyclin B destruction occurred on unattached centrosomes but not on the spindles,
resulting embryos arrest in anaphase (Wakefield et al., 2000). This experiment provides
powerful evidence that destruction of cyclin B begins on spindle poles. In addition to
Cyclin B it is possible that destruction of securin, another APC/C substrate, also is
initiated at the centrosome/spindle pole although the evidence is not strong (Hagting et
al., 2002).

Besides centrosomes’ potential role in regulating destruction of APC/C-Cdc20 substrates
required for the initiation of anaphse, other studies have suggested that the centrosome
protein γ-tubulin and human pericentrin B homolog, Pcp1p, are also involved in the
metaphase to anaphase transition in addition to their roles in microtubule nucleation and
anchoring (Prigozhina et al., 2004; Rajagopalan et al., 2004).
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1.5 Centrosome Abnormalities and Human Diseases
At the turn of the 20th century Boveri’s visionary research suggested that cells
with abnormal centrosomes were precursor turmor cells. During the past decade, Boveri’s
early description of centrosome abnormalities in cancer cells has found enormous
recognition and been extended to a large number of different human tumors (Brinkley,
2001; Duensing, 2005; Lingle WL, 2005; Nigg, 2002; Pihan et al., 2003). Given
centrosome’s critical involvement in cell cycle control it’s not surprising that it has a role
in tumorigenesis. The fact that centrosome abnormailites have been observed in nearly all
type of cancers includeing breast, liver, colon, cervical, bone marrow, prostate and etc
(Nigg, 2004), and overexpression of certain centrosome components resulted in
aneuploidy (Katayama et al., 2003; Lingle WL, 2002) have led to the conclusion that
centrosome plays an important role in cancer development and progression.

Generally speaking, centrosome abnormailites can be classified into two broad
categories: numerical and structural aberrations. Although their origins and consequences
may differ, Numerical centrosome aberrations are frequently accompanied by structural
irregularities and both of them can promote aneuploidy and potentially result in cancer
formation.

1.5.1 Numerical Centrosome Aberrations
Numerical centrosome abnormalities are defined as an erroneous number (either
less than or greater than two) of fully functional centrosomes in mitotic cells that can
interfere with the formation of the normal bipolar mitotic spindle for segregating sister
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genomes. The exact counting of centrosome numbers, however, is not an easy task.
Serial-section electron microscopy can ultimately solve the problem but impractical,
therefore most studies have to rely on immunostaining using antibody labeling. Although
proven to be method of choice, results from these studies have to be interpreted with
caution. Factors to consider include not only antibody quality, cell type, the resolution of
the optical device in use, but also the orientation of the centrosome relative to the
direction of viewing, and the fact that PCM components associate unevenly with mother
and daughter centrioles, respectively. Moreover, possible PCM fragmentation is another
factor and as a result, not every positive staining with antibodies targeting PCM
components necessarily represents a complete centrosome. Despite all these
complications, there is no doubt that numerical centrosome aberrations, particularly extra
copies of centrosomes (also referred to as supernumerary centrosomes or centrosome
amplification) often lead to genome instability which is the hallmark of cancer (Erich,
2006; Lingle WL, 2005).

Majority of cancer cells with supernumerary centrosomes correlate with loss of p53 or
retinoblastoma (Rb) tumour suppressors. This is likely because in these cells, a more
permissive condition for cells with amplified centrosomes to proliferate has been
established. In addition, deficiency of the breast cancer gene BRCA1 and the
overexpression of Aurora-A kinase in transiently transfected cultured cells also result in
centrosome amplification in certain cancer cells (Fukasawa et al., 1996; Pihan et al.,
1998; Xu et al., 1999). Centrosome amplification caused by deregulation of these
centrosome number regulators might arise directly from overreplication of centrosomes
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or indirectly from cytokinesis defects. These will be covered in more details in later
chapters.

1.5.2 Structual Centrosome Aberrations
Structual aberrations of centrosome, on the other hand, are recognized as defects
in centrosome composition that can inhibit the formation of normal bipolar spindles. In
addition, disrupted centrosome integrity can indirectly affect multitude of signaling
pathways and contribute to the cancer formation. Unlike numerical aberrations
manifested only as two phenotypes: less or more than two centrosomes per cell,
phenotypes of structural aberrations include enlarged centrosome size (Due to excessive
accumulation of PCM around centrioles), formation of acentriolar bodies, alterations in
the phosphorylation state of PCM proteins, ectopic appearance of centrosome related
bodies (CRB) and etc (Nigg, 2002). Most likely, structural centrosome aberrations are
caused by deregulated expression of genes coding for centrosomal components or altered
posttranslational modifications and activity of these centrosomal proteins. For most
tumors, the functional consequences of structural centrosomal abnormalities are either
reduced or enhanced microtubule nucleation capacity depends on the identity and
modification state of the deregulated PCM components.
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Chapter 2

Cdc14B, a primer

2.1 Introduction
The Cdc14 gene was first discovered in a genetic screen for genes required for the
cell division cycle (CDC genes) in the budding yeast S.cerevisiae (Hartwell LH, 1974).
From this screening, Cdc14 was characterized as an essential gene in the regulation of
cell cycle events between metaphase and late telophase. Since its discovery, our
understanding of the function of Cdc14 has been dramatically expanded. Cdc14 gene has
been cloned in many different organisms and shown to be encoding a novel family of
dual specificity phosphatases (D'Amours and Amon, 2004). Now we know that the dual
specificity phosphatase Cdc14 is conserved from yeast to mammals. It functions in a
variety of cell cycle events although its requirements vary from one species to another
(Trinkle-Mulcahy and Lamond, 2006).

Although Cdc14 protein contains other sequences, its phosphatase activity was found to
be indespensible for almost all of its known functions. Recent studies have unvealed
many different functions of Cdc14 in different organism including mitotic exit, spindle
assembly, rDNA resolution, centrosome seperation, embryonic division, microtubule
bundling and etc. In spite of their similarities in biochemical properties, the functions of
Cdc14-like proteins seem to vary dramatically between species. Next, I will discuss the
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function of Cdc14 in different organisms in more detail.

2.2 Cdc14 in Saccharomyces Cerevisiae
Cdc14 is essential for the survival of budding yeast Saccharomyces cerevisiae
since it is absolutely required for the cell to exit from mitosis. The mitotic functions of
Cdc14 are associated with its ability to reverse CDK dependent phosphorylation events
by dephosphorylating CDK targets. Changes in subcellular localization constitute an
important mode of regulation for Cdc14 activity. For most of the cell cycle throughout
G1, S phase, G2 and metaphase, Cdc14 is sequestered in the nucleolus by a competitive
inhibitor Net1 (Also referred to as Cfi1). Net1p is a core component of the nucleolar
RENT complex (Shou et al., 1999b; Straight et al., 1999; Visintin et al., 1999a) and has
been proposed to function by occluding the active site of Cdc14, limiting its access to
substrates. As a result, Cdc14 phospatase activity is suppressed (Traverso, E. E. et al,
2001). From early anaphase till the end of mitosis, Cdc14 starts to dissociate with Net1
and moves out from nucleolus to nucleoplasm and cytoplasm. The dissociation of Cdc14
is controlled at least by two different signaling pathways: Cdc fourteen early anaphase
release (FEAR) and mitotic exit network (MEN) (Fig 2.1). At the onset of anaphase,
FEAR pathway first initiates the release of a fraction of the total pool of Cdc14 from
Net1 to the nucleoplasm as well as cytoplasm where Cdc14 is found both at the spindle
pole body (SPBs, the yeast centrosomes) and mitotic spindle (Pereira et al., 2002; Pereira
and Schiebel, 2003; Stegmeier et al., 2002; Yoshida et al., 2002). This process is thought
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Figure 2.1: Substrates and functions of Cdc14 during mitosis. The known targets of Cdc14 in the
regulation of these processes are shown in the gray boxes. Solid arrows indicate reasonably wellestablished Cdc14 targets; dashed arrows indicate more speculative ones. (Image courtesy of Frank
Stegmeier and Angelika Amon, 2004)
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to require phosphorylation of both Cdc14 and Net1 (Azzam et al., 2004; Visintin et al.,
2003). After the initial release, Cdc14 would return to the nucleolus unless the MEN
newtork is activated to sustain its release. As part of the feed forward mechanism, Cdc14
released by the FEAR network in early anaphase stimulates MEN activity, and Cdc14
released by the MEN further activates the MEN itself in a positive feedback loop. This
two coupled processes result in the rapid release of Cdc14 from the nucleolus (Visintin et
al., 2008). Once released, Cdc14 becomes active and antagonizes Cdk1 (also known as
Cdc28p) activity by dephosphorylates Cdk1’s substrates and promotes mitotic exit and
cytokinesis.

In recent years, it has become clear that Cdc14 induces not only mitotic CDK inactivation
and exit from mitosis but regulates a variety of other cellular events such as rDNA and
telomere segregation, mitotic spindle dynamics, and cytokinesis. Remarkably, the
execution of these diverse events relies on temporal Cdc14 activation mediated by the
two different regulatory networks. Although both help the release of Cdc14 from its
inhibitor, there are qualitative and quantitative differences between FEAR and MEN
networks (Stegmeier and Amon, 2004). Cdc14 released by the FEAR network perform
different functions during mitosis than Cdc14 released by the MEN.

2.2.1 Mitotic Exit Network
The MEN network was the first signaling network shown to activate Cdc14 by
regulating its subcellular localization (Shou et al., 1999a; Visintin et al., 1999b). The
MEN resembles a Ras-like GTPase signaling cascade that consists of: A GTPase, Tem1p;
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A putative Guannine-Nucleotide Exchange factor (GEF), Lte1p; A two-component
GTPase activating protein (GAP), Bub2-Bfa1; Two protein kinases, Cdc15p and Dbf2p;
A Dbf2-associated factor: Mob1; A scaffold protein, Nud1; and the protein phosphatase
Cdc14 (Fig 2.2).

Tem1 functions close to the top of the MEN pathway. Its GTPase activity is negatively
regulated by the GAP complex Bub2-Bfa1 and positively regulated by Lte1. The
activated form of Tem1, which is likely to be the GTP-bound, is thought to transmit a
signal to the protein kinase Cdc15 (Sohrmann et al., 1998). Cdc15, in turn, activates the
protein kinase Dbf2, which acts together with the Dbf2-associated factor Mob1 to
activate MEN (Mah AS, 2001). Mutation in any of these components can prevent exit
from mitosis with cells arresting in late anaphase/telophase.

Temporal and spatial regulation of the components of the MEN controls its activation at
the end of mitosis. Notably, Lte1 localized in the bud cortex (Bardin et al., 2000; Pereira
et al., 2000) while other components of MEN were anchored by the scaffold protein
Nud1 at spindle pole body destined to migrate into the daughter cell when the spindle
elongates during nuclear division (Ulrike Gruneberg, 2000). The close spatial association
between Tem1 and Bub2–Bfa1 maintains Tem1 in its inactive GDP-bound form; the
spatial separation between Tem1 and Lte1 prevents premature activation of MEN. Thus
the onset of mitotic exit controlled by MEN won’t happen until the anaphase spindle is
properly oriented and nuclear segregation is achieved.
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Figure 2.2: The FEAR and MEN networks. The ultimate function of these two networks is to activate Cdc14 by
releasing it from its inhibitor Net1/Cfi1. Lines ending with an arrowhead indicate the stimulation of the downstream
effector, whereas lines ending with a perpendicular bar indicate the inhibition of the target protein. (Image courtesy
of Damien D’Amours and Angelika Amon, 2004)
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Cdc14 activated by the MEN network is mainly responsible for promoting exit from
mitosis. Several observations, however, indicate that Cdc14 and the MEN also regulate
cytokinesis independently of their mitotic exit function.

2.2.2 FEAR network
Recent studies revealed the existence of an additional pathway regulating Cdc14
during early anaphase. This came from observations that Cdc14 was still transiently
released from the nucleolus in cells when MEN activity is nonexistent (Pereira et al.,
2002; Stegmeier et al., 2002; Sullivan and Uhlmann, 2003; Yoshida et al., 2002). Factors
involved in this transient release of Cdc14 were subsequently identified and are
collectively referred to as the FEAR network (Stegmeier et al., 2002).

The known FEAR network to date is consisted of five positive factors including a
Seperase (Esp1 in yeast), the kinetochore/spindle protein Slk19, Spo12 and its close
homolog Bns1and the polo kinase Cdc5 (Stegmeier et al., 2002; Visintin et al., 2003);
and two negative regulators Securin (Pds1 in yeast), an inhibitor of Separase, and the
nucleolar protein Fob1 (Cohen-Fix and Koshland, 1999; Stegmeier and Amon, 2004;
Sullivan and Uhlmann, 2003; Tinker-Kulberg and Morgan, 1999) (Fig 2.2).

Esp1 encodes a protease that is important for sister chromatid separation. This protease
acts by cleaving a component of cohesion which holds sister chromatids together thereby
enabling chromosome segregation (Nasmyth, 2002). As a component of the FEAR
network, Esp1 is also responsible for Cdc14 release from the nucleolus. Surprisingly, its
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protease activity is not required (Sullivan and Uhlmann, 2003). In agreement with this,
the cleavage of Slk19, another FEAR network component, at the metaphase to anaphase
transition by Esp1 is also not required for Cdc14 release from the nucleolus and its
mitotic exit function (Stegmeier et al., 2002). And now we know that in the context of
FEAR network Slk19 functions together with Esp1 rather than be controlled by Esp1
through cleavage. Slk19 is in a complex with Esp1 and is required for targeting Esp1 to
kinetochores and the spindle midzone (Sullivan et al., 2001), and this is important for
Cdc14 release from the nucleolus in early anaphase. Importantly, both the proteasedependent and protease-independent functions of Esp1 are inhibited by the securin Pds1
(Sullivan and Uhlmann, 2003). Therefore, Pds1 is the common negative regulator for
prohibiting both the onset of sister chromatid separation and FEAR network-mediated
Cdc14 release.

Most strikingly, Spo12, a protein with no known biochemical function, was also
identified as a component of the FEAR network (Jensen et al., 2002b). Spo12 is a
nucleolar phosphoprotein that is found to physically interact with Fob1, an inhibitor of
the FEAR network which localizes to the same rDNA region and binds directly with Net1
to prevent release of Cdc14 (Iwabuchi M, 2000; Stegmeier et al., 2004). At onset of
anaphase, phosphorylation of Spo12 can potentially trigger a conformational change in
Fob1, which in turn will disrupt the interaction between Cdc14 and its inhibitor Net1,
thus rendering Cdc14 release from nucleolar (Stegmeier et al., 2004).
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The polo kinase Cdc5 acts at more than one stage to regulate mitotic exit. It is both a
component of the FEAR network and a key regulator of the MEN, as a consequence,
Cdc5 mutant have Cdc14 sequestered in the nucleolus at all times (Geymonat et al., 2003;
Hu F, 2002; Hu et al., 2001a; Pereira et al., 2002; Stegmeier et al., 2002). Cdc5 effects on
the MEN network at both upstream and downstream of Tem1. In later stage of mitosis
when MEN network is active, Cdc5 contributes to Cdc14 release from the nucleolus by
phosphorylating the Tem1 inhibitor complex Bub2-Bfa1 (Hu et al., 2001a). Also, Cdc5
promotes Dbf2 kinase activation. The function of Cdc5 in the FEAR network, however,
is inconclusive. Recent studies suggest that Cdc5’s kinase activity is required for FEAR
network function since it can promote the phosphorylation of both Net1 thereby reducing
its affinity for Cdc14 (Shou et al., 2002; Visintin et al., 2003; Yoshida and Toh-e, 2002).

Information regarding the functional relationship among FEAR network components is
rather limited. According to a recent model, the FEAR network can be divided into two
sub-branches: One branch with Esp1, Slk19, and Cdc5; the other includes Spo12, Bns1
and Fob1. Both branches are required to promote Cdc14 release from its inhibitor during
early anaphase although their modes of action may differ.

Although Cdc14 transiently released by the FEAR network is not essential for cell
survival, it helps to regulate several mitotic events: It stimulates MEN activity through
either dephosphorylation of Cdc15 or inactivation of the Bub2-Bfa1 complex (Jaspersen
and Morgan, 2000; Stegmeier et al., 2002); It regulates the subcellular localization of
chromosomal passenger proteins, which possibly contributes to the stabilization of the
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mitotic spindle during early anaphase (Pereira and Schiebel, 2003); It is also important
for division of nucleoli and chromosome segregation, specifically in the resolution of
highly repetitive rDNA and telomere regions (D'Amours and Amon, 2004). In addition,
FEAR network components and Cdc14 are also required for the maintenance of genomic
integrity and viability (D'Amours and Amon, 2004; Hartwell and Smith, 1985).

2.2.3 Inactivation of the MEN and FEAR Network
The inactivation and re-sequester of Cdc14 after mitotic exit has been completed
is as important for successful cell division as its activation during anaphase. FEAR
network activity appears to be limited to a very brief time during early anaphase, as
Cdc14 re-enters into the nucleolus during late anaphase in cells lacking a functional MEN
network (Pereira et al., 2002; Stegmeier et al., 2002; Yoshida et al., 2002). The
inactivation of the MEN network is accomplished in multiple ways: Cdc14
dephosphorylates both Bfa1 and Lte1, which potentially restore the GAP activity of
Bub2-Bfa1 toward Tem1 resulting in the release of Lte1 from the bud cortex (Geymonat
et al., 2003; Hu et al., 2001b; Jensen et al., 2002a; Pereira et al., 2002; Seshan et al.,
2002); The decreased concentration of Lte1 in the bud prevents Tem1 activation (Bardin
et al., 2000; Jensen et al., 2002a; Seshan et al., 2002); Moreover, the released Cdc14
activates APC/CCdh1, which targets the MEN activator Cdc5 for degradation (Charles et
al., 1998; Cheng et al., 1998; Shirayama M, 1998); Finally, Amn1, expressed specifically
in daughter cells following Cdc14 activation, is thought to inhibit MEN function by
competing Cdc15 for Tem1 binding (Wang et al., 2003).
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2.2 Cdc14 in Schizosaccharomyces Pombe
In fission yeast Schizosaccharomyces pombe the Cdc14 homologue Clp1 (cdc
fourteen-like phophatase, also called flp1) is also regulated by cell cycle dependent
changes in its subcellular localization. It functions primarily to regulate the G2/M
transition and cytokinesis through inactivation of mitotic CDKs (Cueille et al., 2001;
Trautmann et al., 2001). It achieves the former by inactivating another phosphatase,
Cdc25 and the latter through septation initiation network (SIN), a signaling pathway
homologous to the MEN network and is essential for cytokinesis in fission yeast (Fig
2.3).

Like budding yeast cdc14, Clp1/Flp1 is largely sequestered in the nucleolus except some
of it also detected at spindle pole bodies during interphase. Unlike its counterpart in
budding yeast, Clp1/Flp1 is released from the nucleolus in early mitosis (prophase) and
spreads throughout the nucleoplasm, kinetochores, the mitotic spindle, and the medial
actomycin ring, a highly dynamic structure that controls the ingression of the division
plane (Clifford et al., 2008; Trautmann et al., 2004).

The cellular mechanism for release of Clp1/Flp1 during prophase remains to be clarified.
Although the initial release of Clp1/Flp1 from the nucleolus at mitotic entry is not
dependent on SIN, this signaling network is required to maintain Clp1/Flp1 in its released
state when the cytokinesis checkpoint has been activated (Cueille et al., 2001; Trautmann
et al., 2001). Therefore, maintenance of budding yeast Cdc14 and Clp1/Flp1 in its
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Figure 2.3: The SIN pathway in S. pombe. (Image courtesy of Andrea Krapp et al.,
2004)
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released state shares conserved pathways. Interestingly, at the end of the mitosis, the
return of Clp1/Flp1 to the nucleolus is dependent on SIN network. In addition, a recent
study showed that under replication stress, Cds1, a checkpoint kinase, triggered nuclear
accumulation of the fission yeast Cdc14 phosphatase homologue (Diaz-Cuervo and
Bueno, 2008).

Although might not be the only mechanism of regulation, the changes in subcellular
localization of Clp1/Flp1 are likely to contribute to its activation. Once released, like
Cdc14 in budding yeast, Clp1/Flp1 antagonizes mitotic CDK (Cdc2p in fission yeast)
activity. However, the mechanisms behind mitotic CDK inactivation and the cellular
processes regulated by Clp1/Flp1 and Cdc14 in budding yeast appear to be quite different
(Stegmeier and Amon, 2004). Unlike Cdc14, Clp1/Flp1 is not essential for mitotic exit
but predominantly counteracts mitotic CDK activity during G2/M transition. In budding
yeast, Cdc14 is responsible for dephosphorylating and activating both Cdh1 and Sic1.
Cdh1 is the APC/C (an E3 ubiquitin ligase) activator and Sic1 is the Cdk1 inhibitor. As a
result, the mitotic CDKs are targeted for destruction by activated APC/CCdh1 while their
activities inhibited by activated Sic1; In fission yeast, the Cdc14 homolog Clp1/Flp1,
however, antaganizes mitotic CDK activity by promoting inhibitory phosphorylation of a
conserved tyrosine residue Y15 on the fission yeast Cdk, Cdc2 (Trautmann et al., 2001).
Clp1/Flp1 promotes this inhibitory tyrosine phosphorylation by activating the protein
kinase Wee1, which in turn phosphorylates Cdc2, and by dephosphorylating,
destabilizing, and inactivating the Cdc25 phosphatase, which dephosphorylates the same
site on Cdc2 (Wolfe BA, 2004). At mitotic entry, Cdc2 participates in its own regulation
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by activating the mitotic inducing phosphatase Cdc25, and inhibiting the opposing
kinase, Wee1. By disrupting this Cdc2 positive feedback loop, Clp1 contributes to Cdc2
inactivation.

Recent data suggests that the Clp1’s activity during mitosis subjects to be regulated by
the mitotic kinase Cdc2 (Wolfe et al., 2006). When phosphorylated, Clp1’s phosphatase
activity is attenuated. The full activation of Clp1 was proposed to occur in two
consecutive steps: first, upon mitotic entry, Clp1 is released from the nucleolus and
localizes to the kinetochores, the mitotic spindle, and the medial actomycin ring. At this
stage, some Clp1 phosphatase activity must exist since it is required at kinetochores for
monitoring chromosome biorientation (Trautmann et al., 2004); As Cdc2 activity declines
during anaphase progression, autodephosphorylation of Clp1 reverses the Cdc2 mediated
inhibitory phosphorylation and lead to full activation of Clp1. Activated Clp1 in turn will
dephosphorylate other Cdc2 substrate(s).

2.4 Cdc14 Homologues in Metazoans
Homologues of Cdc14 exist in the majority of all eukaryotes and have been
characterized at least to some extent in C.elegans, Xenopus, Drosophila and human.
However, their functions and regulations are not well understood.

In the nematode Caenorhabditis elegans, CeCdc14 localizes to the central spindle and the
midbody, similar to Clp1/Flp1 in S. pombe, but the phosphatase was found absent from
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the nucleolus and centrosomes (Stegmeier and Amon, 2004). According to one study,
CeCdc14 is also required for cytokinesis but not mitotic exit (Gruneberg et al., 2002). In
this study, Gruneberg et al showed depletion of Cdc14 using RNA interference caused a
striking mitotic phenotype: the failure in cytokinesis and embryonic lethality (Kipreos,
2004). The observed phenotype is in part due to the complete loss of the central spindle.
CeCdc14 can potentially dephosphorylate Zen4, a mitotic kinesin-like protein that is
essential for central spindle formation in C.elegans. This dephosphorylation is required
for Zen4 to localize to the central spindle and perform its function (Kipreos, 2004). In
contrast, however, a recent study by Saito et al reached the opposite conclusion (Saito et
al., 2004). In this study, mitotic phenotype and embryonic lethality are not observed in
both CeCdc14 null worms and depletion of CeCdc14 using RNAi approach (Saito et al.,
2004). The different outcomes of these two studies are possibly due to off-target effect of
RNAi and/or the strains used in two studies differ in their susceptibilities to loss of
CeCdc14 (Kipreos, 2004). Surprisingly, the latter study revealed an additional unique
role of CeCdc14 in G1 for preventing cell cycle re-entry during prolonged periods of
developmentally regulated quiescence (Saito et al., 2004). Genetic and biochemical
analyses suggest that Cdc14 functions upstream of the CDK inhibitor CKI-1 and prevent
extra cell divisions during periods of cell quiescence by stabilizing CKI-1(Saito et al.,
2004).

Cdc14 homologs in Xenopus and Drosophila haven’t been studied in detail. The Xenopus
homologs of cell cycle regulator phosphatase include XCdc14α and XCdc14β and both
are closely related to human Cdc14A. XCdc14α/β are both localized to nucleoli and the
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centrosome in interphase, and concentrated at the mitotic centrosomes. XCdc14α/β
maybe required for normal cell division since injection of antibodies raised against
XCdc14α/β into Xenopus embryos blocks cell division (Kaiser et al., 2004). In addition, a
recent study suggested that XCdc14α potentially is also involved in regulating G2/M
transition through dephosphorylation of XCdc25 and abscission (Krasinska et al., 2007).
In the case of Drosophila, a recent overexpression screen revealed Cdc14’s possible role
in cytokinesis.

Human cells express two homologs of Cdc14, termed Cdc14A and Cdc14B that are both
functional homologs of yeast Cdc14 (Li et al., 1997b; Vazquez-Novelle et al., 2005a).
After more than a decade of research, however, the functions of these phosphatases in
cell cycle progression remain poorly understood. Although Cdc14A and Cdc14B share
about 50% sequence identity, they show two notable differences: Cdc14B has a unique
54 amino acid N terminal extension; Cdc14A and Cdc14B differ also in their C terminal
domains.

Until recently, most studies focused on Cdc14A. The Cdc14A gene is located on band
1p21 on chromosome 1 and consists of 16 exons spread over 170 kbp of DNA (Paulsen et
al., 2006). Cdc14A can rescue Cdc14 mutants in both S. cerevisiae and S. pombe
suggesting that human Cdc14A and yeast Cdc14s share some conserved functions (Li et
al., 1997c; Vazquez-Novelle et al., 2005b).

Human Cdc14A localizes dynamically to the interphase centrosomes while abscent from
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mitotic centrosomes suggesting a role for Cdc14A in centrosome cycle control. The
evidence for Cdc14A’s centrosomal function comes from the observation that
overexpression of Cdc14A resulted in premature centrosome splitting, while depletion of
Cdc14A using siRNA techniques led to a delay in centrosome separation (Kaiser et al.,
2002b; Mailand et al., 2002c). The physiological substrate(s) of Cdc14A in centrosome
cycle control hasn’t been identified; however, one of the potential candidates is Nek2
kinase. Overexpression of Nek2 kinase can also cause premature centrosome splitting
similar to that observed in cells with deregulated Cdc14A. Potentially, Cdc14A can
activate Nek2, which in turn promote centrosome splitting at mitotic entry (Kaiser et al.,
2002b).

Besides its centrosome function, Cdc14A is also suggested being involved in cytokinesis
regulation since during mitosis, it concentrates at the spindle midzone and the midbody
(Gruneberg et al., 2004; Kaiser et al., 2002b). In consistant with this, downregulation of
endogenous Cdc14A using siRNA prevented cells from undergoing cytokinesis (Mailand
et al., 2002c).

In addition, Cdc14A has been implicated in participating in other functions of cellular
regulations: Cdc14A was shown to dephosphorylate human APC cofactor Cdh1 and
activate APC/CCdh1. When activated, APC/CCdh1 in turn will promote ubiquitination of
mitotic cyclins, allowing the mitotic exit to happen (Bembenek and Yu, 2001); Also,
Cdc14 is capable of dephosphorylating the INCENP protein in vitro, suggesting its role in
the regulation of the translocation of chromosomal passenger proteins in mammals
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(Gruneberg et al., 2004); Moreover, Cdc14A was shown to interact with the tumor
suppressor p53 and dephosphorylate the Ser315 site of p53 which phosphorylated by
Cdk2/Cyclin-A and aurora kinase A, implying that Cdc14A may act as an
counterbalancing phosphatase for those kinases (Li et al., 2000; Paulsen et al., 2006);
Last but not the least, Cdc14A can also reverse Cdk1 phosphorylation of Cdc25A on
Serines 115 and 320, suggesting its role in the cell cyle regulation of Cdc25A stability
(Esteban V, 2006).

In contrast to Cdc14A, much less is known about the function of human Cdc14B.
Previous studies have shown that the localization pattern of Cdc14B differs greatly from
Cdc14A: During interphase, majority of Cdc14B localizes to nucleoli while a small
portion of it found at centrosomes; During mitosis, Cdc14B was found to localize
throughout the nucleous and cytoplasm and associate with the equator of central spindles
in anaphase and concentrated at the center of midbody during telophase and cytokinesis
(Cho et al., 2005b). The dramatic differences between their localization profiles suggest
that Cdc14A and Cdc14B perform different tasks in the cell.

Several Cdc14B related functions have been suggested: Our lab has previously
demonstrated that Cdc14B is a microtubule binding and bundling protein. Ectopic
expression of cytoplasmic Cdc14B leads to microtubule bundling and stabilization in
interphase cells, and impairs microtubule dynamics from microtubule organization
centers (Cho et al., 2005b). Intriguingly, this function of Cdc14B doesn’t rely on its
phosphatase acvitity.
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Cdc14B has also been implicated in the maintenance of nuclear architecture. More than
30 years the hypothetical nuclear matrix or karyoskeleton has been baffling the science
community. The proposed function of this filamentous structure within the nucleus is to
regulate nuclear structure and function. Nalepa et al showed in their studies that Cdc14B
phosphatase was tightly associated with the filamentous structure stretching from the
nucleolar periphery to nuclear envelope. This association was dependent on a bipartite
signal on Cdc14B that directed it to the intranuclear filaments. Therefore, Cdc14B may
serve as a marker of intrinsic nuclear scaffold and Cdc14B-labeled filaments may
represent a physiological relevant nuclear structure that is critical for the maitenance of
proper nuclear structure (Grzegorz Nalepa, 2004).

Another possible albeit controversial function of human Cdc14B is in the regulation of
mitotic exit. According to one study, Cdc14B but not its homolog Cdc14A provokes
mitotic exit by dephosphorylating Sirt2 which targets Sirt2 for degradation by the 26S
proteasome (Dryden et al., 2003a); However, another study showed both Cdc14B and
Cdc14A can dephosphorylate Sirt2 on serine 368, a site targeted by Cdk1 kinase. And
cellular proliferation is dependent on phosphorylation status of this particular site.
However, in this study, degradation of Sirt2 by the 26S proteasome in response to
Cdc14B overexpression wasn’t observed. The differences between these two studies may
due to different cell lines used (North and Verdin, 2007); More interestingly, a recent
study reached a completely opposite conclusion that Cdc14B is dispensable for mitotic
exit in human cells. In their study, Berdougo et al homozygously disrupted the Cdc14B
locus in human somatic cells. Surprisingly, Cdc14B null cells were viable and lacked
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defects in mitotic exit (Berdougo E, 2008). A possible explanation for this discrepancy is
that Cdc14B’s function in mitotic exit regulation may be partially complemented by
Cdc14A (Berdougo E, 2008).

In addition, Cdc14B was shown to regulate S phase entry or G1 length in an Skp2dependent manner (Rodier G, 2008). Skp2 is the p27Kip1 ubiquitin ligase receptor which
targets p27 for degradation. The activity of SCFSkp2 is regulated by the APC/CCdh1.
Cdc14B, but not Cdc14A, can dephosphorylate Skp2 on serine 64 and promote the
degradation of Skp2 by APC/CCdh1 at the M to G1 transition. Also, depletion of Cdc14B
stabilizes Skp2 in HeLa cells and accelerates the progression from mitosis to S phase,
implicating Cdc14B’s role in regulating G1 length (Rodier G, 2008).

Last but not least, a most recent study revealed a surprising role of Cdc14B in DNA
damage induced G2 checkpoint control (Fig 2.4). In this elegant study, Bassermann et al
demonstrated that a network of proteins regulating mitotic exit in budding yeast had been
conserved in human but rewired to serve a different purpose which is G2 checkpoint
control in response to DNA damage (De Wulf and Visintin, 2008). Majority of Cdc14B
protein is sequestered in the nucleolus during interphase. Upon DNA damage, Cdc14B
was shown to translocate to the nucleoplasm, where it physically interacted and activated
APC/CCdh1 by reversing the CDK-mediated phosphorylation of Cdh1 (Bassermann et al.,
2008). In turn, activated APC/CCdh1 promoted degradation of Plk1 which resulted in the
stablilization of Claspin, an activator of the DNA damage induced G2 checkpoint.
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Figure 2.4: The cell cycle and G2 DNA damage response in human Cells. DNA
damage during the cell cycle triggers the DNA-damage checkpoint and results in a
block of the cell cycle (right) at G2 via the inhibition of mitotic cyclin-dependent
kinase (Cdk1) activity. Bassermann et al. find a new regulatory pathway of the G2
DNA-damage checkpoint (shaded box) in which the phosphatase Cdc14B activates
the ubiquitin ligase anaphase-promoting complex or cyclosome (APC/CCdh1) to
degrade the Polo-like kinase 1 (Plk1) and arrest the cell cycle. Plk1 is required for
cell-cycle reentry as its kinase activity triggers inactivation (by the ubiquitin ligase
SCFβTrCP) of Cdk1 inhibitors such as Wee1 and Claspin, an adaptor protein required
by the kinase ATR to maintain Chk1 inhibition of Cdc25, an activator of Cdk1.
During the G2 cell-cycle arrest, APC/CCdh1 specifically degrades only Plk1 and not
other substrates such as Claspin due to the action of the deubiquitinating enzyme
Usp28. Upon DNA repair, Cdk1 is reactivated to allow cell-cycle progression from
G2 to mitosis. (Image courtesy of Peter De Wulf and Rosella Visintin, 2008)
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Although the functions of both human Cdc14B and Cdc14A phosphatases remain elusive,
expression profile analysis using microarray approaches revealed that alteration of
Cdc14A and Cdc14B expression were frequently observed in cancer cells, such as
prostate cancer, breast cancer, MCL, and acute myeloid leukemia (Ashida et al., 2004b;
Martinez et al., 2003b; Neben et al., 2005b; Yu et al., 2004a); Moreover, in response to
anti-cancer drugs, Cdc14B was found to be down regulated in several cancer cell lines (di
Pietro et al., 2003; Zhao et al., 2004); and low Cdc14B expression also correlated with
tumor grade and bad prognosis, suggesting that Cdc14B may act as a tumor suppressor in
certain tissues (Rodier G, 2008).
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Chapter 3

Cdc14B associates with centriole in a cell cycle
dependent manner

3.1 Introduction
Normally, centrosomes are tiny, single copy non-membranous organelles located
near the cell center – hence its name. In animal cells a typical centrosome consists of two
main structures: A pair of mircrotubule-based cylindrical structures known as centrioles,
which are surrounded by a fibrogranular matrix of protein aggregates termed pericentriolar material (PCM).

Besides their major roles in supporting the centrosome structure and centrosome
biogenesis, the two centrioles can also function as basal bodies for the assembly of cilia
and flagella protruding from the surface of most vertebrate cells (Basto et al., 2006). In
mammals, each centriole consists nine triplets of microtubules, which are arranged into a
cylindrical structure that spans ~200 nm in diameter and ~500 nm in length, with
additional filaments, fibers, and dense material attached to both the outside and inside of
the microtubular cylinder (Doxsey, 2001); (Beisson and Wright, 2003). In addition to its
major structural constituents: α-tubulin and β-tubulin, only a small number of proteins
have been found to localize to the centriole in mamamalian cells which include but not
limited to: centrin, ε-tubulin, centriolin, ninein, and poly (ADP-ribose) polymerase-3
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(PARP-3) (Augustin et al., 2003; Chang and Stearns, 2000; Mogensen et al., 2000; Ou et
al., 2002; Paoletti et al., 1996; Piel et al., 2000; Uzawa et al., 1995). In contrast, the PCM
harbors hundreds of proteins that perform many diverse functions: involvement in
multiple signaling pathways; regulation of different cellular processes; and of course its
well-established role as the primary microtubule-organizing center. Among these
proteins, γ-tubulin ring complexes (γ-TURCs) act as templates for nucleating
microtubules (Moritz et al., 1995); peri-centrin scaffolds appear to be in contact with γTURCs and needed for microtubule anchorage (Dictenberg et al., 1998); Other proteins
such as PCM-1 may be involved in microtubule anchoring via recruitment and assembly
of subsets of centrosomal proteins (Dammermann and Merdes, 2002).

Numerous centrosome-associated proteins have been discovered and their “centrosomal”
functions have been characterized. Many centrosomal proteins have been identified
through genetic analysis or through the production of autoimmune sera and subsequent
purification of centrosomal antibodies (Schatten, 2008). Also, the search for interacting
partners of known centrosomal proteins with techniques such as yeast two-hybrid
screenings, immunoprecipitation has expanded the list. Most recently, application of high
resolution and high sensitivity mass spectrometers in biological research has empowered
many groups to analyze protein composition of centrosomes in greater details (Andersen
et al., 2003). Albeit promising, proteomic analysis of isolated centrosomes relies a great
deal on the initial purification step that still constitutes a challenging goal. Even though
centrosomes are by no means the smallest organelles within the cells, the purification is
made difficult by: their low copy numbers; they make up only a small proportion of total
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cell protein; they are not membrane-bound therefore don’t have defined borders; and they
often associate tightly with both the cytoskeleton and other subcellular organelles,
notably the Golgi apparatus and the nucleus. The current centrosome isolation methods
can easily generate false-negatives by removing centrosomal components or falsepositives by including contaminants that are not centrosomal origin (Christopher J.
Wilkinson, 2004; Schatten, 2008). In addition, the centrosome structure is highly
dynamic in nature and undergoes dramatic structural alterations and compositional
changes during the cell cycle. This is reflected by the appearance and disappearance of
many centrosomal proteins at particular cell cycle stages. For example, at the G2/M
transition when the centrosome undergoes maturation, the γ-TURCs is enriched at
centrosomes while other proteins such as C-Nap1 will diminish at the onset of mitosis
(Fry et al., 1998; Zheng et al., 1995).

Some structural proteins constitute the centrosome core struture. These proteins remain
centrosomal bound even after treatment of the centrosome complex with microtubule
depolymerizing agents such as cold, nocodazole, colchicine derivatives, and others
(Schatten, 2008). Centrosome core proteins are permanently associated with the
centrosome structure regardless of changes of different cell cycle stages. In contrast,
other centrosomal proteins, mostly regulatory in nature, transiently associate with the
core centrosome structure during different cell cycle stages to perform cell cycle-specific
functions. These regulatory molecules typically use centrosome as a central docking
station or platform, further complicating the analysis of determining the number of
centrosome proteins (Schatten, 2008).
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Despite these difficulties, many centrosomal proteins have been reported and the number
of which varies depending on the methods applied. Mass spectroscopic analysis has
identified as many as 500 centrosomal proteins (Andersen et al., 2003) while a survey of
published literature suggests a more conservative number of around 100 proteins with
about 60 being present in the interphase centrosomes (Christopher J. Wilkinson, 2004).

Cdc14B has been shown to associate with distinctive cellular structures such as the
nucleolus, nuclear filament, centrosome, and the spindle midzone and midbody (Cho et
al., 2005b; Grzegorz Nalepa, 2004; Kaiser et al., 2002b; Mailand et al., 2002a), and to
undergo active nucleocytoplasmic translocation (Bembenek J, 2005). Yet, the functional
significance of Cdc14B in centrosome cycle regulation has never been explored. Before
further investigation of Cdc14B’s centrosomal function, a more detailed localization
study is needed to pinpoint where Cdc14B localizes with respect to centrioles/PCM and
whether the centrosomal localization pattern differ in each cell cycle stage.

3.2 Results
3.2.1 Cdc14B associates with centriole in a cell cycle dependent manner
First, we isolated a full-lengh Cdc14B cDNA (isofrom 1) from the marathon
human heart cDNA library (Clontech), fused it with an enhanced green fluorescent
protein (EGFP) tag at the C-terminus and subcloned the Cdc14BWT-EGFP construct into
the pBI-tet vector (Clontech). The expression of Cdc14BWT-EGFP is under the control of
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a doxycycline-regulatable promoter. We then co-transfected pBI-tet-Cdc14BWT-EGFP
plasmid together with the pBabe-puro (a kind gift from Dr. Gerald Evans) into U2OSTet-on
cells (Clontech) to establish stable clones with the selection of both G418 and puromycin.
The expression of Cdc14BWT-EGFP in these stable U2OStet-on stable clones can be turned
on by the addition of doxycycline (Dox, a tetracycline derivative) to the culture medium.
When induced, we found that Cdc14BWT-EGFP is frequently present at centrosomes as
judged by co-localization with γ-tubulin, a bona fide centrosome marker (Fig 3.1A). In
order to distinguish whether Cdc14BWT-EGFP localizes to centrioles or PCM, we studied
the co-localization of Cdc14BWT-EGFP with a mouse monoclonal Centrin-2 antibody
used as the centriole marker. Centrin-2 antibody marks the distal ends of both centrioles
and procentrioles and doesn’t stain on PCM. By immunofluorescence analysis, we found
that the Cdc14BWT-EGFP partially co-localized with Centrin-2 throughout the cell cycle
(Fig 3.1B), implying that Cdc14BWT-EGFP localizes to the centriole instead of PCM.
Also, we noted that the staining pattern of Cdc14BWT-EGFP differed in cells that
appeared to be at different stages of the cell cycle, suggesting the possibility that
Cdc14BWT-EGFP may differentially localize at either the mother or daughter centrioles.
To further explore this possibility, we focused on the cells that are in S phase of the cell
cycle when the daughter centriole can be easily distinguished from mother centriole by
the size of Centrin-2 dots. And we found that the majority of cells exhibited only one
strongly stained Cdc14BWT-EGFP dot at each centrosome. Superimposing Centrin-2 and
Cdc14BWT-EGFP signal further demonstrated that the Cdc14BWT-EGFP dot only
partially overlap with the stronger/bigger Centrin-2 dot (mother centriole) while there is
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Figure 3.1: A fraction of Cdc14BWT-EGFP associates with centrioles. (A)
Cdc14BWT-EGFP localizes to centrosomes, Cdc14BWT-EGFP (green) and γ-Tubulin
(Red). B) Overlay images illustrate partial colocalization of Cdc14BWT-EGFP (green)
with Centrin-2 (red) in U2OS cells during different stages of the cell cycle. Stages of
the cell cycle were determined by the Centrin-2-labeled centrioles as well as DAPIstained DNA (blue). Arrows indicate the Centrin-2 and Cdc14B-GFP labeled
centrioles. Magnified images of centrioles were shown in insets. We noticed that
Cdc14BWT-EGFP became diffused in mitotic cells and partially overlapped with DNA
which might be due to Cdc14BWT-EGFP overexpression. Bar, 5 µm.
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essentially no Cdc14BWT-EGFP signal associated with the weaker/smaller Centrin-2
staining (daughter centriole) (Fig 3.1B). In addition, during G2, prophase and metaphase,
Cdc14BWT-EGFP seemingly only partially associates with the “stronger/bigger ” Centrin2 staining within each centrosome indicating that Cdc14BWT-EGFP is preferentially
associated with the mother centriole during the S/G2 and early M phases of the cell cycle.

Since Cdc14BWT-EGFP and Centrin-2 staining only partially overlap with each other, we
used a second centriole marker anti-C-Nap1antibody that marks the proximal end of
centrioles (Mayor et al., 2000) to help potentially pinpoint where Cdc14BWT-EGFP
localizes on the centriole. As a result, we found that Cdc14BWT-EGFP also partially colocalized with C-Nap1 staining, confirming that Cdc14BWT-EGFP localizes to centrioles
instead of PCM (Fig 3.2). This observation also implicates that Cdc14BWT-EGFP
localized to the centriole somewhere between Centrin-2 and C-Nap1 staining and places
it somewhere in the middle of centriole. The observation that there was seemingly more
overlap or shorter distance between Cdc14BWT-EGFP and C-Nap1 staining compared to
Cdc14BWT-EGFP and Centrin-2 staining suggests the possibility that Cdc14BWT-EGFP
may localize more toward the proximal end of the centriole.

Also, the combination of immunostaining with both Centrin-2 and C-Nap1 antibodies can
help distinguish engaged versus disengaged centrioles based on the numerical ratio
between Centrin-2- and C-Nap1- marked centriole dots as illustrated in (Fig. 3.3). Each
engaged centriole pair has two Centrin-2 dots while only one C-Nap1 dot (2:1 ratio of
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Figure 3.2: Colocalization of Cdc14BWT-EGFP and C-Nap1. Partial colocalization
of Cdc14BWT-EGFP (green) with C-Nap1 (red) in U2OS cells. Schematics at the
bottoms show potential localization of Cdc14BWT-EGFP relative to C-Nap1 staining
which marks the proximal end of the centriole.
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Figure 3.3: Centrin-GFP vs C-Nap1 DsRed during cell cycle. Schematics of centriole cycle depicting how to
distinguish engaged centrioles (S, G2, early M) from disengaged centrioles (late M and early G1) based on the
localization pattern of Centrin-GFP and C-NAP1-DsRed, and numerical ratio between Centrin-GFP and C-NAP1DsRed dots.
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Centrin-2: C-Nap1); Disenganged centriole pair has one Centrin-2 dot and one C-Nap1
dot per centriole (1:1 ratio of Centrin-2: C-Nap1) (Tsou and Stearns, 2006a). Just like CNap1, during the S, G2 and early M phases of the cell cycle when the centriole pair is in
the engaged configuration, there is only one Cdc14BWT-EGFP dot at each centrosome,
and the numerical ratio between Centrin-2 staining and Cdc14BWT-EGFP is 2:1; While
during G1 and late M phases when the two centrioles within each centrosome are in
disengaged conformation, there are two Cdc14BWT-EGFP dots associated with each
centrosome, and the ratio between Centrin-2 focus and Cdc14BWT-EGFP is 1:1 (Fig 3.1).

To investigate whether a similar localization pattern on centrioles also exists for
endogenous human Cdc14B, we performed immunoflurorescence studies with three
different commercial available Cdc14B antibodies.

Although a rabbit anti-Cdc14B antibody from Sigma (Cho et al., 2005b) can specifically
recognize Cdc14B in western blots, and stains on distinctive cellular structures such as
the nucleolus, nuclear filament, the spindle midzone and midbody in agreement with
previous reports (Cho et al., 2005b; Grzegorz Nalepa, 2004; Kaiser et al., 2002b; Mailand
et al., 2002a), it failed to reveal the centriole-associated Cdc14B in our
immunoflurorecence studies. We believe the reason is that this antibody might react with
epitope(s) that were not exposed at centrioles under the fixation/extraction conditions
tested. In fact, Nalepa et al previous reported that the centrosomal Cdc14B only became
visible after 3 minutes with 0.5% Triton X-100 extraction prior to paraformaldehyde
fixation using another rabbit anti-Cdc14B antibody (Grzegorz Nalepa, 2004).
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Second, a mouse Cdc14B polyclonal antibody from Abnova was tested for
immunostaining. Surprisingly, in three different fixation conditions tested (3.7%
paraformaldehyde, 100% methanol or 0.5% glutaraldehyde), when using Centrin-2 as a
centriole marker, Abnova Cdc14B antibody stains exclusively on the centrioles while not
found on any other cellular structures as expected. Also, when this antibody was
subjected to western analysis, it fails to recognize endogenous Cdc14B and even
transfected exogenous Cdc14B (Data not shown). And when the specificity of this
antibody was tested in cells where Cdc14B is depleted using siRNA approach, Abnova
Cdc14B antibody still stains strongly on the centrioles in immunostaining (Data not
shown), suggesting that the mouse polyclonal Cdc14B antibody from Abnova may detect
another non-specific centrosomal component instead of Cdc14B. Therefore this antibody
was not used in later studies.

Finally, a chicken anti-Cdc14B antibody from Geneway was used. After pre-extraction
and methanol fixation of U2OS cells, immunofluorescence analysis revealed that this
Cdc14B antibody partially co-localized with both Centrin-2- and C-Nap1- labeled
centrioles in addition to nucleolus, nuclear filament, the spindle midzone, midbody and
intercellular bridge reported using Zymed Cdc14B antibody (Fig 3.5 & Fig 3.6). Also, the
staining pattern of Geneway Cdc14B antibody exactly matches Cdc14BWT-EGFP as we
have seen in Fig 3.1 and Fig 3.2. More importantly, when Cdc14B is depleted in the
HeLa cells, the corresponding centrosomal signal of this antibody is significantly
reduced, proving the specificity of this antibody for centriole-associated endogenous
Cdc14B (Chapter 4, Fig 4.3). We therefore used this antibody for all our
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Figure 3.4: A fraction of Cdc14B associates with centrioles. Overlay images depict
partial co-localization of endogenous Cdc14B (red) with centrin (green), a centriole
marker in U2OS cells during different stages of the cell cycle. Stages of the cell cycle
were determined by the centrin-labeled centrioles as well as DAPI-stained DNA
(blue). Arrowheads indicate centrin and Cdc14B-GFP labeled centrioles. Magnified
images of centrioles were shown in insets. Bar, 5 mm.
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Figure 3.5: Colocalization of endogenous Cdc14B and C-Nap1. Partial
colocalization of endogenous Cdc14B (Red) with C-Nap1 (Green) in U2OS cells.
Schematics at the bottoms show potential localization of endogenous Cdc14B relative
to C-Nap1 staining which situates at the proximal end of the centriole.

63

immunoflurorescence studies on endogenous Cdc14B.

To futher corroborate our observation that Cdc14B localizes to the centrosomes, we
independently evaluate the centrosome association of Cdc14B with purified centrosome
fractions from asynchronized HeLa cells by discontinuous sucrose gradient centrifugation
according to a published protocol (Moudjou, 1998 ). Proteins in each fraction were
resolved by SDS-PAGE and analyzed by Western blotting. At the expected 60% sucrose
density, fractions 14 to 17 contained the most abundant amounts of γ-tubulin. In parallel,
Cdc14B was highly enriched in those γ-tubulin containing centrosome fractions when
probed with Zymed Cdc14B antibody (Fig 3.7A). Moreover, when a purified centrosome
fraction (fraction 15) was subject to immunostaining, we found that Cdc14B (Geneway
Cdc14B antibody) but not nucleolin, a noncentrosomal protein, stained positive at the
purified centrosomes (Fig 3.7B).

Taken together, these data suggests that a fraction of both Cdc14BWT-EGFP and
endogenous Cdc14B specifically localize to the mother centrioles when the centriole pair
is in the engaged configuration; in contrast, when the two centrioles are disengaged or
disoriented, both Cdc14BWT-EGFP and endogenous Cdc14B associate with each of the
disoriented centrioles.
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Figure 3.6: Isolated centrosomes contain Cdc14B. Top panel: Cdc14B cofractionates with γ-tubulin. Lysates of asynchronized HeLa cells were fractionated on
a 50 to 70% sucrose gradient. Proteins from fractions 4 to 22 were analyzed by
western blot with γ-tubulin and Cdc14B antibodies. Bottom panel: Cdc14B but not
nucleolin (a non-centrosomal protein) co-stains with γ-tubulin on purified centrosomes
(fraction 15 of top panel).
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3.2.2 Cdc14B’s phosphatase activity is indispensable for targeting
Cdc14B to centrioles.
In yeast, Cdc14’s phosphatase activity is required in almost all its known
functions. Thus, it’s tempting to test whether catalytic activity is also required for
targeting human Cdc14B to centrosomes. In a previous study we generated a construct
harboring a phosphatase-dead mutant of Cdc14B by mutating the critical cysteine residue
within the active site to serine (C314S) and fused it with a C-terminal EGFP tag
(abbreviated as Cdc14BC314S-EGFP mutant). The expression of Cdc14BC314S-EGFP is
also under the control of a doxycycline-regulatable promoter in pBI-tet vector. To
establish stable clones we co-transfected pBI-tet-Cdc14BC314S-EGFP plasmid together
with the pBabe-puro (a kind gift from Dr. Gerald Evans) into U2OStet-on cells (Clontech)
and selected with both G418 and puromycin. In tested stable clones, upon treatment with
doxycycline, Cdc14BC314S-EGFP expression was induced, and its centrosomal
localization was assessed. As shown in Fig 3.8, majority of Cdc14BC314S-EGFP localized
in nuclei/nucleoli and was absent from the centrosomes in virtually all the interphase
cells examined. In contrast, wild-type Cdc14BWT-EGFP was found to associate with
centrosomes in about 75% of EGFP positive interphase cells.

Although these findings may suggest that catalytic activity is essential for Cdc14B
centrosomal localization, its perturbation may also disrupt shuttling of Cdc14B between
nucleoplasm and cytoplasm either directly or indirectly since >95% of the
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Figure 3.7: Cdc14B centrosomal retention requires Cdc14B phosphatase activity.
(A) Cdc14B-GFP fusion proteins were induced by DOX for 72 h in U2OSteton stable
cell lines carrying different Cdc14B-GFP constructs as indicated. Centrosomes were
visualized by γ-tubulin staining (red) and overlaid with Cdc14B-GFP (green) and
DAPI (blue). Cdc14BC314S-GFP was not detectable at interphase or mitotic
centrosomes (arrows). Insets represent magnified images of centrosomes. Bar, 5 mm.
(B) Histogram shows the percentage of interphase and mitotic cells with the indicated
Cdc14B-GFP at centrosomes 72 h after DOX addition. The interphase data represent
the means ±SD of three independent experiments and at least 500 cells were counted
in each experiment. The mitotic experiment was performed at triplicate and a total of
113 Cdc14BC314S-GFP- and 374 Cdc14BWT-GFP-positive cells were counted
respectively.
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Cdc14BC314S-EGFP mutant localized to the nucleolus. It is possible that mutation of a
critical residue at the active site may dramatically changed the Cdc14B protein’s
conformation, therefore potentially interfered with the NES (Nuclear export signal)
located at the C terminal part of the Cdc14B protein; or, hypothetically, the mutation
disrupted interaction of Cdc14B with other proteins which are required for shuttling
Cdc14B out of nucleus. Either way, as a consequence, it could indirectly prevent Cdc14B
from reaching centrosomes in interphase cells where the nuclear envelope is still intact.
To exclude this possibility, we studied the localization of Cdc14BC314S-EGFP at the
centrosomes of mitotic cells where the nuclear envelopes have disassembled. As shown
in Fig 3.8, no Cdc14B C314S-EGFP was found to associate with mitotic centrosomes (0%,
n = 113), whereas Cdc14BWT-EGFP associated with a majority (61%, n = 374) of mitotic
centrosomes examined. This finding suggests that the failure of Cdc14BC314S-EGFP
centrosomal retention is not due to the lack of nucleocytoplasmic shuttling activity and
thus supports the possibility that Cdc14B phosphatase activity is indispensable for its
centrosome localization.

Amino acids from 7 to 32 (7RRSSWAAAPPCSRRCSSTSPGVKKIR32) on Cdc14B
contain a potential bipartite nuclear localization sequence (K/R2-X10-20-K/R3; in
boldface type in the sequence above). We generated a mutant by changing three basic
residues at positions 29, 30, and 32 to alanines (Cdc14BKKIR29-32AAIA, abbreviated as
Cdc14BKKIR mutant) and subcloned it into pBI-tet vector and also established stable
clones. As expected, the nuclear localization of Cdc14B was abrogated with majority of
Cdc14BKKIR-EGFP mutant stayed in cytoplasm. All of the cytoplasmic Cdc14BKKIR69

EGFP protein appeared in rings or MT-like bundles and partially colocalized with MTs
(Cho et al., 2005b). When we studied the localization pattern of Cdc14BKKIR-EGFP with
respect to centrosome, we found in comparison with Cdc14BWT-EGFP, the percentage of
cells with centrosomal EGFP signal was significantly increased (Fig 3.8, t test; P <0.01).
In addition, we previously demonstrated that the cytoplasmic translocation/microtubule
bundling ability of Cdc14BC314S mutant was impaired but restored when the additional
KKIR mutation was introduced to the Cdc14BC314S mutant (KKIR29-32AAIA+C314S,
abbreviated as Cdc14BK& C) (Cho et al., 2005b). Surprisingly, introduction of KKIR
mutation also restored Cdc14BC314S localization to both interphase and mitotic
centrosomes (Fig 3.8). Because the lack of nuclear/cytoplasmic barrier in mitosis did not
help to restore Cdc14BC314S to centrosomes, this finding indicates that the additional
KKIR mutation not only helps Cdc14BC314S regain cytoplasmic translocation but may
also act as a gain-of-function mutant that facilitates Cdc14BC314S to re-associate with
centrosomes in a process that doesn’t rely on its catalytic activity.

3.3 Discussion
In mammals, two Cdc14 paralogs, Cdc14A and Cdc14 B have been identified (Li
et al., 1997b). Human Cdc14A dynamically localizes to centrosomes and may play a role
in centrosome separation and cytokinesis regulation (Bembenek and Yu, 2001; Kaiser et
al., 2002b; Mailand et al., 2002a). This is based on the observation that overexpression of
Cdc14A causes premature centrosome separation in early S-phase cells, and RNAimediated Cdc14A depletion leads to severe centrosome separation defect and thus
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cytokinesis failure. Genetic studies demonstrate that the Xenopus orthologs of human
Cdc14A, called XCdc14a and XCdc14b, are required for embryonic division and localize
to nucleoli and centrosomes (Kaiser et al., 2004). In contrast to Cdc14A, Cdc14B has not
been studied in detail. Unlike Cdc14A, centrosomal localization of human Cdc14B was a
bit controversial based on previous reports. Our lab first reported that a portion of wild
type C-terminal EGFP tagged Cdc14B co-localized with γ-tubulin to centrosomes (Cho et
al., 2005b). In contrast, Mailand et al showed that N-terminal Myc-tagged Cdc14B did
not co-localize with centrosomal markers tested (Li et al., 1997b; Mailand et al., 2002a).
And the reason for this discrepancy is possibly due to different isoforms of Cdc14B used.
In their study, the Cdc14B isoform-2 (accession number AF064104.1, abbreviated as
Cdc14B2) was used, however, in contrast, we used the isoform-1 of Cdc14B instead
(accession number AF023158.1, abbreviated as Cdc14B). In agreement with this, two
other reports also failed to detect Cdc14B2’s localization on centrosomes when they
fused it with GFP tag either at C-terminus or N-terminus (Kaiser et al., 2002b; Li et al.,
1997b). Indeed, in our hands, a wild type Cdc14B2 fused with C-terminal flag tag doesn’t
show any centrosomal signal either (Data not shown). Although the first 1-448 amino
acids of the two isoforms are identical, Cdc14B2 has a longer distinct C-terminus (aa
449-498) compared with Cdc14B (aa 449-459). The additional C-terminal tail may have
prevented Cdc14B2 from being recruited to the centrosomes. Using a polyclonal rabbit
anti-Cdc14B antibody, Nalepa et al documented that after preextraction with Triton X100 prior fixation, small amounts of endogenous Cdc14B could be visualized on
centrosomes (Grzegorz Nalepa, 2004). Since the endogenous rabbit anti-Cdc14B
antibody used was designed against 1-54 amino acids of Cdc14B and thus can recognize
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both isoforms. And the centrosomal signal might have come from endogenous Cdc14B
isoform 1 instead of Cdc14B2.

In order to reveal Cdc14B’s centrosomal functions, we first sought to study its
centrosome localization in more detail. Although previous studies showed a fraction of
both exogenous and endogenous Cdc14B associated with centrosomes, many questions
remain unanswered. These questions include but not limited to: where does Cdc14B
localize within centrosome, centriole or PCM? Is Cdc14B associated with centrosome in
a cell cycle dependent manner? Is Cdc14B’s phosphatase activity required for its
centrosomal association? In order to address these questions, we studied the localization
pattern of both Cdc14BWT-EGFP and endogeous Cdc14B in much more details. First we
used two centriole markers: Centrin-2 and C-Nap1 to study whether Cdc14B is a
centriole-associated protein. Both of these markers localized to the centriole with
Centrin-2 at the distal end and C-Nap1 at the proximal end. By co-immunostaing, our
analysis showed that Cdc14B, both exogenous and endogenous forms, partially colocalized with both Centrin-2 and C-Nap1 staining. Careful observation and comparison
further enabled us to propose that Cdc14B was sandwiched between Centrin-2 and CNap1 and seemingly closer to C-Nap1 in a cell cycle dependent manner (Fig 3.8). In
summary, we characterized Cdc14B as a centriole-associated protein and localized close
to the proximal end of mother centriole during S, G2 and early M phases and marked the
proximal part of both centrioles in late M and G1 phases. Even though the exact
localization of Cdc14B on centriole needs to be further investigated by triple-labeling or
Immuno-electromicroscopy experiments, our current co-immunostaining studies using
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Figure 3.8: Mapping of Cdc14B to centrioles. Hypothetical localization of Cdc14B (Yellow) on centriole. Centrin
(Green) marks the distal end and C-Nap1 (Red) marks the proximal end of centriol, PCM (Blue).
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both Centrin-2 and C-Nap1 as centriole markers suggested that Cdc14B may localize
very close to a structure called “cartwheel” (or “central tube” in C.elegans and
Drosophila) where the procentriole starts to assemble into a new centriole. The
cartwheel, a structure with a hub and nine radiating spokes, is proposed to be the
centriolar precursor and it is the first structure appearing in the centriole assembly.
Recently, several proteins such as SAS-6 have been identified as essential component of
the cartwheel and help to stabilize the 9-triplet structure. If Cdc14B is indeed localize to
or close to the cartwheel, it may raise the possibility that Cdc14B is involved in centriole
biogenesis by potentially regulating its centriole substrate(s) at the cartwheel. Thus,
during centriole duplication, Cdc14B will be at the right place to perform its job.

Also, based on our immunofluorescence studies, Cdc14B associates with engaged
mother, not engaged daughter, but with both disengaged mother and daughter centrioles
when they are in disengaged configuration. The reason for this is unknown. One
tantalizing possibility is that Cdc14B may keep the disengaged centrioles in check to
prevent overduplication or keep engaged centrioles tied together to prevent reduplication. Thus, it’s tempting to propose that Cdc14B may also be involved in
centriole-cohesion. According to a recent model, centriole engagment is proposed to be
the intrinsic block to re-duplication while centriole disengagment is a prerequisitive for
duplication (Tsou and Stearns, 2006c). Disengagment of centrioles happens at the onset
of anaphase and depends on the activity of seperase, a caspase-related protease. Separase
is best known for its requirement in promoting sister chromatid separation. The protease
cleaves a component of cohesin, the protein complex that holds sister chromatids
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together, thereby triggering chromosome segregation (D'Amours and Amon, 2004;
Nasmyth, 2002).

One possibility is that separase cuts one or more of its centriole-associated targets that
glue centrioles together. Alternatively, it may act indirectly by regulating the activity of
another enzyme (a kinase or phosphatase) that in turn triggers centriole disengagement
(Nigg, 2006). Recent evidence showed that when a splice variant of Shugoshin1 (sSgo1),
a protein that protects sister chromatids from separase activity during prophase, is
depleted in human cells, centriole–procentriole pairs disengage prematurely, suggesting
sSgo1 potentially could be a substrate for separase in centriole disengagement (Strnad
and Gˆnczy, 2008). In budding yeast, it’s been well known that Esp1/Separase is required
for Cdc14 release from the nucleolus as a component of the FEAR network and thus
Cdc14 acts in the downstream of Esp1/Separase in controlling mitotic exit. Therefore, it’s
tempting to further test whether Cdc14B or Cdc14A can be also acting in the downstream
of human separase in controlling centriole disengagment at the onset of anaphase. In line
with this, sSgo1 interacts with Plk1 and its centrosomal localization is Plk1 dependent.
Centriole disengagement triggered by sSgo1 depletion or expression of a dominant
negative mutant is suppressed by ectopic expression of sSgo1 or by RNAi based Plk1
knockdown (Wang et al., 2008). A most recent study, although in a different context,
identified the Cdc14B-Cdh1-Plk1 axis in controlling G2 DNA-damage checkpoint
implicating Plk1 may act at the downstream of Cdc14B (Bassermann et al., 2008).

Kaiser et al reported previously deletion of the first 54 amino acids resulted in Cdc14B2’s
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(Isoform-2, here referred to as Cdc14B2) localization to the cytoplasm and centrosomes
rather than nucleolus. This data suggested the first 54 amino acids of Cdc14B encode a
nucleolar localization signal (NLoS) targeting Cdc14B (both isoforms 1 and 2) to
nucleolus. This NLoS may be enough to inhibit Cdc14B2’s centrosomal localization by
restricting it to the nucleolus, however, may be inadequate to prevent Cdc14B’s (isoform
1) centrosomal retention. In general, sequences of Cdc14B can be primarily divided into
three regions, the N-terminal region (containing nucleolar targeting domain in Cdc14B),
the middle region (phosphatase domain) and the C-terminal region (Ser and Asn rich
region). Mutation of the basic amino acid residues of nuclear localization signal (NLS) at
the N-terminal region of Cdc14B facilitated, to some extent, microtubule bundling and
stabilizing activities of Cdc14B (Cho et al., 2005b). Structural analysis of Cdc14B
revealed a novel arrangement of two domains, designated as A- and B-domains in the
phosphatase domain, which are conserved within the Cdc14 family members (Gray et al.,
2003). The A-domain, which has no sequence similarity to other dual specificity
phosphatase, determines substrate specificity but does not possess phosphatase activity.
The B-domain, containing the conserved catalytic motifs of protein tyrosine phosphatases
(PTPs), has phosphatase activity. The C-terminal Ser/Asn rich region contains a nuclear
exit signal (NES) (Kaiser et al., 2002a; Mailand et al., 2002b). After establishing that
Cdc14B is a centriole-associated protein, although hasn’t been addressed in the current
study of ours, next logic step will be mapping domains of Cdc14B required for
centrosome association. Deletion mutants will enable us to determine centrosome binding
domain(s) and its (their) relationship with the phosphatase domains in Cdc14B. Once
centrosome binding domains of Cdc14B are resolved, site-directed mutagenesis to mutate
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specific amino acids of the domain and determine the specific amino acids required for
centrosome binding will be followed. Determination of Cdc14B centrosome binding
domains or motifs will also help us to understand or design experiments to Fig out how
Cdc14B centrosome localization is regulated during the cell cycle and thus its function in
centrosome cycle regulation.

In the current study, however, we sought to determine whether Cdc14B’s phosphatase
activity is required for its centrosomal association. The idea behind this is that in budding
yeast, almost all the Cdc14 related functions rely on its phosphatase activity. Our study
did show that a phosphatase-dead mutant of Cdc14B (Cdc14BC/S-EGFP) failed to localize
to both interphase and mitotic centrosomes indicating catalytic activity is indeed required
for Cdc14B’s loading onto centrosome. However, whether this mutation is within the
Cdc14B centrosomal localization signal is not known. The mutation could either directly
or indirectly inhibits Cdc14B association with centrosomes. By changing a critical
residue at the active site, the Cdc14B protein conformation might have undergone a
dramatic change that resulted in dissociation of Cdc14B either with centrosome or with
other proteins that can recruit Cdc14B to centrosomes.

3.4 Summay
In summary, we identified a fraction of both endogenous Cdc14B and Cdc14BWTEGFP asscociates with centrioles throughout the cell cycle. During cell cycles when two
centrioles are in engaged configuration (S, G2 and early M phase), Cdc14B seemingly
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only associates with mother centriole; in cell cycles when two centrioles are disengaged
(G1 and late M phase), Cdc14B assocatiates with both centrioles. Further, the association
of Cdc14B with centrioles requires an intact phosphatase activity.

3.4 Experimental Procedures
3.4.1 Cloning and site-directed mutagenesis
Cdc14B open reading frame (ORF) cDNA was amplified by PCR from the
Marathon human heart cDNA library (Clontech) using the following primers: forward, 5'ACTCCCGGGTCCATGAAGCGGAAAAGCGAGC-3'; and reverse, 5'AGTCCCGGGTTAACGCAAGACTGTTTTAGTCC-3'. The PCR product was digested
with SmaI endonuclease and cloned into the SnaBI site of pMX-pie vector (a kind gift
from Gerry Nolan) carrying an N-terminal 6-myc epitope tag. Sequencing analysis of the
resulting plasmid confirmed that the Cdc14B cDNA was identical to hCdc14B isoform-1
in GenBank (AF023158.1), except for a T-to-C transition at position 52 from the first
ATG. The inducible expression system of Cdc14B was generated by subcloning the Cterminal EGFP-tagged (enhanced green fluorescent protein) Cdc14B into pBI-tet vector
(Clontech). All of the Cdc14B mutants (C314S, KKIR29-32AAIA, and KKIR2932AAIA plus C314S) were generated by site-directed mutagenesis using the QuikChange
Site-Directed Mutagenesis kit (Stratagene) and verified by sequencing analysis.

3.4.2 Cell Culture, Transfection and Drug Treatment
U2OS (ATCC), U2OSTet-On (BD Biosciences) cells were cultured under 5% CO2
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at 37°C in high-glucose Dulbecco’s Modified Eagle’s medium (DMEM, Invitrogen),
10% fetal bovine serum (FBS), and antibiotics (100ug/ml penicillin and 50ug/ml
streptomycin sulfate). Cells were transfected with either FuGene 6 (Roche) or
Lipofectamine Plus (Invitrogen). To establish DOX-inducible Cdc14B-EGFP stable
clones, the pBI-tet-Cdc14BWT-EGFP, pBI-tet-Cdc14BKKIR-EGFP , pBI-tet-Cdc14BC314SEGFP , or pBI-tet-Cdc14BK&C-EGFP plasmids were co-transfected with pBabe-puro into
U2OSTet-On cells harboring endogenous Cdc14B. Stable clones were obtained after
selection with 500 μg/ml G418 and 2 μg/ml puromycin in the absence of DOX.
The DOX-inducible Cdc14B-EGFP stable clones were maintained in 100ug/ml of G418
(Invitrogen) and 2ug/ml of puromycin (Sigma-Aldrich). The expressions of Cdc14BWTEGFP, Cdc14BKKIR-EGFP, Cdc14BC314S-EGFP and Cdc14BK+C/S-EGFP were induced by
the addition of 4ug/ml of doxycyclin and cultured up to 96 h. To study the localization of
Cdc14BWT-EGFP and Cdc14BC314S-EGFP on mitotic centrosomes, U2OSTet-On cells were
treated with 0.2 ug/ml nocadazole (Sigma) for 18 h before fixation.

3.4.3 Antibodies and Immunofluorescence
Centrosome markers used include: γ-tubulin (GTU-88 [Monoclonal, SigmaAlrich] and C-20 [Polyclonal, Santa Cruz Biotechnology, Inc.]); Rabbit anti-Peri-centrin
polyclonal antibody (Abcam); Mouse anti-Centrin-2 monoclonal antibody (20H5; a gift
from J. Salisbury, Mayo Clinic Foundation, Rochester, MN); Mouse anti-C-Nap1
monoclonal antibody (BD Biosciences). Cdc14B antibodies: Rabbit anti-Cdc14B
polyclonal antibody (Zymed Laboratories, Inc.); Mouse anti-Cdc14B polyclonal antibody
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(Abnova); Chicken anti-Cdc14B polyclonal antibody (Geneway Biotech, Inc.).

For indirect immunofluorescence, cells were grown on glass coverslip and fixed with
either paraformaldehyde or cold 100% methanol. The cells were then permeabilized with
PBS/0.5% Triton X-100 for 10 min at room temperature followed by blocking with
PBS/1% BSA for 30 min. Centrosomes or centrioles were visualized by immunostaining
with antibodies against γ-tubulin, pericentrin, Centrin-2 or C-Nap1 antibodies. For
visualization of centriole-associated endogenous Cdc14B, cells were treated with or
without 10 μg/ml nocodazole (for better exposure of centrosome Cdc14B) for 2 h, briefly
extracted with 0.5% Triton X-100 on ice, fixed with cold 100% methanol, and
immunostained with chicken anti-Cdc14B antibody (GenWay Biotech, Inc.). In our
hands, methanol fixation preserved GFP signals and, thus, anti-GFP immunostaining was
not used to visualize Cdc14B-GFP fusion proteins in the fixed cells. Secondary
antibodies including Alexa Fluor 488 and 594 donkey anti-mouse and anti-goat and goat
anti-rabbit, and anti-chicken IgY antibodies were obtained from Invitrogen. DNA was
counterstained by DAPI. Cells were visualized with a 100 °- Plan Neofluar objective
(1.30 oil; /0.17; Carl Zeiss, Inc.) under an epifluorescence microscope (Axioskop 2; Carl
Zeiss Inc). Images were acquired with a charge-coupled device camera (AxioCam HRC;
Carl Zeiss, Inc.) controlled by Openlab software (version 3.5; PerkinElmer). For confocal
microscopy, images were captured with an HCX-PL/APO 63 X 1.32 oil objective (Leica)
under a SP2 laser scanning confocal microscope (Leica) equipped with confocal software
(LCS version 2.0; Leica). The coverslips were mounted using PermaFlour Mountant
media (Thermo Fisher Scientific) and imaging was performed at room temperature.
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Image processing was performed using Photoshop CS (8.0).

3.4.4 Centrosome fractionation experiments
Centrosomes were prepared from exponentially growing HeLa cells according to
a previously published procedure (Moudjou and Bornens, 1998). In brief, a total of 6x108
cells were treated with 1 μg/ml cytochalasin D and 2.2 μM nocodazole. Cells were lysed
in a buffer containing 1 M Hepes, pH 7.2, 0.5% NP-40, 0.5 mM MgCl 2, 0.1%
mercaptoethanol, and protease inhibitor cocktail (Roche) and centrifuged at 2,500 g. The
resulting supernatant was filtered, incubated with 2 U/ml DNase I, and loaded over a 60%
sucrose cushion for centrifugation at 10,000 g with a SW28 rotor (Beckman Coulter).
Concentrated centrosomes were centrifuged again over a discontinuous gradient
containing 70, 50, and 40% sucrose solutions at 75,000 g. A total of 32 fractions were
collected from the bottom of the tube. Each fraction was separated by SDS-PAGE.
Centrosome-enriched fractions were determined by immunoblotting with anti-γ-tubulin
antibody, and the presence of Cdc14B was judged by immunoblotting with anti-Cdc14B
antibody (Zymed Laboratories, Inc.). For immunofluorescence analysis of isolated
centrosomes, each 10 μl of fraction 15 was diluted into 4 ml of 10 mM Pipes buffer, pH
7.2, and transferred into a 38.5-ml ultracentrifuge tube (Beckman Coulter) with a
specially designed adaptor to fit to a 15-mm round coverslip. The samples were then
subjected to centrifugation at 20,000 g (10,000 rpm) for 20 min with a SW28 rotor
followed by fixation in methanol at 20 ° C for 10 min and immunostaining with
antibodies against Centrin (20H5; a gift from J. Salisbury, Mayo Clinic Foundation,
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Rochester, MN), Cdc14B (GenWay Biotech, Inc.), and nucleolin (4E2; Research
Diagnostics, Inc.), respectively. Finally, coverslips were placed in pure ethanol for 2 min
at room temperature, air-dried, and mounted with a drop of Permaflour (Thermo Fischer
Scientifi c) on a microscope slide. Images were captured as described in the preceding
paragraph.
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Chapter 4

Cdc14B phosphatase is a negative regulator for
centrosome duplication

4.1 Introduction
As the primary MTOC of animal cells, centrosomes play important role in all
microtubule related processes by controlling the number, polarity and distribution of
microtubules. These processes include cell polarity, shape, mobility, adhesion as well as
intercellular transport. More importantly, centrosomes are crucial for chromosome
segregation and cytokinesis during mitosis (Nigg, 2002). When the nuclear envelope
breaks down during mitosis, the two sister centrosomes will separate from each other and
relocate to each pole of the cell and start to nucleate astral arrays contributing most of the
microtubules to the formation of the bipolar spindle. Mitotic centrosomes, through these
microtubule arrays, determine spindle polarity, spindle position and spindle orientation
within the cell (Nigg, 2004).

In order to be ready to perform its normal function during mitosis, the single interphase
centrosome needs to be duplicated once, and only once. Although elementary in concept,
to make sure there are no errors occurring during the process of centrosome duplication
cell cycle after cell cycle is not as simple as it may appear. The centrosomes must
duplicate (exactly once), separate at the right time in relation to nuclear events in the cell
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cycle. Considering the multitude of critical cellular functions that depend on the correct
number of centrosomes, it’s not surprising that the numeral integrity of centrosomes is
tightly regulated and involves multiple mechanisms. Although our understanding of the
molecular mechanism behind this “once and only once” control is still incomplete, many
critical steps have been described: Some suggests an intrinsic mechanism in controlling
centrosome reproduction while others illustrated phosphorylation and ubiqutin-dependent
proteolysis are indispensible in centrosome number control.

The presence of two centrosomes at the onset of mitosis is crucial for the formation of a
bipolar spindle. Extra copies, a condition called centrosome amplification, frequently
leads to the formation of multipolar spindle, an aberrant mitotic spindle with more than
two spindle poles. This in turn can lead to unequal distribution of chromosomes during
mitosis and genomic instability, which is regarded as a major driving force in multi-step
carcinogenesis (Nigg, 2004).

4.1.1 The Events of Centrosome Reproduction
Except in some specialized cell types and unusual conditions in which
centrosomes can form de novo, the typical centrosome duplication pathway requires a
pre-existing centrosome. The classical centrosome duplication cycle can be divided into
several consecutive steps: In M phase, one centrosome consists of two centrioles is
present at each spindle pole; at the end of mitosis and early G1, the two centrioles lose
their orthogonal configuration and become “disengaged”, according to recent
publications, constitutes a necessary “licensing” step for centrosome duplication in the
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next cell cycle. After disengagement, the two centrioles are still loosely connected by
cohesion fibers during G1 phase; at the G1/S transition when the activity of Cdk2/CyclinE starts to rise centrosome duplication is initiated along with DNA replication.
Procentrioles start to grow orthogonally from the proximity of each pre-existing maternal
centrioles and continue to elongate throughout S and G2 phase; in early mitosis the
connecting fiber between two newly formed centrosomes is severed and each centrosome
will migrate toward the cellular pole and participates in mitotic spindle pole formation
(Tsou and Stearns, 2006b).

Procentriole assembly normally initiates around the time of the transition between the G1
and S phases of the cell cycle when the activation of the Cdk2/Cyclin-E complex also
starts. Thus, it is possible that the centriolar components triggering the onset of
procentriole assembly are regulated by the rise in Cdk2/Cyclin-E activity. In agreement
with this idea, the first “licensing” model proposed for centrosome duplication by Okuda,
M. et al in 2000 involved a nucleolar phosphoprotein B23 (also called NPM1,
Nucleophosmin or NO38). In this model, B23 was identified as one of the targets of
Cdk2/Cyclin-E kinase and could be specifically phosphorylated at the Thr199 postion.
This site-specific phosphorylation is important for the initiation of centrosome
duplication but not DNA replication(Tsou and Stearns, 2006a). The unphosphorylated
form of B23 is present in the loose connection between the two centrioles in cells in the
G1 phase of the cell cycle. Upon phosphorylation by the Cdk2/Cyclin-E complex, B23
dissociates from the centrosome, triggering procentriole assembly (Tokuyama et al.,
2001)y. Toward the end of mitosis, B23 loses its Thr199 phosphorylation due to some
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unknown phosphatase and re-associates with the centrosome. Expression of a nonphosphorlatable mutant of B23 (T199A, Thr199 change to Ala, could not be
phosphorylated by Cdk2/Cyclin-E) blocked centrosome reproduction (Tokuyama et al.,
2001). The B23T199A mutant remained at the centrosomes, likely accounting for its
dominant negative characteristics. In addition, microinjection of anti-B23 monoclonal
antibody, which sterically blocked phosphorylation of B23 by Cdk2/Cyclin-E also
inhibited the duplication of centrosomes (Tokuyama et al., 2001). It is also worth
mentioning that the Cdk2/Cyclin-A complex phosphorylates Thr199 of B23 at a similar
efficency with Cdk2/Cyclin-E, and possibly be responsible for preventing re-association
of any cytoplasmic B23 to centrosomes during S and G2 phases, continuing to support
centrosome duplication (Tokuyama et al., 2001). Thus, phosphorylation of B23 by
Cdk2/Cyclin-E/A is part of the molecular machinery that may license centrosome
duplication. Consistant with this, Wang et al. further demonstrated that the centrosomal
loading of B23 was dependent on the Ran/Crm1 complex, a nuclear-cytoplasmic shuttle
system that, when inhibited, resulted in supernumanary centrosomes, similar to the
phenotype caused by B23 depletion by RNAi (Wang et al., 2005). Based on the fndings
made to date, a model for the role of Cdk2/Cyclin-E/A and B23 in the regulation of the
centrosome duplication cycle can be summarized as follow (Fig 4.1): During G1 phase,
upon phosphorylation by Cdk2/Cyclin-E, Centrosome-bound B23 dissapears from
centrosomes (either through dissociation or degradation), which in turn triggers initiation
of centrosome duplication; During S and G2 phases, any residual B23 present in the
cytoplasm are prevented from re-association with centrosomes potentially
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Figure 4.1: Centrosome duplication cycle. The central panel shows the centrosome
duplication–segregation cycle. Each centrosome is shown as a red circle; G1, S, G2
and M are stages of the cell-division cycle. The arrangements of the centrioles at
different stages of the cell cycle are shown in the insets. Centrioles are the orange and
yellow cylinders; the pericentriolar protein matrix that surrounds them is green; a
putative tether connecting parental centrioles is shown as a black dotted line; and the
protein structure ('glue') presumed to be responsible for centriole engagement is red.
Only disengaged centrioles are competent for duplication, whereas engagement
prevents a second duplication. This 'licensing' mechanism thus ensures that centrioles
are duplicated only once in every cell cycle. Tsou and Stearns show that the enzyme
separase is essential for disengagement of the centrioles. But it is not known whether
separase acts directly on the glue proteins itself, or whether it activates some other
factor that then divides the centrioles. (Image courtesy of Erich A. Nigg, 2007)
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through the activity of Cdk2/Cyclin-A; During late mitosis, B23 re-associates with
centrosomes, hence each daughter cell receives one centrosome bound by B23 upon
cytokinesis (Masaru, 2002). Albeit interesting, this model fails to explain why
centrosomes do not readily re-duplicate during late S, G2 and early mitosis when B23 is
not present at centrosome, suggesting Cdk2/Cyclin-E/A-B23 pathway may not be the sole
licensing factor for centrosome duplication.

The concepts of a ‘license’ step for centrosome duplication and a “block” to reduplication within the same cell cycle in part draw from extensive studies of DNA
replication. During DNA replication, it’s been generally accepted that the licensing step
is the loading of MCM helicases onto DNA to help unwrap the DNA duplex for
replication. And once the DNA duplex is unwound and primed, the licensing factors are
no longer required (Blow and Dutta, 2005). Also, the “block” to re-duplication in the
context of DNA replication is intrinsic to the double helix itself, which is not accessible
for another round of replication without a second licensing event in next cell cycle. By
analogy to DNA replication, a centrosome-intrinsic block to re-duplication has been
proposed (Tsou and Stearns, 2006c). Strong evidence for such a block comes from cell
fusion experiments. When a cell in the G1 phase was fused with a cell in the G2 phase,
the G1 cell cycle status became dominant and drove the fusion cell into S phase instead
of mitosis. During this S phase, a new procentriole assembled next to each centriole
coming from the G1 cell, but not next to those originating from the G2 cell (Strnad and
Gˆnczy, 2008). It has been suggested that the centrosome-intrinsic block to re-duplication
is maintained by the tight association between each daughter-mother centriole pair. This
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tight association or centriole “engagement” configuration is established during centriole
duplication in S phase and continues till “disengagement’ in late M-phase and early G1
that renders mother and daughter centrioles loosely tethered to one another (Nigg, 2006).
Evidence of recent elegant work strongly supports the notion that engaged centrioles
prevent centriole re-duplication during S and G2 phases whereas disengaged centrioles
are prerequisite for the growth of new centrioles from the mature centriole templates
(Nigg, 2006; Tsou and Stearns, 2006c; Wong and Stearns, 2003). Also, centriole
disengagement at the end of mitosis seemingly requires the activity of separase, a
caspase-related protease best known for its requirement in promoting sister chromatid
separation by cleavage of cohesion at anaphase (Tsou and Stearns, 2006c). Depletion of
separase prevented centriole disengagement from happening in the late anaphase. In
supporting this idea, a study by Thein et al have recently demonstrated that depletion of
the microtubule and kinetochore protein astrin resulted in premature sister chromatid
separation as well as centriole disengagement which is consistent with untimely separase
activation. Supporting this idea, astrin-depleted cells contain active separase, and
separase depletion suppresses the premature sister chromatid separation and centriole
disengagement in these cells (Thein et al., 2007). Conversely, when a splice variant of
Shugoshin1 (sSgo1), a protein that protects sister chromatids from separase activity
during prophase, is depleted in human cells, centriole-procentriole pairs disengage
prematurely (Tsang and Dynlacht, 2008). Taken together, these findings suggest that,
during mitosis, separase cleaves a substrate, which might be sSgo1, and that this cleavage
results in disengagement of the centriole-procentriole, thus licensing each of them for
another round of procentriole formation during the subsequent cell cycle.
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4.1.2 RNA interference
RNA Interference (RNAi) is among the most important technological
breakthroughs in modern biology, revolutionizing the way that researchers study gene
function. As a novel biological pathway, RNAi has had significant impact on the ease,
speed, and specificity with which the loss of function of specific genes can be directly
studied in mammalian systems.

Overexpression has been used extensively to study the function of a particular gene.
However, oftentimes the phenotypes due to overexpression don’t respresent the real
function of the gene of interest. Loss of function studies can be performed using
dominant negative constructs because when overexpressing these mutants, the
endogenous function of genes can be blocked. However not all the protein has a
dominant negative mutant and results may sometimes be hard to interpret. Another
method to study loss of function of genes is to generate knockout mice. While proved to
be the ultimate way of dissecting a gene’s function, this method is extremely labor
intensive, expensive, time consuming as well as may result in an embryonic lethal
phenotype. Other nucleic acid-based silencing technologies such as oligonucleotide and
ribozymes also have been used, yet these may not work for all targets.

Historically, RNAi has been around for a little less than 20 years. It was in the early
1990s when for the first time RNA was found to be able to inhibit protein expression in
plants and fungi. This phenomenon was referred to as “posttranscriptional gene
silencing” and “quelling” at that time because it was not fully understood how it worked.
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It was not until 1998 when Fire and Mellow discovered that when C.elegans was fed with
double-stranded RNA (dsRNA), the protein expression was inhibited in a sequencespecific manner, thus the term “RNA interference” was coined. Fire and Mellow won the
2006 Nobel Prize in Physiology or Medicine for their discovery of RNA interference.

Since its discovery in C.elegans the use of long dsRNAs (>400bp) has been successful in
inhibiting protein expression in many organisms including Drosophila (Misquitta L,
1999), zebrafish (Wargelius et al., 1999), Planaria (Sánchez Alvarado A, 1999) and
numerous plants (Fukusaki et al., 2004; Jensen et al., 2004; Jørgensen F, 1990). However,
dsRNA was limited to lower organisms because delivering long dsRNA to mammalian
cells can trigger endogenous nonspecific antiviral responses that target longer dsRNAs
for degradation. Further studies demonstrated that small interfering RNA strands (siRNA)
are keys to the RNAi process in mammalian cells. siRNA molecule is typically 21
nucleotides in length, processed internally by an enzyme called “Dicer”. Subsequently in
2001, it was discovered that delivery of siRNA to mammalian cells avoided nonspecific
effects and thus could directly trigger RNAi.

Today we have a much better understanding of entire RNAi pathway. Now we define
RNAi (RNA interference) as a process during which a target protein expression can be
inhibited by specifically targeting its mRNA for degradation. RNA interference involves
multiple steps: The RNAi pathway is initiated by an RNase III family member enzyme
dicer, which chops long dsRNA molecules into short fragments of 20–25 base pairs
(Agrawal et al., 2003; Bernstein et al., 2001; Elbashir et al., 2001). One of the two strands
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of each fragment, known as the guide strand, is then incorporated into the RNAi targeting
complex known as RISC (RNA-induced silencing complex) and pairs with
complementary mRNA sequences to induce cleavage of the target mRNA molecule by
argonaute, the catalytic component of the RISC complex (Bernstein et al., 2001). The
target mRNA is cleaved in the center of the region complementary to the siRNA, and
broken down into smaller pieces that can no longer be translated into protein (Elbashir et
al., 2001).

Besides siRNAs, it has been demonstrated that a small hairpin RNA or short hairpin
RNA (shRNA) can be as efficient as siRNAs in inducing RNA interference. (Barton GM,
2002; Brummelkamp et al., 2002; Yu JY, 2002). shRNA is a sequence of RNA that bears
a fold-back, stem-loop structure of approximately 19 perfectly matched nucleotides
connected by various spacer regions and ending in a 2-nucleotide 3′-overhang. shRNA
can be introduced into cells using a vector with a polIII promoter to ensure that the
shRNA is consitutively expressed. Once inside the cells, shRNA hairpin structure can be
cleaved and integrated into the RISC complex in the same way as the normal siRNA does.

4.2 Results
4.2.1 Ablation of Cdc14B leads to centriole amplification in HeLa cells
To determine whether Cdc14B plays a role in centrosome cycle regulation, we
first performed loss-of-function experiments. In this regard, we took three different RNAi
approaches to knockdown endogenous Cdc14B.
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Short siRNA molecules can be prepared either by direct chemical synthesis of two
unmodified 21-oligonucleotide molecules annealed together, or by transcription driven by
RNA polymerase promoters. The direct transfection of chemically synthesized siRNA
duplexes into cells, originally demonstrated by Tuschl Lab in Rockefeller University's, is
currently the most popular approach. However, the success of this technique is heavily
dependent on the ability of the model cell system to undergo transfection and to sustain
the RNAi effect. Also, the transient presence of siRNA in the cell renders this technique
less feasible for long-term studies. Vector-based siRNA technology, in contrast, involves
cloning a small DNA insert of about 70 bp into a commercially available or custom-made
vector. This vector can be transfected into the cell, where the DNA insert expresses a
short hairpin RNA to specifically target your mRNA of interest for degradation.

As a first approach, we used a vector-based RNAi approach to knockdown endogenous
Cdc14B. In search of the optimal siRNA target sequence to deplete the endogenous
Cdc14B, we have tested as many as 17 different oligos and finally we found that an oligo
corresponding to nucleotide position 1234-1254 relative to the Cdc14B start codon was
most effective in ablating endogenous Cdc14B expression in HeLa cells (designated as
Cdc14B1234 siRNA). We cloned this siRNA oligo into pSuperior-neo-GFP vector
purchased from Oligoengine whose expression is driven by the H1 promoter. With
pSuperior vectors, expression of Cdc14B1234 siRNA is repressed in the absence of
tetracycline and induced when tetracycline is added to the culture medium. This is due to
the prescence of a TetO2 (tetracycline operator 2) site serving as the binding site for two
molecules of the Tet repressor. In the absence of tetracycline, the Tet repressor forms a
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homo-dimer that binds with extremely high affinity to the TetO2 sequence (Hillen and
Berens, 1994). This in turn represses transcription of the RNA hairpin precursor of
Cdc14B1234 siRNA. Upon addition, tetracycline binds with high affinity to the Tet
repressor homodimer in a 1:1 stoichiometry and causes a conformational change in the
repressor that renders it unable to bind to the Tet operator. The Tet repressor tetracycline
complex then dissociates from the Tet operator and allows transcription of the RNA
hairpin precursor of the Cdc14B1234 siRNA duplex. After successful cloning, the
resulting plasmid was transfected into TREx-HeLa cells that already has stably
incorporated a construct expressing Tet-repressor. Transfected TREx-HeLa cells were
selected under both G418 and blasticidin to obtain Cdc14B knockdown stable clones.
After several weeks’ selection, several clones were obtained. The levels of siRNA
expression and gene knockdown will typically vary widely among cells. Therefore, we
first try to validate with these stable clones whether expression of endogenous Cdc14B
can be successfully knocked down or not when induced with tetracycline. Western blot
analysis showed a reduction of endogenous Cdc14B expression at the protein level in
those two clones (clones #2 and #3) in the presence of tetracycline while in stable clone
#1, there is no suppression of Cdc14B protein expression as shown in Fig 4.2A. Also, the
same siRNA plasmid could also knockdown exogenous Cdc14B-EGFP expression in
U2OSTeton cells confirming target specificity of the Cdc14B1234 siRNA (Fig 4.2A).
Moreover, immunostaining with the anti-Cdc14B antibody revealed that centrosomal
Cdc14B expression was greatly reduced in Cdc14B1234siRNA stable clone #3 cells (Fig
4.3A).
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Figure 4.2: Depletion of Cdc14B leads to centriole amplification in HeLa cells.
(A) Western blot analysis using anti-Cdc14B antibody showed Cdc14B knockdown in
TREx-HeLa Cdc14BsiRNA clones #2 and #3, but not in TREx HeLa and clone #1.
The same Cdc14BsiRNA also led to Cdc14B-GFP knockdown in U2OSteton cells
visualized by immunoblot with anti-GFP antibody. β-actin was used as a loading
control. (B) Images of supernumerary centrioles. Centrioles were visualized by anticentrin antibody and DNA by DAPI (not shown). Insets, magnified images of
centrioles. Bar, 4 μm. (C) Percentage of cells with > 4 centrioles was calculated from
the experiments shown in A and B (left panel). Note that the data shown here does not
include polyploid cells with >4 centrioles described in Fig. S3A. (D) Top panel:
Immunoblot shows the level of endogenous Cdc14B and Cdc14A in HeLa cells
transfected with siGLO control oligos (lane 1), Dharmacon SMARTpool
Cdc14BsiRNAs (lane 2), pSuper empty vector (lane 3) and pSuper-Cdc14BshRNAE9 (lane 4). Bottom panel: HeLa cells were transfected with the corresponding oligos
and vectors as in top panel. Percentages of cells with > 4 centrioles were calculated
from experiments shown in B (middle and right panels). All the data are presented as
the means + SD of three independent experiments. At least 300 cells were counted in
each experiment. Note that the indicated fold changes in A and D (top panel) were
calculated based on the densitometric values of each lane normalized against the βactin loading controls.
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Fig 4.3: Specificity of Chicken anti-Cdc14B antibody and centrosome
amplification in Cdc14B knockdown cells using γ-tubulin as a centrosome
marker. (A) Reduction of centriole Cdc14B expression by siRNA. TREx-HeLa and
TREx-HeLa Cdc14BsiRNA stable clone No. 3 were briefly extracted with 0.5%
Triton X-100, fixed in 100% cold methanol, and stained with chicken anti-Cdc14B
and -Centrin-2 antibodies. Note that the extent of centriole Cdc14B knockdown varied
in each TREx-HeLa Cdc14BsiRNA cell. Insets show magnified images of centrioles.
Arrows indicate reduction of centriole Cdc14B expression and centriole amplification.
Bar, 5 µm. (B) Depletion of Cdc14B leads to centrosome amplification. Percentage of
cells with more than two centrosomes was calculated upon immunostaining with antiγ-tubulin antibody in TREx-HeLa or TREx-HeLa-Cdc14BsiRNA stable lines (clones
No. 1, 2, and 3). Data shown represent the means ± SD of three independent
experiments. At least 300 cells were counted in each experiment.
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Careful examination of those clones with successful Cdc14B knockdown revealed a
centriole amplification phenotype (Fig 4.2B [Left panel] & C). In comparison with the
parental TREx-HeLa and clone #1 which did not exhibit any reduction of Cdc14B
expression (Fig. 4.3A), clones #2 and #3 showed 2 to 3-fold increases in the number of
cells with > 4 centrioles (Fig. 4.2B [Left panel]& C and Fig 4.3A) judged by
immunostaining with anti-centrin antibody. The centriole number usually ranged from 5
to 20 with the majority around 6-8 centrioles per cell. Similar results were obtained when
γ-tubulin was used as a centrosome marker (Fig 4.3B).

Ideally, siRNAs would be absolutely specific, regulating only the target gene of interest.
However, a growing body of evidence suggests that this is not necessarily the case.
Non-specific effects can be induced by siRNAs, both at the level of mRNA and protein
(Jackson and Linsley, 2004). Therefore, to ascertain the specificity of Cdc14B
knockdown phenotype and exclude the possibility of off-target effects of Cdc14B1234
siRNA, we tested a second small hairpin RNA duplex (989-1017, relative to Cdc14B
start codon, designated as pSuper-Cdc14BshRNA-E9). After sub-cloning it into the
pSuper-neo-GFP vector (OligoEngine), Stable transfectants pool were obtained by cotransfection with pBabe-puro vector into HeLa cells followed by selection with both
G418 and puromycin up to a month. Compared with pSuperior-neo-GFP vector, pSuperneo-GFP doesn’t have binding sites for Tet repressor. Therefore, expression of pSuperCdc14BshRNA-E9 is not Tet regulatable. Western blot analysis confirmed that
endogenous Cdc14B protein level was significantly reduced in these pooled HeLa stable
transfectants constitutively expressing pSuper-Cdc14BshRNA-E9 (Fig 4.2D [Lanes 3
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&4]).). As a control, when the same membrane was probed for Cdc14A, a paralog of
Cdc14B in mammalian cells, the protein level of Cdc14A was almost the same across all
the samples (Fig 4.2D [Lanes 3 &4]).). More importantly, knockdown of Cdc14B by this
shRNA also led to a significant accumulation of cells with > 4 centrioles in these cells
compared with the control HeLa stable pool with pSuper-neo-GFP vector backbone and
pBabe-puro transfected (Fig 4.2B [Right panel] and Fig 4.2D [Lower panel 3 &4]).

In the third approach, we transiently transfected an in vito synthesized Cdc14B siRNA
oligo pool (Dharmacon Smartpool containing four different Cdc14B siRNA oligos) each
targeting different regions of Cdc14B coding sequences. As a nonspecific control, we
used the siGLO control oligo (Dharmacon) that are designed in a way that no particular
genes are targeted. Here, we are trying to exclude the possibility that the centrosome
amplification phenotype observed in the two previous cases were due to stable clone
selections. Also, a third siRNA approach will further confirm the specificity of knocking
down endogenous Cdc14B. Transfection of Cdc14B smartpool, but not the siGLO
control, resulted in a dramatic reduction of Cdc14B protein levels in HeLa cells as was
revealed by western blot analysis (Fig 4.2D [Lanes 1 &2]). Also, probing the same
membrane with anti-Cdc14A antibody showed the expression of Cdc14A was intact (Fig
4.2D [Lanes 1 &2]). Again, knockdown of Cdc14B by the Dharmacon siRNA pool
resulted in a significant accumulation of cells with more than four centrioles (Fig 4.2B
[Middle panel] and Fig 4.2D [Lower panel 1 &2]).

101

4.2.3 Ablation of Cdc14B leads to centriole amplification in normal
human fibroblasts
Although HeLa cells have been widely used for centrosome studies, it is a cancer
cell line which p53 pathway is frequently disrupted. HeLa is a transformed human
epithelioid carcinoma cell line (CCL-2, ATCC). Although HeLa cells do not exhibit
mutations in the p53 gene itself, they continuously express the E6 protein from human
papillomavirus type 18 that targets the p53 tumor suppressor for degradation by the
proteasome pathway. Therefore, in HeLa cells, the p53 protein level was reported to be
low. Centrosome amplification phenotype is often found within cancer cells that don’t
have a functional p53 pathway. This is either due to direct loss of p53 function in
centrosome cycle control or indirectly through absence of a p53-dependent checkpoint in
the elimination of cells that arise from aborted divisions (Andreassen et al., 2001; Borel F,
2002; Meraldi P, 2002; Nigg, 2002). Indeed, in the control HeLa cells without Cdc14B
knockdown, we did observe a small but significant percentage of cells harboring more
than four centrioles. Thus, in order to study whether Cdc14B is involved in centrosome
duplication in a normal situation, we used normal human diploid fibroblast BJ and MRC5 cells. We transiently transfected both BJ and MRC-5 cells with the Dharmacon
Cdc14BsiRNA smartpool to specifically knock down endogenous expression of Cdc14B
in these cells. As a result shown in Fig. 4.4, the centriole amplification phenotype was
faithfully reproduced in these normal fibroblast cells depleted of Cdc14B. These results
demonstrate that depletion of Cdc14B leads to centrosome amplification in both normal
and transformed cells.
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Figure 4.4: Depletion of Cdc14B causes centriole amplification in normal human
fibroblast cells. (A) Representative confocal images of BJ and MRC-5 cells with
clustered supernumerary centrioles are shown. Centrioles were labeled by anti-centrin
antibody. Insets, magnified images of centrioles. Bar, 10 mm. (B) Percentage of cells
with > 4 centrioles was calculated from the experiments shown in A. siGLO, control
oligo; SMARTpool, Dharmacon SMARTpool Cdc14BsiRNAs. Data shown represent
the means + SD of three independent experiments. At least 300 cells were counted in
each experiment.
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4.2.4 Overexpression of Cdc14BWT-EGFP leads to gradual loss of
centrosomes
Our siRNA based loss-of-function experiments in both HeLa and normal human
fibroblasts BJ and MRC5 cells have suggested Cdc14B’s potential role in the negative
regulation centrosome duplication. If this is true, we will be expecting a reduction in the
number of centrioles as cells pass through successive cell cycles when excessive Cdc14B
protein is present. To test this possibility, U2OS cells were transiently transfected with
Cdc14BWT-EGFP construct and centriole numbers were examined at 24h, 48h and 72h
time points. We focused our analysis on mitotic population of the EGFP positive cells. To
analyze centriole numbers, fixed cells were immunostained with an antibody against
Centrin-2. Counting the number of centrioles revealed that virtually all mock transfected
cells showed the expected number of centrioles, four, two at each pole, regardless of the
length of incubation time (Data not shown). By contrast, examination of the Cdc14BWTEGFP positive mitotic cells revealed a progressive reduction in centriole numbers (Fig
4.5): After 24h transfection, the vast majority of all mitotic cells still appeared to form
bipolar spindles haboring 4 centrioles (64 out of 100, Fig 4.5); after 48 h, however, many
cells with only two or one centrioles were observed (27 and 25 out of 100, Fig 4.5);
surprisingly, after 72 h of transfection, majority of mitotic cells observed only had one or
no centriole (72 out of 100, Fig 4.5), and these cells appeared to be very small and
seemingly was in the process of dying.
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Figure 4.5: Stepwise loss of centrioles in cells with overexpressed Cdc14BWTEGFP. U2OS cells were transiently transfected with Cdc14BWT-EGFP and incubated
for indicated times. Cells were then fixed for immunostaining with anti-Centrin-2
antibody. Cenriole numbers were counted for mitotic cells and divided into four
groups: 4 centrioles (Blue), 3 centrioles (Red), 2 centrioles (Yellow) and 1 centriole
(Green). Percentage of each group were calculated and plotted accordingly in the
column. Totally 100 mitotic cells were counted for each indicated transfection time.
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Taken together, the above results demonstrated that overexpression of Cdc14BWT-EGFP
in U2OS cells triggered a step-wise (4;2;1) loss of centrioles with continued passage
through the cell cycle, further indicating that Cdc14B may control centriole duplication in
a negative fashion.

4.2.5 Ectopic expression of centriole-associated Cdc14B inhibits
centriole overduplication in prolonged S-phase-arrested cells
In certain transformed cells, such as U2OS cells, prolonged S-phase arrest by
hydroxyurea (HU) or aphidicolin (APH) causes multiple rounds of centriole duplication
in the absence of DNA replication and mitotic division (Balczon et al., 1995a; Chang et
al., 2003). We therefore utilized this well-established centriole overduplication system to
directly evaluate whether Cdc14B plays a negative role in the regulation of centriole
duplication. For this purpose, we first tested if Cdc14B overexpression could inhibit HUinduced centriole overduplication in the stable doxycycline (DOX)-inducible Cdc14BWTEGFP U2OSTet-on cells. Based on the localization of Cdc14BWT-EGFP at centrioles (Fig.
3.1), the Cdc14BWT-EGFP positive cells can be divided into two groups: Cdc14BWTEGFP at centrioles and not at centrioles. This provides an ideal system to directly
examine whether localization of Cdc14B at centrioles conveys a critical function in
centriole duplication. The number of Centrin-2-labeled centriole was counted in the
inducible Cdc14BWT-EGFP cells after cultivation in the presence of HU without DOX
induction, and HU + DOX for 72 hrs. As expected, hydroxyurea treatment led to
centriole amplification in un-induced Cdc14BWT-EGFP cells or mock-transfected
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U2OSTet-on cells (Fig 4.6A). Remarkably, this centriole amplification phenotype was
significantly attenuated in cells where Cdc14BWT-EGFP was at centrioles, but not in cells
where Cdc14BWT-EGFP signal was invisible at centrioles (Fig 4.6A). This finding was
confirmed in the same sets of cells treated with HU + DOX for 72 hrs using γ-tubulin as a
centrosome marker (Fig 4.7A & B). Similar and yet more dramatic results were obtained
in transient transfection experiments in which cells transfected with DOX-inducible
Cdc14BWT-EGFP exhibited an even more significant reduction of HU-induced
centrosome amplification in comparison with the mock-transfected cells (Fig 4.6B).
Together, these results suggest that Cdc14B overexpression suppresses abnormal
centriole amplification and this inhibitory function requires the presence of Cdc14BEGFP at centrioles in the HU-induced centriole overduplication system. Similar results
were obtained with U2OSTet-on cells treated with aphidicolin (Data not shown).
Fluorescence-activated cell sorting (FACS) analysis revealed that induction of
Cdc14BWT-EGFP did not perturb cell cycle progression at the expression level set by the
DOX-inducible promoter (Fig 4.6C), suggesting that the inhibition of centriole
amplification in HU-arrested cells was not the result of a potential G1 cell cycle arrest.

4.2.5 Cdc14B phosphatase activity is essential to prevent centriole
overduplication in prolonged S-phase arrested cells
In order to investigate whether inhibition of centriole overduplication in HUarrested U2OS cells requires the intact phostatase activity of Cdc14B at centrioles, we
took advantage of and tested the centriole-bound catalytic “dead” Cdc14BK&C-EGFP
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Figure 4.6: Cdc14B phosphatase activity is required to prevent HU-induced
centriole amplification. (A, top) Cdc14B-GFP fusion proteins were induced by 4
µg/ml DOX in the presence of 2 mM HU for 72 h in U2OS Tet-On stable cell lines
carrying different Cdc14B-GFP constructs as indicated. Centrioles were visualized by
anti-centrin staining (red) and overlaid with Cdc14B-GFP (green) and DAPI (blue).
Note that Cdc14BC314S-GFP was not detectable at centrioles (arrow). Insets show
magnified images of centrioles. Bar, 5 µm. (bottom) The percentage of cells with
more than four centrioles was calculated from both induced (+DOX) and uninduced (–
DOX) Cdc14B-GFP stable clones as indicated. Data shown represent the means ± SD
of three independent experiments from two individual Cdc14B-GFP stable clones. At
least 500 cells were counted in each experiment. (B, top) U2OS Tet-On cells were
transfected as indicated. 16 h after transfection, cells were incubated with (+HU) or
without (–HU) 2 mM HU and 4 µg/ml DOX for 72 h. Centrosomes were visualized by
γ-tubulin staining (red). Representative centrosome amplification was detected in
mock-transfected cells after HU treatment but not in pBI-tet-Cdc14BWT-GFP
transfected cells where Cdc14BWT-GFP (green) associated with centrosomes. Insets
show magnified images of centrosomes. DAPI (blue), DNA. Bar, 5 µm. (bottom) The
percentage of cells with the indicated centrosome numbers was calculated from the
experiments shown in the top panel. Centrosomes were counted in both mock and
Cdc14B-GFP–transfected cells (Cdc14B-GFP–positive at centrosomes). All the data
are shown as the means ± SD of three independent experiments. At least 500 cells
were counted in each experiment. (C) Representative fluorescence-activated cell
sorting profile on cell cycle distribution of DOX-inducible Cdc14B-GFP U2OS TetOn stable clones. Cells were cultivated in the presence or absence of 4 µg/ml DOX for
72 h. Positions of cells with 2 N and 4 N DNA contents are labeled with arrowheads.
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Figure 4.7: Cdc14B catalytic activity is required to prevent HU-induced
centrosome overduplication. (A) DOX-inducible U2OS Tet-On cell lines carrying
the indicated Cdc14B-GFPs were induced by DOX in the presence of HU for 72 h.
Centrosomes were visualized by γ-tubulin staining (red) and overlaid with Cdc14BGFP (green) and DAPI (blue). Insets show magnified images of centrosomes. Bar, 5
µm. (B) The percentage of cells with normal (one or two) and overduplicated (more
than two) centrosomes was calculated from the experiments shown in A and as
indicated. At least 300 cells were counted in each experiment. Data shown represent
the means ± SD of three independent experiments from at least two individual stable
clones for each Cdc14B-GFP construct. C314S, Cdc14BC314S-GFP; DOX, 4 mg/ml
doxycycline; HU, 2 mM HU; K&C, Cdc14BK&C-GFP; KKIR, Cdc14BKKIR-GFP;
NO, no treatment; WT, wild-type Cdc14B-GFP. (C) Western blot analysis of Cdc14BGFP expression in the U2OS Tet-On stable clones described in A.
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mutant as described in chapter three (Fig 3.8). When the Cdc14BK&C-EGFP cells were
exposed to HU, the DOX-induced Cdc14BK&C-EGFP was unable to block centriole
overduplication, whereas the centriole-associated catalytic “active” Cdc14BKKIR-EGFP
mutant was as potent as its wild-type counterpart in inhibition of centriole
overduplication (Fig. 4.6A). Similar results were obtained when the HU-treated cells
were examined by γ-tubulin staining (Fig 4.7A & B). Western blot analysis revealed that
all the Cdc14B-EGFPs expressed at the comparable level after DOX induction (Fig.
4.7C), indicating that failure of Cdc14BK&C-EGFP to inhibit centriole overduplication
was not due to its expression level. This finding strongly argues that Cdc14B phosphatase
activity is indispensable for the inhibition of centriole duplication and that docking a
catalytically inactive Cdc14B-GFP to centrioles is not sufficient to prevent centriole
overduplication.

4.2.6 Inhibition of Z-L3VS - induced centriole overduplication requires
Cdc14B phosphatase activity
It has been documented that treatment of U2OS cells with a proteasome inhibitor
Z-L3VS causes multiple daughter centriole growth from a single mother centriole
template (Duensing et al., 2007a). This aberrant daughter centriole overduplication
requires both Cdk2/Cyclin-E and Plk4 activities, the known positive regulators of
centriole duplication (Nigg, 2007b). We thus used the Z-L3VS induced centriole
duplication system to evaluate the possibility of Cdc14B as a counterbalancing
phosphatase of Cdk2/Cyclin-E and/or Plk4 in centriole duplication control. In the absence
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of Cdc14BWT-EGFP induction (DOX), treatment of U2OSTet-on-Cdc14BWT-EGFP cells
with Z-L3VS evoked an aberrant centriole overgrowth, whereas in the presence of
Cdc14BWT-EGFP induction (+DOX), centriole-bound Cdc14BWT-EGFP significantly
attenuated the centriole overduplication phenotype (Fig 4.8). Moreover, similar to our
observation in the HU experiment (Fig 4.6 A and 4.7 A & B), the centriole-bound
catalytic dead Cdc14BK&C-EGFP mutant failed to prevent Z-L3VS induced centriole
overduplication (Fig 4.8), indicating that this inhibition also requires Cdc14B catalytic
activity. Although additional experiments are required, our study supports the possibility
that Cdc14B may counterbalance centrosomal kinases required for centriole
overduplication in the Z-L3VS induction system.

4.3 Discussion
RNA interference has provided biologists with a very powerful tool with which to
turn off expression of a particular gene of interest. Previously, similar loss-of-function
study using other approach such as knock out technology was proven to be very difficult,
expensive and time-consuming in many organisms, especially mammals. RNA
interference has made discovering the unknown function of a known gene which is also
referred as 'reverse genetics' to be much more straightforward not only in mammals, but
also in flies and worms.

Up to date, there are no Cdc14B knockout mice available. Therefore, RNAi approach
maybe one of the few ways to perform loss-of-function studies on Cdc14B in mammals.
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Figure 4.8: Cdc14B phosphatase activity is required to prevent Z-L3-VS–induced centriole overduplication.
(A) Dox-inducible U2OS Tet-On cell lines carrying the indicated Cdc14B-GFPs and mock controls were treated
with 1 µM Z-L3-VS in the presence or absence of 4 µg/ml Dox for 48 h. Representative centrioles (red) were
visualized by an anti-centrin antibody and DNA (blue) was visualized by DAPI. Bar, 5 µM. (B) The percentage of
cells with more than four centrioles was calculated from the experiments shown in A and as indicated. Centrioles
were counted in mock, uninduced controls (–Dox) and Cdc14B-GFP–induced (+Dox) cells (Cdc14B-GFP–positive
at centrioles). All the data are shown as the means ± SD of three independent experiments. At least 400 cells were
counted in each experiment.
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Here, we have used three independent RNAi approaches to switch off expression of
Cdc14B in both transformed and non-transformed human cell lines. Despite the
differences in knock down efficiencies, all three approaches confirm the same phenotype
when Cdc14B is depleted in these cells, which is centrosome amplification. Centrosome
amplification leads to aberrant mitotic spindle formation with more than two spindle
poles, and subsequent chromosome segregation errors and genomic instability. Typically,
normal cells either have two or four centrioles depend on the cell cycle. In our studies,
when Cdc14B expression was down regulated in either stable siRNA clones or transient
transfection, there was significant increase of the percentage of cells harboring more than
four centrin dots (Fig 4.2), indicating unscheduled centriole duplication has occurred.
This is the first study to dissect Cdc14B’s novel function in centrosome cycle control
even its localization on centrosomes has been suggested by several previous reports.
Interesting, according to a recent study, when both Cdc14B loci were homozygously
disrupted in human somatic cells, there were no evident lack of defects in spindle
assembly, anaphase progression, mitotic exit, and cytokinesis, contrary to several
previous studies (Berdougo E, 2008). It’s tempting to know whether centrosome
amplification phenotype exists in these Cdc14B null cells.

Supernumerary centrosomes we observed from Cdc14B depleteted cells, however, can
arise from fundamentally distinct mechanisms:

The first possible mechanism is deregulation of centrosome duplication control. And we
believe this is the case with our studies on Cdc14B. Normal centrosome duplication
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involves proper timing for initiation of duplication and suppression of re-duplication of
already duplicated centrosomes. If either or both of these controls are deregulated,
centrosomes will duplicate more than once within a single cell cycle, also called
centrosome re-duplication which results in supernumerary centrosomes (Balczon et al.,
1995b; Meraldi et al., 1999).

A second plausible mechanism for the generation of cells with supernumerary
centrosomes involves an aborted cell division. Interestingly, examination of TREx-HeLa
Cdc14B1234siRNA stable cells revealed a slight increase in the number of polyploid cells,
such as multinucleate and macronuclear cells (Fig 4.9). Macronuclear and multinucleate
cells were determined by visual judgment of the sizes (nuclear diameter and area) of
DAPI-stained nuclei and the number of nuclei per cell respectively. It is important to note
that among the TREx-HeLa Cdc14B1234siRNA stable cells with centriole amplification
phenotype, only about 1/5 (n= 300) were polyploid. Using the same criteria, however, we
were unable to detect any significant increase of polyploid cells in HeLa cells transiently
transfected with Dharmacon Cdc14BsiRNA smartpool (Fig. 4.9). In line with this finding,
flow cytometry analysis did not reveal any significant increase of polyploidy in those
Cdc14B knockdown cells (Fig. 4.9). Moreover, none of the Cdc14B-depleted BJ (0%;
n=115) or MRC-5 (0%; n=74) cells with >4 centrioles were polyploid. Thus the centriole
amplification phenotype in Cdc14B knockdown cells may not be the product of aborted
cell division, and the slight increase in the number of polyploid cells in the TREx-HeLa
Cdc14BsiRNA stable clones may have evolved during the course of stable clone
selection.
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Figure 4.9: Polyploidy in Cdc14B knockdown cells. Polyploid (macronuclear and
multinucleate) cells in TREx-HeLa Cdc14BsiRNA stable clones (A) and HeLa cells
transiently transfected with SiGLO control oligo and Cdc14BsiRNA SMARTpool (B).
Polyploid cells with more than four centrioles were determined by DAPI and centrin
staining. All the data are presented as the means ± SD of three independent
experiments. At least 900 cells were counted in each experiment. (C) Representative
fluorescence-activated cell sorting profile on cell cycle distribution of Hela cells
transfected with Cdc14BsiRNA SMARTpool and siGLO for 72 h. The positions of
cells with 2 N and 4 N DNA contents were labeled with arrowheads. Note that no
significant tetraploid peak (8 N) was observed in Cdc14BsiRNA SMARTpool
transfected cells.
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A third possiblility is that supernumerary centrioles as observed using Centrin-2 as
centriole marker are caused by centrosome fragmentation. In this case, additional γtubulin or centrin dots may arise from fragments of PCM/Centriole instead of intact
centrosomes. To exclude this possibility, we carefully evaluated the γ-tubullin-decorated
centrosomes in HeLa cells transiently transfected with Cdc14BsiRNA smartpool. We
found that a majority of the supernumerary centrosomes were clustered together and
similar in size (Fig. 4.2B). All the supernumerary centrosomes (n=105) contained centrinlabeled centrioles and many of the centrioles were in pairs (Fig 4.3C). These data suggest
that the supernumerary centrosomes may not arise from centrosome fragmentation.

Certain tumour-derived cell lines for example U2OS osteosarcoma cells can be induced
to undergo several rounds of centrosome re-duplication when the DNA replication is
arrested for an extended period of times by drugs such as hydroxyurea or aphidicolin
(Balczon et al., 1995b; Meraldi et al., 1999). This in vito centrosome duplication system
proves to be a good assay for studying proteins involved in centrosome duplication. The
findings that overexpression of Cdc14B inhibits HU induced centriole overduplication
directly confirmed Cdc14B’s essential role in the regulation of centriole duplication cycle.
In order to suppress the centrosome ampification phenotype caused by HU, Cdc14BWTEGFP has to localize to the centrosomes. As is shown in Fig 4.6 & 4.7, when Cdc14BWTEGFP was not found at centrosomes, centrosome amplification still persisted in these
cells. Therefore the centriole-bound catalytic “dead” Cdc14BK&C-EGFP mutant came as
convenient tool to study whether Cdc14B’s phosphatase activity is also responsible for its
function in centrosome duplication control beside its centrosomal localization. And
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indeed, our findings supported the claim that catalytic activity of Cdc14B is required to
harness centriole overduplication in HU experimental systems (Fig 4.6 & 4.7). Cdc14B
may exert its effect through modulating the phosphorylation status of its substrates on
centrosomes, in particular those involved in the control of centrosome duplication. It has
been well-documented that the activities of centrosome-associated protein kinases, such
as Cdk2/Cyclin-E/A, Plk2, Plk4, calcium-calmodulin kinase II, MpsI and etc are required
for centriole duplication in various species and experimental settings (Duensing et al.,
2007b; Fisk et al., 2003; Fisk and Winey, 2001; Habedanck et al., 2005b; Kleylein-Sohn
et al., 2007b; Matsumoto et al., 1999b; Matsumoto and Maller, 2002; Meraldi et al., 1999;
O'Connell et al., 2001b; Tsou and Stearns, 2006e; Warnke et al., 2004), suggesting that
phosphorylation plays an important role for the precise reproduction of centrosomes
during the cell cycle (Nigg, 2007a; Tsou and Stearns, 2006d). Phosphorylation of
centrosome-associated proteins, such as nucleophosmin/B23, CP110 and Mps1 has been
implicated in centrosome duplication control. In particular, phosphorylation of B23
Thr199 by Cdk2/Cyclin-E and of B23 Thr95 by an unknown kinase(s) dissociates B23
from centrosomes, which in turn allows centrosome duplication or re-duplication to occur
(Budhu and Wang, 2005; Okuda et al., 2000b). Likewise, depletion of CP110 abolishes
centrosome re-duplication in S-phase arrested cells (Chen et al., 2002b) and suppresses
Plk4-induced procentriole re-duplication (Habedanck et al., 2005b), whereas inactivation
of Cdk2 activity abolishes Mps1-dependent centrosome duplication (Fisk and Winey,
2001). Based on our observation in this study, it is possible that Cdc14B regulates
centriole duplication cycle through counterbalancing centrosomal kinases through
modulating the phosphorylation status of potential common centrosomal substrates, such
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as B23, CP110 and Mps1.

A counter-balance mechanism of kinase and phosphatase has been proposed for
governing centrosome splitting (Meraldi and Nigg, 2001). A similar mechanism may
prevail in the regulation of centrosome duplication. Despite the significance of so many
kinases characterized in the process, to date no phosphatase that may counterpoise the
kinase effect has been identified to our knowledge.

Cdc14B has been implicated in the regulation of nuclear structure maintenance (Nalepa
and Harper, 2004), microtubule dynamics (Cho et al., 2005a), mitotic exit control
(Dryden et al., 2003b) and G1 progression (Rodier et al., 2008). The abnormal
centrosome amplification observed in Cdc14B-depleted cells may arise from the
combinatorial events involving failures in nuclear structure, cell and centrosome cycle
regulation. However, because active Cdc14B can directly inhibit unscheduled centriole
overduplication, and Cdc14B depletion leads to centriole amplification in the absence of
obvious polyploidy in normal human fibroblast cells, it is possible one of Cdc14B
functions is to serve as a centrosomal regulatory protein, and compromising centrosomal
regulatory function of Cdc14B may account for at least part of the observed centriole
amplification phenotype. Since it is frequently down-regulated in tumor cells (Ashida et
al., 2004a; Martinez et al., 2003a; Neben et al., 2005a; Rubio-Moscardo et al., 2005;
Wong et al., 1999; Yu et al., 2004b), Cdc14B may function as a tumor suppressor to
maintain the fidelity of centrosome duplication cycle and genomic stability in human
cells.
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4.4 Summary
In summary, we have shown that: siRNA mediated depletion of Cdc14B
expression led to centrosome duplication in both Hela cells and normal human fibroblasts
(BJ and MRC-5); Overexpression of Cdc14B resulted in progressive loss of centrioles;
overexpression Cdc14B could also suppress centriole overduplication in several
established in vitro centriole duplication systems: HU/APH treated U2OS or CHO cells
and Z-L3VS treated U2OS cells. Taken together, these evidences support the negative
role of Cdc14B in centrosome duplication control.

4.4 Experimental Procedures
4.4.1 Cell lines, Transfection and Drug treatment
U2OSTet-on (BD Biosciences), U2OS (Invitrogen), HeLa, and TREx-HeLa
(Invitrogen) cells were cultured as described previously (Cho et al., 2005a). Normal
human fibroblasts BJ and MRC-5 cells were purchased from ATCC and maintained in
Dulbecco’s Modified Eagle Medium supplied with 10% fetal bovine serum, 50 U/ml
penicillin and 50 ug/ml streptomycin. To establish stable cell lines carrying DOXinducible Cdc14B-EGFP, U2OS-TetON cells were co-transfected with pBI-tetCdc14BWT-EGFP, pBI-tet-Cdc14BKKIR-EGFP, pBI-tet-Cdc14BC314S-EGFP, or pBI-tetCdc14BK&C -EGFP plasmid (Cho et al., 2005a) and pBabe-puro vector (a kind gift from
Dr. Gerald Evans) by FuGene6 (Roche) following the manufacture’s protocol. Stable
clones were obtained after selection with G418 (500 µg/ml) and puromycin (2 mg/ml) in
the absence of DOX. For prolonged S-phase arrest experiment, the Cdc14B-EGFP stable
121

clones were treated with or without 4 mg/ml DOX, 2 mM hydroxyurea (HU, Sigma)
alone, or 2 mM HU and 4 mg/ml DOX together for 72 hrs.

4.4.2 Cell cycle analysis
For cell cycle analysis, ~1x106 HeLa cells were collected and span down at 1,000
rpm for 3 minutes. Cell pellet was resuspended in 474ul of cold PBS and followed by
fixation with 526ul of 95% ice-cold ethanol for 10 minutes. The fixed cells were then
span down again and resuspended in 500ul PBS. Then 1 ul of 10mg/ml RNase A was
added and incubated at 37C for 30 minutes. Finally, 5 ul of 1mg/ml propidium iodide
were added to cells and then analyzed by a fluorescence-activated cell sorter (GUAVA).
The percentage of cells in difference phases of the cell cycle was determined using
ModFit LT software.

4.4.3 siRNA and shRNA experiments
Cdc14B protein was depleted using the following three approaches: First, small
interfering RNA oligos that target the sequences 5’-GAACCCGAACCGTACAGTG-3’
(1234-1254, relative to the start codon of Cdc14B) were annealed and cloned into the
HindIII and BglII sites of pSuperior-neo-GFP vector (OligoEngine). Tetracyclineinducible cell lines expressing pSuperiorCdc14B1234siRNA were generated by cotransfection with pBabe-puro (a kind gift from Dr. Gerald Evans) into TREx-HeLa cells
that contain Tet repressors using Lipofectamine PLUS (Invitrogen) following the
manufacture’s recommended protocol. Stable clones were established by selection in a
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growth medium containing 800 mg/ml G418 and 1 mg/ml puromycin in the absence of
tetracycline. Before functional studies, pSuperiorCdc14B1234siRNA stable clones were
induced with 1 μg/ml tetracycline for 24-hrs and harvested.

Second, a small hairpin RNA expression vector carrying a Cdc14B shRNA oligo (9891017, relative to Cdc14B start codon; cat#RHS-1271-8957575) was obtained from
OpenBiosystems, and subcloned into the pSuper-neo-GFP vector (OligoEngine), which
was designated as pSuper-Cdc14BshRNA-E9. Stable transfectants were obtained by cotransfection with pBabe-puro into HeLa cells followed by selection with 800 μg/ml G418
and 1μg/ml puromycin up to a month.

Third, Cdc14BsiRNA smartpool (targeting four different regions of Cdc14B mRNA
sequences) and siGLO control oligo were obtained from the siGENOME collection
(Dharmacon, Lafayette, CO) and transfected into HeLa, BJ and MRC-5 cells using
siPORT NeoFX reagent (Ambion) or Dharmafect I transfect reagent (Dharmacon,
Lafayette, CO) according to the manufacturer’s recommendations followed by up to 96h
incubation.

4.4.4 Western Analysis
Cultures were washed twice in ice-cold phosphate-buffered saline (PBS), lysed in
lysis buffer containing 1% of SDS and Tris-Hcl at pH 7.4, samples were then boiled in
6X SDS sample buffer for 10 min, votexed and centrifuged at 13,000g for 10 min. For
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western blotting, protein lysates were separated by SDS-PAGE and transferred to
nitrocellulose membranes (Millipore). Immunoblots were then probed with antibodies
specific to Cdc14A (Zymed), Cdc14B (Zymed), GFP (BD Pharmingen) and β-actin
(Cytoskeleton).

4.4.5 Immunofluorescence
For indirect immunofluorescence, cells were grown on glass coverslips, and fixed
with either paraformaldehyde or cold 100% methanol. The cells were then permeabilized
with PBS/0.5% Triton X-100 for 10 min followed by blocking with PBS/1% BSA for 30
min. Centrosomes or centrioles were visualized by immunostaining with antibodies
against γ-tubulin (GTU-88, Sigma; C-20, Santa Cruz), pericentrin (Abcam) or centrin
(20H5; a kind gift from Dr. J. Salisbury, Mayo Clinic Foundation). For visualization of
centriole-associated endogenous Cdc14B, cells were treated without or with 10 µg/ml
nocodazole (for better exposure of centrosomal Cdc14B) for 2 hrs, briefly extracted with
0.5% Triton X-100 on ice and fixed with cold 100% methanol and immunostained with
chicken anti-Cdc14B antibody (GenWay Biotech). In our hands, methanol fixation
preserved GFP signals and thus anti-GFP immunostaining was not employed to visualize
Cdc14B-GFP fusion proteins in the fixed cells. Both GFP and chicken anti-Cdc14B
antibodies recognized Cdc14B-GFP (data not shown). Secondary antibodies including
Alexa Fluor 488 and 594 donkey-anti-mouse, -anti-goat, goat-anti-rabbit, and -antichicken IgY antibodies were purchased from Molecular Probes. DNA was counterstained by DAPI. Cells were visualized with a 100 x Plan-Neofluar objective (1.30 oil;
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∞/0.17) under an epi-fluorescence microscope (Axioskop 2, Carl Zeiss Inc). Images were
acquired with a charge-coupled device camera (AxioCam HRC) controlled by Openlab
software (version 3.5, Improvision Inc). For confocal microscopy, images were captured
with a HCX-PL/APO 63 X 1.32 oil objective under a Leica SP2 laser scanning confocal
microscope equipped with Leica confocal software (LCS Lite V. 2.0; Leica
Microsystems Inc). The coverslips were mounted using PermaFlour Mountant media
(Thermo Electron Inc) and imaging was performed at room temperature. Image
processing was performed using Photoshop CS (V8.0).
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Chapter 5

Potential counterbalance effect between Cdc14B
phophatase and Plk4 kinase in regulating centrosome
duplication

5.1 Introduction
The C. elegans Zyg1 kinase is among the five proteins suggested to be important
for centrosome duplication in embryogenesis (O'Connell et al., 2001a). Zyg1 was first
identified in a genetic screen for temperature sensitive embryonic lethal mutants in the
nematode C. elegans (Wood et al., 1980). Another genetic screen showed that Zyg1
activity is not only indispensable for embryonic development, but also requireed
throughout development (O'Connell et al., 1998). Interestingly, in Zyg1 mutant embryos,
the centrosomes failed to reproduce during the first or second round of division and
resulted in blocked formation of a bipolar mitotic spindle, suggesting Zyg1’s possible
role in centrosome duplication (O'Connell et al., 1998). The first direct evidence of
Zyg1’s role in centrosome duplication came from a recent study in 2001. In this study,
the authors demonstrated that Zyg1 was required for daughter centriole formation in early
embryos with paternal Zyg1 activity required for centrosome duplication during the first
cell cycle while maternal Zyg1 activity regulated centrosome duplication during later cell
cycles (O'Connell et al., 2001a). Immunoflurescence analysis showed that Zyg1 appeared
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on centrosomes from late anaphase till telophase but was absent from centrosome during
interphase and prophase (O'Connell et al., 2001a). Since S phase starts right after
telophase in early embryos, Zyg1 may be at the right place at the right time to promote
centrosome duplication (Nigg, 2004).

The kinase Plk4 (also known as Sak) has unequivocally been identified as a positive
regulator for centriole duplication in both human and Drosophila (Bettencourt-Dias et al.,
2005; Habedanck et al., 2005a). Although Plk4 shares only low sequence similarity with
C.elegans Zyg1, it is has been proposed to be the functional equivalent of C. elegans
Zyg1 (Nigg, 2007b). Plk4 was originally cloned as a short-lived protein kinase subjected
to cell cycle regulation. It is maximally expressed in testis and other actively dividing
tissues (Fode C, 1994; Fode, 1997). Plk4–/– mouse embryos arrest after gastrulation at
E7.5, displaying an increased incidence of apoptosis and anaphase arrest, indicating that
Plk4 is essential for embryogenesis in mice (Hudson et al., 2001; Swallow et al., 2005).
And, interestingly, adult Plk4+/– mice were prone for tumor formation, with spontaneous
tumors developing in the liver and other organs, indicating that deregulation of Plk4
kinase can contribute to tumorigenesis (Ko et al., 2005). More importantly, when Plk4
activity is absent, both human and Drosophila cells will gradually lose centrioles through
impaired centrosome duplication, resulting in severe abnormalities in spindle formation.
On the contrary, overexpression of Plk4 in human cells resulted in centrosome
overduplication, indicating a crucial role of Plk4 in regulating centriole duplication
(Habedanck et al., 2005; Rodrigues-Martins et al., 2007). It is of particular interest that
further electron microscopy analysis of Plk4 overexpressed cells revealed multiple
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centriole precursors surrounded a single parental centriole, which often formed rosettelike structures in cross-sections (Habedanck et al., 2005a). No rosettes structures were
formed, however, when a catalytically inactive Plk4 was overexpressed, demonstrating
that their formation was strictly dependent on kinase activity (Habedanck et al., 2005a).
In addition, this remarkable phenotype also relied on Plk4’s association with centrioles.
Pooled together, these evidences suggested that procentriole formation might critically
depend on the phosphorylation of one or more substrates by Plk4 at the procentriole
assembly site. Therefore, it’s tempting to hypothesize that centrosomal Plk4 kinase
activity is needed to phosphorylate a centrosomal substrate which in turn triggers the
formation of a “seed” either through protein stabilization of recruitment that initiates the
procentriole assembly process; When deregulated, unchecked phosphorylation of the
substrate may promote the formation of multiple “grow” sites for the assembly of
procentrioles which lead to multiple centriole progeny formation. If so, in normal cell
cycle, Plk4 kinase activity will be expected to be closely balanced by phosphatases to
prevent the simultaneous formation of multiple centrioles (Nigg, 2007b).

Multiple procentrioles formation around one maternal centriole is not limited only to Plk4
overexpression. Similarly, several procentrioles assembling from the base of one mother
centriole has been previously observed in CHO or U2OS cells blocked in S phase
(Balczon et al., 1995b; Meraldi et al., 1999); Also, as discussed in Chapter 4, treatment of
human cells with a peptide vinyl sulfone proteasome inhibitor Z-L3VS triggered more
than one daughter formation at maternal centrioles in certain cells. And this effect
requires Cdk2/Cyclin-E and more importantly, Plk4 activity (Duensing et al., 2007a);
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Moroever, the same study showed human papillomavirus type 16 E7 oncoprotein could
also promote the same phenotype (Duensing et al., 2007a); Most interestingly, a recent
study by Strnad et al demonstrated that increased human Sas-6 levels also triggered
formation of more than one procentriole per centriole (Strnad et al., 2007).

Like Zyg-1, Sas-6 is also among the five core components required for daughter centriole
assembly in C.elegans (Dammermann et al., 2004; Leidel et al., 2005). Unlike Zyg-1
which was first discovered through forward genetic screens, the identification of Sas-6 as
required for centriole formation in C.elegans benefited from comprehensive RNAi-based
reverse genetic screens. In Sas-6 (RNAi) embryos, during the one-cell stage a biopolar
spindle was formed, however, a monopolar spindle assembled in each blastomere at the
two-cell stage, suggesting Sas-6 maybe required for normal centrosome duplication
(Dammermann et al., 2004; Leidel et al., 2005; Leidel and Gˆnczy, 2005). Sas-6 is the
founding member of an evolutionary conserved protein family with no obvious sequence
module other than a coiled-coil motif in the middle of the coding region and a potential
novel ~50 amino acid region of homology toward the N terminus, referred to as PISA
motif. Sas-6 physically interacts with Sas-5, another core components for procentriole
biogenesis in C.elegans. Sas-6/Sas5 is recruited to mother centrioles once per cell cycle
at the onset of the centrosome duplication and this recruitment requires Zyg1 activity
(Leidel et al., 2005). After been recruited, Sas-6/Sas-5 will in turn guide Sas-4 to
procentriole and promote daughter centriole formation.
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HsSas-6, the human homolog, was first identified as a potential centrosomal component
by mass spectrometry based proteomic analysis (Andersen et al., 2003). Two later studies
using GFP or YFP tagged full-length HsSas-6 confirmed its localization to centrosomes
in cultured human cells (Dammermann et al., 2004; Leidel et al., 2005). Overexpression
of HsSAS-6 resulted in an excess of centrioles; while siRNA mediated inactivation of
HsSas-6 abrogated the centrosome re-duplication in aphidicolin treated U2OS cells. Also,
depletion of HsSas-6 impaired normal centrosome duplication cycle as about half of
mitotic cells depleted of HsSas-6 showed a monopolar spindle reminiscent of its
C.elegans kin (Leidel et al., 2005). These data clearly suggests that HsSas-6 is required
for progression through the centrosome duplication cycle in human cells. A recent study
from Dr Pierre’s lab confirmed HsSas-6’s requirement for procentriole formation (Strnad
et al., 2007). Immunofluorecence studies showed HsSas-6 localized to the proximal end
of the procentrioles either in normal centrosome cycle or Plk4-induced “flowers” like
multiple procentrioles generated around a single maternal centriole (Kleylein-Sohn et al.,
2007a; Strnad et al., 2007). Similar as in C.elegans, HsSas-6 was recruited to the
procentriole in a Plk4-dependent manner (Strnad et al., 2007) although another study
concluded Plk4 is despensible for initial recruitment of HsSas-6 to the procentriole while
instead is important for stabilizing centriolar HsSas-6 once recruited (Kleylein-Sohn et
al., 2007a). Also, HsSas-6 protein levels oscillated during the cell cycle with its
appearance on centrosomes during S, G2 until metaphase while absence from
centrosomes in late mitosis and G1 phase (Strnad et al., 2007). Down regulation of
HsSas-6 protein started in anaphase and was mediated by APC/CCdh1 ubiqutination which
targeted HsSas-6 for degradation by the 26S proteasome (Strnad et al., 2007).
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When Cdc14B was knocked down in human cells, among the cells harboring more than 4
centrioles, we did observe “rosette” pattern of Centrin-2 staining in some cases, implying
multiple procentriole generation around one maternal centriole. This piece of evidence,
although needs to be confirmed by electron microscopy studies, has potentially placed
Cdc14B phosphatase in the same pathway with both Plk4 kinase and HsSas-6 to establish
the “copy number” control for procentriole biogenesis. In this chapter, we will be testing
this hypothesis through a series of experiments.

5.2 Results
5.2.1 Overexpression of Cdc14B suppress centrosome amplification
triggered by deregulated Plk4
When cells were treated with the peptide vinyl sulfone proteasome inhibitor ZL3VS for an extended period of time, multiple daughter centrioles simultaneously grew
from a single mother centriole and this effect required the activities of both Cdk2/CyclinE and most importantly Plk4 (Duensing et al., 2007a). Similarly, overexpression of Plk4
kinase alone mimicked the centriole overduplication pheynotype in the absence of ZL3VS (Habedanck et al., 2005a; Kleylein-Sohn et al., 2007a). In Chapter three, we have
demonstrated that Cdc14B may counterbalance centrosomal kinases required for
centriole overduplication in the Z-L3VS induction system. Thus, it’s tempting to test
whether Cdc14B phosphatase can directly counteract Plk4 kinase activity in centrosome
duplication control. In the current study, we took advantage of the Plk4-induced
centrosome amplification system to determine whether ectopic expression of Cdc14B
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phosphatase can suppress the centriole overduplication phenotype caused by Plk4
overexpression. First we tried to confirm the phenotype caused by Plk4 overexpression.
In our hand, when co-tranfected with Centrin-EGFP, ectopic expression of a wild type
Plk4 in both U2OS and HeLa cells did lead to significant increase in the percentage of
cells with excessive centriole formation (>4 Centrin-EGFP focuses) (Fig 5.1A [upper
panel]). Notably, among the cells with overduplicated centrioles, many exhibited the
phenotype with one mother centriole surrounded by more than one newly generated
procentrioles arranged in a rosette-like structure (Fig 5.1A [upper panel]). Next, we cotransfected Cdc14BWT - EGFP together with the same wild type Plk4 construct into
U2OS or HeLa cells. After transfection, cells were incubated for additional 40 hours and
fixed for immunofluorecence studies. γ-tubulin was used as a centrosome marker. As
expected, in the control groups, transient Plk4 transfection triggered centrosome
amplification (Fig 5.1A [middle panel]). When counted (Fig 5.1B), about 37% of
Plk4/Centrin-EGFP transfected cells harboring more than two γ-tubulin focuses per cell,
in agreement with previous studies (Duensing et al., 2007a; Habedanck et al., 2005a).
Remarkably, this centrosome amplifcation phenotype was greatly attenuated in
Cdc14BWT - EGFP positive cells. The percentage of EGFP positive cells having more
than two centrosomes significantly reduced to about 5% and majority of them showed
either one or two γ-tubulin spots (Fig 5.1B). This result suggests that Cdc14B
overexpression suppresses abnormal centrosome duplication caused by deregulated Plk4.

132

Figure 5.1: Cdc14B phosphatase suppresses centriole amplification triggered by deregulated Plk4 expression.
(A) U2OS cells were transiently co-transfected with Plk4/Centrin-EGFP, Plk4/Cdc14BWT-EGFP or
Plk4/Cdc14BK&C-EGFP at a 4:1 ratio. Cells were fixed after 40 h transfection for immunostaining. Representative
centrosomes (red) were visualized by anti-γ-tubulin antibody Bar, 5 µM. (B) Percentage of cells with > 2
centrosomes were calculated from the experiments shown in A and as indicated. Data shown represent three
individual experiments. At least 100 cells were counted in each experiment.
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Since catalytic-dead centrosome-bound mutant Cdc14BK&C has been verified in our
hydroxyurea and Z- L3VS experiments, we therefore used the Cdc14BK&C -EGFP
construct to test whether Cdc14B’s phosphates activity is directly involved. We then cotransfected the Cdc14BK&C-EGFP mutant together with wild type Plk4 into U2OS cells to
examine the centrosome number in EGFP positive cell population. Interestingly, counting
of the γ-tubulin spots in these EGFP positive cells revealed that the catalytic dead
Cdc14BK&C-EGFP mutant failed to block centrosome amplifcation, with about 33% of
cells with more than two centrosomes, a number comparable to the control (37%)(Fig
5.1B). Similar result was also obtained with HeLa cells and stable U2OSTet-on clones
expressing Cdc14BWT-EGFP (clone 4D) or Cdc14BK&C-EGFP mutant (Clone #2) (Data
not shown). Therefore, we concluded that Cdc14B phosphatase activity is indispensable
for the inhibition of centrosome amplification in cells with ectopic Plk4 expression.
Taken together, our data suggests that Cdc14B is a counterbalancing phosphatase of Plk4
kinase in the centrosome cycle control. It may act through opposing kinase
phosphorylation on their common centrosomal substrate(s).

5.2.2 Depletion of both Plk4 and Cdc14B prevents centriole from
overduplication caused by knocking down Cdc14B alone
We have demonstrated that when Cdc14B expression was ablated centriole
overduplication occurred in both transformed and non-transformed human cells. Also we
have shown that when both overexpressed, Cdc14B phosphatase may keep the Plk4
kinase activity in check in an in vitro centriole overduplication system. Thus, it’s
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reasonable to hypothesize that the centriole amplifcation phenotype observed in cells
depleted of Cdc14B phosphatase might have arisen from the loss of control over
endogenous Plk4 kinase. Therefore, in the next step, we further tested whether
simultaneous depletion of both Cdc14B and Plk4 can restore the balance between
endogenous phosphatase and kinase required for normal centriole duplication. For this
purpose, HeLa cells were transiently transfected with either Cdc14B siRNA oligo pool
(smartpool, Dharmacon) alone or together with a Plk4 siRNA oligo pool (on-target pool,
Dharmacon). siGLO (a fluorescent, non-targeting control siRNA oligo pool) transfected
cells were used as control. After transfection, cells were incubated for additional 60 hours
and fixed for immunofluorescence studies. γ-tubulin was used as a centrosome marker. In
cells with only Cdc14B knocked down, as expected, there was a significant increase of
cells with more than two γ-tubulin labeled centrosomes compared with the siGLO siRNA
oligo control transfected cells (23.78% vs 3.33%, Fig 5.2); Remarkably, when both
Cdc14B and Plk4 were simultaneously depleted, the percentage of cells harboring more
than two centrosomes greatly decreased (9.78%, Fig 5.2). Similar results were also
obtained when U2OS cells was used (Data not shown). Taken together, these results
further demonstrated that endogenous Plk4 and Cdc14B could also counterbalance with
each other’s activities in the control of centriole duplication. In situations such as ectopic
Plk4 expression and Cdc14B depletion, disruption of this balance will lead to
misregulation of normal centriole duplication cycle, and as a result unscheduled centriole
overduplication occurs.
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Figure 5.2: Counterbalance effect between Cdc14B and Plk4. Hela cells were
transiently transfected with siRNA oligo pools (Dharmacon) targeting siGLO (control
oligo), Cdc14B (smartpoo) or Plk4 (on-target pool) & Cdc14B (smartpool). Cells
were fixed after 60 h transfection and immunostained with anti-γ-tubulin antibody as a
centrosome marker. Percentage of cells with > 2 centrosomes were calculated in each
transfection group and data shown represent three individual experiments. At least 300
cells were counted in each experiment.
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5.2.3 Depletion of both HsSas-6 and Cdc14B prevents centriole from
overduplication caused by knocking down Cdc14B alone
Plk4-induced centriole overduplication requires HsSas-6 since when HsSas-6 was
depleted by siRNA, the percentage of cells bearing multiple centrosomes was greatly
reduced (Habedanck et al., 2005a). Also, mitotic cells with inactivated HsSas-6 also
showed increased number of monopolar cells similar to what was observed in Plk4
depleted mitotic cells (Leidel et al., 2005; Strnad et al., 2007). Further evidence showed
Plk4 kinase activity might be required for initial recruitment of HsSas-6 to centrosome
and the stability of centrosomal HsSas-6 (although another study found otherwise)
(Kleylein-Sohn et al., 2007a; Strnad et al., 2007). More interestingly, careful
examination of the HsSas-6 overexpressed cells revealed the same phenotype as expected
with Plk4 overexpression, that is, multiple daughter centrioles surrounded one single
mother centriole. This clearly raised the possibility that HsSas-6 may be the substrate of
Plk4 kinase and act as the downstream effector of Plk4 in controlling centrosome
duplication although further investigation is needed. Alternatively, HsSas-6 may
constitute limiting building blocks that are recruited to a “site” marked by Plk4, thereby
forming a “seed” for a nascent procentriole (Nigg, 2007b). Either case, based on our
preliminary data for the counterbalancing effect between Plk4 and Cdc14B, it’s
interesting to test whether HsSas-6 also is a downstream effector or substrate for Cdc14B
in regulating centrosome duplication.
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In order to do so, we have used a similar scheme, that is, to ask whether simutanous
inactivation of both HsSas-6 and Cdc14B using siRNA can abolish centriole
overduplication phenotype as expected by depletion of Cdc14B alone. First, we sought to
verify the siRNA oligo pool targeting HsSas-6 purchased from Dharmacon. Hela cells
were transfected either with siGLO oligo control or HsSas-6 siRNA on-target pool. 66h
post transfection, cell lysates were prepared and analyzed by immunoblot using
antibodies against HsSas-6 (Fig 5.3A [top panel]) and β-actin (Fig 5.3A [bottom panel],
loading control). As shown in Fig 5.3A, HsSas-6 protein level was greatly attenuated in
cells transfected with HsSas-6 siRNA oligos, confirming the specificities of both HsSas-6
antibody (Abcam) and the siRNA pool (Dharmacon). Next we used this siRNA pool for
double knock down experiment. HeLa cells were transiently transfected with either
Cdc14B siRNA pool alone or together with the HsSas-6 siRNA pool. Non-targeting (NT)
siRNA oligo transfected cells were used as control. 60 hours after transfection, cells were
fixed and immunostained with anti-Centrin-2 antibody, a centriole marker. Interestingly,
simultaneously knocking down both Cdc14B and HsSas-6 expression prevented the
centriole amplification from occurring. As shown in Fig 5.3, when Cdc14B was depleted
alone, about 28.33% of cells harboring more than four Centrin-2 labeled centrioles,
significantly higher than non-targeting oligo transfected cells (~4%). However, when
simultaneously knockdown both Cdc14B and HsSas-6 expression, only about 9.33% of
cells showing more than four centrioles in their cytoplasms, indicating the requirement of
HsSas-6 in Cdc14B’s negative regulation of centrosome cycle. In summary, it is potential
that HsSas-6 may also act downstream of Cdc14B and by eliminating HsSas-6
expression, Cdc14B’s function in controlling centriole duplication is impaired.
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Figure 5.3: HsSas-6 as a potential downstream effector of Cdc14B in centriole
duplication control. (A) Hela cells were transiently transfected with siGLO oligo
control or siRNA on-target oligo pool targeting HsSas-6 (Dharmacon). 66h post
transfection, cell lysates were analyzed by westerblot probed with antibodies against
HsSas-6 (top) and β-actin (bottom, loading control). (B) Hela cells were transiently
transfected with Non-targeting (NT) siRNA oligo, siRNA oligo pools targeting
Cdc14B (smartpool, Dharmacon) or Cdc14B (smartpool, Dharmacon) & HsSAS-6
(on-target pool, Dharmacon). Cells were fixed after 60 h transfection and
immunostained with anti-Centrin-2 antibody as a centriole marker. Percentage of cells
with > 4 centrioles were calculated in each transfection group and data shown
represent three individual experiments. At least 300 cells were counted in each
experiment.
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5.2.4 Depletion of Cdc14B stabilizes HsSas-6 in G1 phase
The presence of HsSas-6 at centrioles, and more importantly, the cellular HsSas-6
protein level is cell cycle regulated. Levels of HsSas-6 expression increase gradually
from early S phase till late mitosis when the protein disappears suddenly. The
disappearance of HsSas-6 expression is caused by the 26S proteasome mediated protein
degradation since MG132, a specific 26S proteasome inihibitor could restore HsSas-6
appearance at centrioles in telophase cells(Strnad et al., 2007). Our double knockdown
(Both Cdc14B and HsSas-6) experiment in Section 5.2.3 has shown Cdc14B’s
centrosomal function may rely on the presence of HsSas-6, next we want to further test
whether Cdc14B can directly regulate endogenous HsSas-6 level. Since depletion of
Cdc14B did not lead to obvious cell cycle defect, we can synchronize HeLa cells
depleted of Cdc14B into different stages of the cell cycle and evaluate its effect on
HsSas-6 level. First, we transiently transfected HeLa cells with siGLO control oligos or
Cdc14B siRNA smartpool. After 24 h transfection, cells were blocked at G1/S boundary
with double thymidine block. HeLa cells were then released from the block and cellular
protein lysates were prepared at various timepoints after release. We focused our study
on G1 cell lystates (14h post release) since during this time endogenous HsSas-6 level
was minimal. We carried out western analysis using HsSAS-6 antibody (Fig 5.4A [top
panel]), Cdc14B antibody (Fig 5.4A [middle panel]) and antibody against β-actin as a
loading control (Fig 5.4A [bottom panel]). Compared with siGLO transfected cells, G1
cells with depleted Cdc14B showed significant increase of HsSas-6 level (Fig 5.4A).
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Figure 5.4: Downregulation of Cdc14B expression in G1 stabilizes HsSas-6. (A)
HeLa cells transfected with either siGLO oligo control or Cdc14B smartpool siRNA
pool. Shown are cells 14h (G1 phase) after released from a double thymidine block
and analyzed by western blot using HsSAS-6 antibody (top), Cdc14B antibody
(middle) and antibody against β-actin as a loading control (bottom). (B) Hela cells
transfected with either siGLO oligo control or Cdc14B smartpool siRNA pool were
blocked at G0/G1 phase by serum starvation for 48 h. After 2 h release into medium
containing serum, cells were lysed and analyzed by western blot with HsSAS-6
antibody (top), Cdc14B antibody (middle) and antibody against β-actin as a loading
control (bottom).
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Similar results were obtained when HeLa cells were synchronized at G1 phase by 48h
serum starvation and then released into medium containing serum for 2h (Fig 5.4B).
Taken together, these results suggest that depletion of Cdc14B expression may help
stabilize HsSas-6 protein level during G1 phase of the cell cycle. In another word,
Cdc14B may be responsible for targeting HsSas-6 for degradation during G1 phase.

5.3 Discussion
How only one procentriole assembles at the base next to each maternal centriole
has been baffling the cell and developmental biology community for a long time. This
“copy number” control limits the formation of procentrioles to one per pre-existing
mother centriole (Nigg, 2007b). Violation of this “one and only one” per centriole rule
will result in the aberrant formation of more than one procentrioles per template. This
interesting phenotype has been observed in a number of cases including CHO or U2OS
cells blocked in S phase (Balczon et al., 1995b; Meraldi et al., 1999) as well as
overexpression of Plk4, of HsSas-6, or of the human papillomavirus type 16 E7
oncoprotein and in cells treated with the proteasome inhibitor Z-L3VS (Duensing et al.,
2007a; Habedanck et al., 2005a; Kleylein-Sohn et al., 2007a; Strnad et al., 2007).

Although attractive, the “engagement-disengagement” licensing model discussed
previously in chapter four alone does not readily account for this phenotype. One possible
alternative explaination is that the duplication block imparted by the presence of a
procentriole is regulatory in nature rather based solely on structural constrains (Strnad
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and Gˆnczy, 2008). Studies of Zyg-1 kinase in C.elegans have raised the possibility that
Zyg-1 might play such a regulatory role. Zyg-1 appeared on centrosome primarily at the
onset of procentriole assembly (Telo/S phase transition) in wild type embryos and was
absent from centrosome when centrosome duplication already started (Interphase till
early anaphase). Interestingly, when procentriole assembly is prevented following Sas-6
depletion, Zyg-1 remains at centrosomes (Delattre et al., 2006; O'Connell et al., 2001a).
This observation suggests that the disappearance of centriolar Zyg-1 upon procentriole
assembly might normally serve as a mechanism to prevent ectopic multiple procentriole
assembly events in C.elegans (Dammermann et al., 2008).

Although there is no obvious sequence homology of Zyg-1 in human genome, the similar
requirement of Plk4 activity at centrosome has led to the proposal that Plk4 is the
functional homolog of Zyg-1 in mammals. It is of particular interest that the
overexpression of Plk4 in human cells leads to the concurrent formation of multiple
procentriole around each mother template, arranged in a “rosette” conformation. More
interestingly, multiple procentrioles generated remained tightly associated with the center
mother centriole throughout the rest of interphase and early M phase while started to
disassemble in late M phase, in agreement with the proposed disengagement model. This
observation further supported the idea that structural constraints are not the only
mechanism that governs centriole duplication. Also worth mentioning is that
overexpression of Plk4 induced excess procentriole assembly in cells arrested in S phase
when one procentriole has already assembled, implying an ectopic Plk4 expression could
override the regulation normally imposed by the existing procentriole (Kleylein-Sohn et
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al., 2007a). Therefore, tight regulation of either association of Plk4 with centrosomes or
centrosomal Plk4 kinase activity is critical for controlling centriole number (copy number
control). In C.elegans, Zyg-1 protein level and localization are cell cycle regulated and its
appearance on centrosome corresponds well with new round of centrosome duplication.
However, unlike its functional homology Zyg-1 in C.elegans, Plk4 was found to localize
at centrioles throughout the cell cycle (Habedanck et al., 2005a). Thus, centrosomal Plk4
kinase activity is expected to be modulated and counterbalanced by a potential
phosphatase upon procentriole assembly. If there is a loss of balance between kinase and
phosphatase, disastrous consequences may follow.

In the current study, our data suggests Cdc14B may be one of the counterbalancing
phosphatases of Plk4 in centrosome cycle control: First, overexpression of Cdc14B can
suppress centriole amplification triggered by ectopic Plk4 expression; Second, concurrent
ablation of both Plk4 and Cdc14B expression in human cells inhibited the centriole
overduplication caused by knocking down Cdc14B alone; Third, it has been shown in
chapter three that induction of Cdc14BWT-EGFP in U2OSTet-on cells led to a gradual loss
of centrioles in mitotic cells with continued passage through the cell cycle, reminiscent of
the phenotype observed in cells depleted of Plk4 (Habedanck et al., 2005a).

Also, it is interesting to mention that Cdk2 and Plk4 kinases may cooperate in controlling
centrosome duplication since overexpression of Plk4 can’t trigger centriole
overduplication in the absence of Cdk2 activity and Cdk2 is not able to cause centriole
amplification in the absence of Plk4 vice versa (Duensing et al., 2007a). Another study
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showed overexpression of Cdk2/Cyclin-E together with Plk4 caused additional increase
of abnormal centriole formation at maternal centriole when compared with
overexpressing Plk4 alone, further reflecting their cooperative nature. Therefore, Plk4
clearly is not the sole regulator and further experiments to elucidate how Cdk2 and Plk4
may cooperate will provide important insights into the regulation of centriole duplication.

Beside Plk4, another distinct possibility responsible for the “copy number” control is that
a centrosomal component needed for procentriole assembly is limiting around the G1 to S
transition and is recruited to procentriole in a cooperative manner. This could favor
procentriole assembly at just one site, and thus conceivably prevent concurrent growth at
other sites (Strnad and Gˆnczy, 2008).

One of the most promising candidates of this limiting centrosomal component is HsSas-6.
Strnad and co-workers have found recently HsSas-6 was indispensible for procentriole
formation in human cells, and its protein levels were tightly regulated at the G1 to S
transition to restrict procentriole formation (Strnad et al., 2007). The fluctuation of
HsSas-6 level was not due to regulation at the transcription level since the HsSas-6
mRNA stayed relative the same across the cell cycle. Instead, protein degradation was
shown to be responsible for HsSas-6 downregulation starting from anaphase till onset of
S phase (Strnad et al., 2007). Treatment with 26S proteasome inhibitor MG132 restored
HsSas-6 level in telophase cells suggesting E3 ubiquitin ligase APC/C coupled with
adaptor protein Cdh1 is responsible for HsSas-6 degradation. A priori, the E3 ubiquitin
ligase APC/C becomes active when coupled with its adaptor protein Cdh1 during late
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mitosis and G1 phase. Cdh1 binds substrates containing a KEN box. Indeed, sequence
analysis identified a KEN box in the C terminus of HsSas-6 and further mutagenesis
studies confirmed the C terminal KEN box was required for targeting HsSas-6 for
degradation by APC/CCdh1. When three critical residues within the KEN box on HsSas-6
were mutated to alanine (the HsSas-6-ΔKEN mutant with K589A, E590A, N591A),
degradation of HsSas-6 was prevented. In addition, overexpression of Myc-tagged Cdh1,
which resulted in constitutive activation of APC/CCdh1, decreased HsSas-6 protein level in
S phase arrested cells. In summary, ubiquitination by APC/CCdh1 from late anaphase till
the end of G1 phase targets HsSas-6 protein for degradation by the 26S proteasome. As a
result, HsSas-6 level is kept low at the onset of procentriole assembly possibly to ensure
only one procentriole would form around a single mother template.

Cdc14B has been shown to specifically dephosphorylate Skp2 on Ser64 and render it
more susceptible to APC/CCdh1 degradation at the M to G1 transition (Rodier G, 2008).
Therefore, it’s reasonable to hypothesize that HsSas-6 level may also in part be regulated
by Cdc14B phosphatase. And the observed low level of HsSas-6 duing G1 phase may
due to dominant Cdc14B phosphatase activity. Although preliminary in nature, our study
demonstrated that depletion of Cdc14B in G1 cells did lead to the increased expression of
HsSas-6. This certainly raises the possibility that Cdc14B can target HsSas-6 for
degradation through counterbalancing a kinase activity (Plk4?) whose action would
stabilize HsSas-6. It’ll be interesting to test whether overexpressing Plk4 kinase in G1
cells will achieve the same result. If true, Cdc14B may corporative with Plk4 in the
pathway to limit HsSas-6 expression before centrosome duplication initiates. And this
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regulated low level of HsSas-6 may ensure only one procentriole will be generated at the
base of each mother centriole.

5.4 Summary
Taken together, as shown in Fig5.5, we propose that there is a balance between
Plk4 kinase and Cdc14B phosphatase in the control of centriole duplication: In situations
when there is excessive Plk4 expression or Cdc14B being depleted, Plk4 kinase activity
predominates and the restriction for procentriole assembly (possibly imposed by limited
expression of HsSas-6 during G1) is relaxed thereby allowing more than one procentriole
generated per maternal centriole; On the other hand, siRNA mediated depletion of Plk4
or overexpression of wild type Cdc14B shift the balance toward the other direction where
Cdc14B phosphatase activity prevails. And as a consequence, normal centrosome
duplication cycle is disrupted and centrioles are gradually lost in successive passages.

5.5 Experimental Procedures
5.5.1 Plasmids and Antibodies
Transfection-ready plasmids encoding human Plk4 were purchased from
OriGene. (Non-tagged [Cat. No SC115082] and C-terminal Myc/DDK-tagged [Cat. No
RC206015]). HsCentrin-1 in pEGFP-C1 (Clontech) vector was kindly provided by Dr.
Michel Bornens (Institut curie, Section De Recherche, France). Cdc14BWT and
Cdc14BK+C/S were subcloned into pEGFP-N3 vector (Clontech) fused to a C-terminal
EGFP tag whose expression was driven by the CMV promoters.
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B

Figure 5.5: Cdc14B antagonizes Plk4 kinase activity in centriole duplication control. (A) Overexpression of
Plk4 kinase or downregulation Cdc14B phosphatase through siRNA could lead to multiple procentrioles generated
around a single mother centriole. HsSas-6 (Yellow circles) could be the common effector of both Plk4 and Cdc14B.
When phosphorylated (“P”), HsSas-6 may be stabilized during G1, which resulted in unscheduled centriole
duplication. (B) Overexpression of Cdc14B phosphatase or downregulation Plk4 kinase, on the other hand, could
lead to gradual loss of centrioles. HsSas-6 may be targeted for degradation due to excessive Cdc14B phosphatase
activity
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Mouse polyclonal antibody against HsSas-6 was purchased from Abcam Inc (Cat No
ab67395). Rabbit polyclonal antibody against human Cdc14B was bought from Zymed
Labotories (Cat No 34-8900). Goat polyclonal antibody against human Plk4/Sak was
purchased from Santa Cruz Biotechnology, Inc (Sak C-14, Cat No SC-49101). AntiCentrin-2 antibody was purchased from Santa Cruz Biotechnology, Inc (Centrin-2 N-17,
Cat No SC-27793-R). Monoclonal Anti-γ-tubulin antibody was obtained from SigmaAldrich (GTU-88, Cat No T6557).

5.5.2 Cell Culture and Transfections
U2OS (ATCC), U2OSTeton (BD Bioscience) and HeLa cells were cultured under
5% CO2 at 37°C in high-glucose Dulbecco’s Modified Eagle’s medium (DMEM,
Invitrogen), 10% fetal bovine serum (FBS), and antibiotics (100ug/ml penicillin and
50ug/ml streptomycin sulfate). Cells were splited to 50% to 70% confluency and
transfected with Fugene HD (Roche) using 2ug of DNA and 6ul of Fugene HD reagent
per well in six-well plates. Co-transfection of Plk4 plasmids with Centrin-1-EGFP,
Cdc14BWT-EGFP and Cdc14BK+C/S-EGFP were performed using a ratio of 4:1 (Plk4:
Centrin-1/Cdc14BWT/Cdc14BK+C/S).

The doxycyclin-inducible cell lines stably expressing C-terminal EGFP-tagged
Cdc14BWT (Clone 4D) and Cdc14BK+C/S (Clone #2) were maintained in 100ug/ml of
G418 (Invitrogen) and 2ug/ml of puromycin (Sigma-Aldrich). The expressions of
constructs were induced by the addition of 4ug/ml of doxycyclin.
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5.5.3 Indirect Immunofluorescence
For indirect immunofluorescence, cells grown on glass coverslips were fixed
rapidly for 30 minutes in -20°C 100% methanol, washed in PBS, permeabilized with
PBS/0.5% Triton X-100 for 10 min at room temperature, and followed by blocking with
antibody dilution solution (1% bovine serum albumin in PBS) for 1 hour at room
temperature. Cells were then incubated either 1 hour at room temperature or overnight at
4°C with primary antibodies, washed three times in PBS, and incubated for 1 hour at
room temperature with secondary antibodies, washed, incubated with 0.1ug/ml of DAPI
in PBS and mounted using PermaFlour Mountant media (Thermo Electron Inc) and
imaging was performed at room temperature.

Primary antibodies were 1:2000 mouse anti-γ-tubulin (GTU-88, Sigma); 1:1500 goat
anti-Centrin-2 (N-17, Santa Cruz Biotechnology, Inc). Secondary antibodies were 1:750
donkey anti-mouse coupled to Alexa 594, 1:750 donkey anti-goat coupled to Alexa 568
(Molecular Probes).

Cells were visualized with a 100 x Plan-Neofluar objective (1.30 oil; ∞/0.17) under an
epi-fluorescence microscope (Axioskop 2, Carl Zeiss Inc). Images were acquired with a
charge-coupled device camera (AxioCam HRC) controlled by Openlab software (version
3.5, Improvision Inc). Image processing was performed using Photoshop CS (V8.0).
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5.5.4 RNA interference
Oligonucleotides targeting human Cdc14B were obtained from Dharmacon
(siGENOME SMARTpool, Cat No M-003470-02-0010) which correspond to the flowing
sequences: 5’GAUAAUACCAGACCGAUUUUU3’,
5’GAUGCUACAUGGUUAUAUAUU3’, 5’CAGUAUGGCUUCCUUAAUUUU3’ and
5’CAACUCAUUUAACCUUGAUUU3’ Oligonucleotides targeting human Plk4 were
obtained from Dharmacon (On-TARGETplus SMARTpool, Cat No L-005036-00-0005)
which correspond to the flowing sequences: 5’GAAGAUAGCAAUUAUGUGU3’,
5’GUGGAAGACUCAAUUGAUA3’, 5’GGACCUUAUUCACCAGUUA3’ and
5’GGACUUGGUCUUACAACUA3’. Oligonucleotides targeting human Sas-6 were
obtained from Dharmacon (On-TARGETplus SMARTpool, Cat No L-005036-00-0005)
which correspond to the flowing sequences:
Oligos were transfected into HeLa or U2OS cells using DharmaFECT 1 transfection
reagent (Dharmacon, Cat No T-2001-02). Briefly, cells were seeded at 40%-70%
confluency in an antibiotic-free culture medium and transfected with siRNA oligo pools
at a final concentration of 100nM for 60 hours (unless otherwise specified). Negative
controls were cells transfected with 100nM siGLO RISC-Free Control siRNA
(Dharmacon, Cat No D-001600-01-20). In co-transfection experiments, oligo pools were
mixed at 1:1 ratio with 50mM final concentration of each.
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5.5.5 Western Analysis
Cells were first lysed in a buffer containing 1% SDS in Tris-Hcl pH 7.4. Then
6xSDS sample buffer was added and samples were boiled for 10 minutes, votexed and
cell debris spun down at 15,000 rpm for 5 minutes. An equal amount of proteins were
loaded for SDS-PAGE and transferred onto nitrocellulose membrane (Biorad).
Membranes were then blocked by 5% skim milk dissolved in PBST (0.01% Tween20 in
PBS) for 1 hour at room temperature. After blocking, membranes were subjected to
incubation with primary antibody diluted in 3% BSA in PBS for overnight at 4°C. After
primary antibody incubation, membranes were washed three times with PBST and
incubated with horseradish peroxidase (HRP) conjugated secondary antibodies (Sigma)
for 1 hour at room temperature. Membranes were then washed again and specific signals
were detected using enhanced chemiluminescence reagents (Amersham Pharmacia
Biotech).
Dilutions of primary antibodies used: Cdc14B (Zymed) 1:300; HsSas-6 (Abcam)
1:500; β-actin (Cytoskeleton, Inc) 1:5000.

5.5.6 Cell Synchronization
To study how Cdc14B can affect endogenous HsSas-6 level during the cell cycle,
HeLa cells were synchronized by a double thymidine block. Briefly, 24 hours after
transfection with siRNA oligos, HeLa cells were cultured in fresh medium containing
2mM thymidine for 19 hours. After first thymidine block, cells were washed three times
with 1xPBS and incubated in fresh medium without thymidine for 9 hours to release
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cells. After releasing, 2mM thymidine was added again to the culture medium and
incubated for another 16 hours. After second block, cells were washed again and released
into the fresh medium without thymidine, and samples of synchronized cells were
collected and lysed at successive time points.

In a separate approach: For G0/G1 block, HeLa cells were washed and incubated in low
serum medium (0.5% FBS in DMEM) for 48 hours; For S phase arrest, HeLa cells were
treated with either 2mM hydroxyurea (HU,) or 10ug/ml aphidicolin (APH) for 48 hours.
After incubation, lysates of cells blocked at each cell cyles were prepared and subjected
to western analysis.
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Chapter 6

Role of Cdc14B phosphatase in counterbalancing
Cdk2/Cyclin-E/A in centrosome cycle control through
regulation of its substrates

6.1 Introduction
Cyclin-E, a regulatory subunit of cyclin dependent kinase 2 (Cdk2), is a known
inducer of S phase entry in the mammalian cell cycle. In normal dividing cells, Cyclin-E
expression increases at the G1/S phase boundary and is downregulated as cell progress
through S phase (Duliƒá et al., 1992; Koff et al., 1992; Spruck et al., 1999). When paired
with Cyclin-E, Cdk2 is activated and plays a part in triggering the initiation of both DNA
synthesis and centrosome duplication (Hinchcliffe EH, 2002).

The evidence for Cdk2/Cyclin-E’s involvement in centrosome duplication control
initially came from two separate in vitro studies using S-phase arrested Xenopus egg
extract. Hinchcliffe et al developed an in vitro system by using S phase arrested frog egg
extract. In this system, the investigators observed the repeated assembly of daughter
centrosomes using polarized light microscopy (Hinchcliffe et al., 1999). When Cdk2
activity was selective inhibited using Δ34Xic-1, an NH3-terminal truncated form of
Xenopus Cdk inhibitor Xic-1p27, multiple rounds of centrosome reproduction was
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blocked, indicating that Cdk2/Cyclin-E is required for repeated centrosome duplication
(Hinchcliffe et al., 1999; Hinchcliffe EH, 2002). In a second study, Lacey and coworkers used a different system in which isolated mammalian centrosomes were added to
Xenopus egg extract and centriole disengagement phenotype was observed (Lacey KR,
1999). Centriole disengagement or centriole disorientation was used as a measure of
centrosome duplication because it is regarded as the leading morphological event in
centrosome reproduction (Kuriyama and Borisy, 1981) and recently is suggested as a
licensing step to release the centrosome-intrinsic block to re-duplication during a single
cell cycle (Tsou and Stearns, 2006c). This study showed that centriole disorientation in
the frog extract is dependent on active Cdk2/Cyclin-E as centriole disjunction didn’t
occur when Cdk2 kinase inhibitors (CKIs) p21 or p27 were added to the extract; In
contrast, mother-daughter centriole pairs disjoined in the control extracts with intact
Cdk2/Cyclin-E activity (Lacey KR, 1999). In summary, these in vitro experiments using
Xenopus egg extracts demonstrated Cdk2/Cyclin-E activity is required for centrosome
duplication in early embryo model systems (Hinchcliffe EH, 2002).

In mammalian somatic cells, in addition to Cyclin-E, a different Cdk2 cyclin, Cyclin-A,
has also been shown to be important in promoting centrosome duplication, and in some
cases is even more effective than Cyclin-E (Meraldi et al., 1999). Prolonged treatment of
CHO cells with agents such as hydroxyurea (HU) or aphidicolin (APH) allows
centrosome re-duplication to occur in the absence of DNA replication (Balczon et al.,
1995b). Taking advantage of this in vitro centrosome duplication system, Matsumoto et
al demonstrated that when Cdk2 activity was blocked by drugs such as butyrolactone-I
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and roscovitine, or by expression of the Cdk inhibitor p21Waf1/Cip1, centrosome reduplication is inhibited (Matsumoto et al., 1999a), indicating the requirement of Cdk2
activity in centrosome duplication. Subsequent study using the same system led to the
finding that Cdk2/Cyclin-A instead of Cdk2/Cyclin-E was mainly responsible for
multiple rounds of centrosome duplication in CHO cells arrested at the G1/S boundary
(Meraldi et al., 1999).

The above discrepancy between early embryo model system and mammalian somatic
cells suggest the possibility that there may be functional redundancy for kinases that
positively regulate centrosome duplication. Indeed, both Cyclin-E1 and Cyclin-E2
knockout mice developed normally and were viable, except that about half the Cyclin-E2
knockout male mice were sterile due to incomplete testis development (Geng et al.,
2003). When these mice were crossed, the Cyclin-E1/E2 double knockout mice were
embryonic lethal due to problems with placental development. Nevertheless, these
embryos survived until the 10th day of gestation and fibroblasts derived from double
knockout mice embryos were able to undergo several rounds of division before becoming
senescent. These observations make a strong argument that Cyclin-E is dispensable for
cell proliferation and development in the mouse.

A recent study further showed the initiation of centrosome duplication is not significantly
affected in cells derived from these mice, suggesting that the function of Cyclin-E can be
readily replaced by other kinases (Fukasawa, 2008; Hanashiro et al., 2008). Hanashiro et
al also showed that initiation of centrosome duplication was significantly delayed when
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Cyclin-A expression was silenced in Cyclin E-deficient cells, implying that Cyclin-A is a
primary candidate that compensates for the loss of Cyclin-E function for initiation of
centrosome duplication (Hanashiro et al., 2008). However, as long as Cyclin-E is present,
the role of cyclin A in the initiation of centrosome duplication appears to be minimal as
initiation of centrosome duplication is noticeably delayed in Cyclin-E deficient cells
compared with cells with normal level of Cyclin-E (Hanashiro et al., 2008).

Cdk2/Cyclin-E/A activity, although not essential, may nevertheless be important for the
fidelity of centrosome duplication. Cdk2 complexed with either Cyclin-E or Cyclin-A are
responsible for unscheduled centrosome re-duplication in a number of scenarios. It has
been shown that cell cycle arrest in G1/S boundary by hydroxyurea (HU, a ribonucleotide
reductase inhibitor) as well as aphidicolin (APH, a DNA polymerase inhibitor) and in late
G2 phase by the G2/M checkpoint in response to DNA damage allowed centrosomes to
regain the duplication competency and go through multiple rounds of re-duplication upon
availability of the active Cdk2. However, Cyclin-A and Cyclin-E participated in
centrosome re-duplication in a distinct manner depending on which cell cycle stage that
cells are arrested: In cells arrested in early S phase, Cyclin-E is more important in
centrosome re-duplication while Cyclin-A is a backup kinase; however, in contrast to the
early S phase arrest, Cyclin-A is more important in the induction of centrosome reduplication in cells arrested in late G2 due to DNA damage induced G2/M checkpoint. In
addition, p53 also plays a part in centrosome re-duplication in these systems. In normal
cells, upon treatment with inhibitors such as HU or APH, p53 is stabilized by the ARFmediated inhibition of Mdm2 (Sherr, 2006), resulting in the up-regulation of p21Waf1/Cip1,
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a potent CDK inhibitor and major transactivation target of p53 . This leads to continuous
inhibition of Cdk2, therefore blocking initiation of centrosome re-duplication; in cells
lacking p53, however, Cdk2 activation is unchecked, causing centrosome to re-duplicate
(Hanashiro et al., 2008).

It is known that phosphorylation of critical substrates by CDKs drives the cell cycle.
When present, Cdk2/Cyclin-E/A appears to directly phosphorylate its centrosomal
substrate(s) to regulate centrosome duplication. Up to date, however, only a few in vivo
Cdk2/Cyclin-E/A centrosomal substrates have been identified. Therefore, the
identification of physiological Cdk2/Cyclin-E/A centrosomal substrates is an important
first step toward elucidation of the molecular mechanism underlying how Cdk2/CyclinE/A drives centrosome duplication.

B23 (also called nucleophosmin, NPM1, NO38, numatrin) is a multifunctional protein
localized to the nucleolus and the centrosome, and is a substrate of Cdk2/Cyclin-E/A. It
has been reported to play roles in ribosomal protein assembly, centrosome duplication,
protein and histone chaperone activity and etc (Szebeni and Olson, 1999; Zou et al.,
2008). Immunofluorescence evidence from Okuda and co-workers suggests that B23
controls centrosome duplication. Upon phosphorylation by Cdk2/Cyclin-E on Thr199
(threonine at position 199) at G1/S boundary, B23 dissociates from the centrosome
allowing centrosome duplication to occur in S phase (Okuda et al., 2000a). Duplicated
centrosomes remain free of B23 until mitosis when it re-associates with centrosomes to
inhibit unscheduled centrosome duplication. Functional evidence for B23’s involvement
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in centrosome reproduction came from the finding that centrosome duplication was
inhibited by the expression of non-phosphorylatable mutant of B23 (B23T199A,
threonine 199 was mutated to alanine) that constitutively associated with centrosomes; in
addition, microinjections of antibodies against B23 that sterically block its
phosphorylation site by Cdk2/Cyclin-E also inhibited centrosome duplication. Together,
these data led the authors to propose that Cdk2/CycE specifically phosphorylates B23 on
T199 causing it to dissociate from the centrosome thereby allowing centrosome
duplication to start (Okuda et al., 2000a; Tokuyama et al., 2001). Also, the authors argued
that potentially B23 could be a licensing factor that limits centrosome duplication to once
per cell cycle. Consistent with B23’s inhibitory role in controlling centrosome
duplication, Wang et al. further showed that the docking of B23 onto centrosome relied
on the Ran/Crm1 complex (Wang et al., 2005), a nuclear-cytoplasmic shuttle system that,
when disrupted, led to unrestricted centrosome duplication, similar to the phenotype
observed in B23 deficient MEFs (Grisendi et al., 2005). However, if absence of B23 at
centrosomes licenses them for duplication, this model cannot explain why centrosomes
do not readily re-duplicate during S and G2 when B23 is not on centrosomes. Therefore,
there seems to be more to the story for the molecular mechanisms underlying B23’s role
in centrosome duplication control.

A second possible centrosomal target of Cdk2/Cyclin-E is CP110, a protein localized to
the centrioles. The expression of CP110 coincides with the activation of Cdk2/Cyclin-E
as it’s induced at the G1/S transition and its levels peaked around S phase, diminishing in
mitosis (Chen et al., 2002a). Indeed, CP110 can be phosphorylated by by Cdk2/Cyclin159

E/A both in vitro and in vivo. Downregulation of CP110 expression by RNAi and
blocking of Cdk2/Cyclin-E/A phosphorylation by mutations resulted in unscheduled
centrosome separation. Also, RNAi-mediated reductions in CP110 inhibited centrosome
reproduction in S phase arrested U2OS cells which otherwise exhibit centrosome
overduplication (Chen et al., 2002a). More recently, Kleylein-Sohn et al identified CP110
is required for centriole biogenesis in human cells. In this study, they showed that CP110
associated with the distal ends of both parental centrioles and procentrioles. In particular,
during centriole biogenesis, CP110 was recruited and decorated the distal tips of
procentrioles and assembled into a cap-like structure underneath which α-/β- tubulin
dimmers are inserted in support of procentrioles growth (Kleylein-Sohn et al., 2007a).
Also, CP110 has been shown to suppress primary cilia formation (Spektor et al., 2007;
Tsang et al., 2008).

Mps1 kinase was originally identified as essential for the duplication of the spindle pole
body in budding yeast. Although it has been controversial, recent studies suggest that
Mps1 plays a role in centrosome duplication. In mouse cells, Frisk and co-workers
showed mMps1 localized to centrosomes throughout the cell cycle. Functional evidence
for mMps1’s involvement in centrosome duplication control came from the following
findings: catalytically dead mMps1 mutant prevented centrosome duplication and
suppress centrosome re-duplication in S-phase arrested cells; overexpression of active
mMps1 directly caused centrosome re-duplication in a cell line that wouldn’t readily
undergo centrosome overduplication during S-phase arrest. Also, in the same study,
mMps1 was identified as an in vitro substrate of Cdk2/Cyclin-E and Cdk2/Cyclin-E can
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stabilize the protein levels of Mps1 kinase (Fisk and Winey, 2001). In contrast, a separate
study by Stucke and co-workers did not find Mps1 at the centrosomes in U2OS cells by
immunofluorescence and failed to collect functional evidence for an involvement of
Mps1 in centrosome duplication by antibody injections, expression of kinase dead
mutants, and siRNA mediated depletion (Stucke VM, 2002 ). These surprising
differences between the two studies have led to a further investigation by Fisk and coworkers. And the new results confirmed their previous conclusions that Mps1 is present
at centrosomes and its activity is required for centrosome duplication (Fisk HA, 2003).
More recently, Kasbek et al from Fisk lab identified a single Cdk2 phosphorylation site
and a degradation signal within Mps1 that regulate the accumulation of Mps1 at
centrosomes. Also the new study showed Cdk2 coupled with Cyclin-A instead of CyclinE can phosphorylate Mps1 on T468 and prevent Mps1 degradation at centrosomes. And
stabilized centrosomal Mps1 is sufficient enough to cause centrosome re-duplication in
human cells (Kasbek et al., 2007).

In chapter four, we have shown that Cdc14B phosphatase can suppress unscheduled
centrosome duplication in both HU and Z-L3VS treated U2OS cells. It’s important to note
that in both of these settings Cdk2/Cyclin-E/A activity is in part responsible for the
centrosome amplification phenotype. Thus, there is a potential counterbalancing effect
between Cdc14B phosphatase and Cdk2/Cyclin-E/A kinase in the centrosome cycle
control and here we will test this hypothesis in more details.
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6.2 Results
6.2.1 Cdc14B phosphatase suppressed centrosome amplification caused
by doxyrubisin treatment
When exposed to certain genotoxic drugs such as DNA intercalating drugs and
topoisomerase II inhibitors (for example, doxorubicin, DXR), the majority of cells
become arrested in late G2 due to the DNA damage activated G2/M checkpoint. Similar
to the hydroxyurea and aphidicolin mediated early S-phase arrest, cells arrested in G2 is
also believed to regain the centrosome duplication competency allowing newly
duplicated centrosomes to re-duplicate upon availability of active Cdk2 (Hanashiro et al.,
2008). Cyclin-E is unlikely to play a role here since it is only highly expressed
specifically in late G1 to early S phase. Cyclin-A, on the other hand, is known to be
expressed at high levels in S and G2/M and has been shown to be upregulated when cells
were treated with DXR in both cyclin-E-/- and cyclin-E+/+ MEFs (Desdouets C, 1995;
Hanashiro et al., 2008). More importantly, RNAi mediated depletion of cyclin-A
suppressed the centrosome amplifcation caused by DXR exposure regardless of the
presence of cyclin-E (Hanashiro et al., 2008). Thus, cyclin-A, instead of cyclin-E, is
critical for centrosome re-duplication in cells arrested in late G2 in response to DNA
damage.

Therefore, treating cells with DXR becomes a perfect system for us to test whether
Cdc14B phosphatase can also counterbalance Cdk2/cyclin-A during the DNA damaged
induced centrosome amplifcation. This may further add to our pool of evidence that
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Cdc14B may also be a negative regulator for abnormal centrosome duplication due to
environmental cues. In order to do so, wild type U2OSTet-on cells and doxycyclininducible cell lines stably expressing either C-terminal EGFP-tagged Cdc14BWT (Clone
4D) or Cdc14BK&C (Clone #2) were treated with DXR in presence of DOX induction for
48 h and then fixed for immunostaining with γ-tubulin antibody, a centrosome marker. In
control U2OSTet-on cells, centrosome amplification phenotype was faithfully reproduced,
with about 48.67% of cells haboring more than two centrosomes (Fig 6.1A&B).
Remarkably, when induced, only 23.33% of Cdc14BWT-EGFP positive cells showed
more than two γ-tubulin spots, indicating centrosome overduplication was significantly
inhibited in the presence of Cdc14BWT-EGFP (Fig 6.1A&B). When the Cdc14BK+C/S EGFP (Clone #2) were examined for centrosome number instead, around 41.33% of
EGFP positive cells had more than two centrosomes, at a level similar to what we
observed in wild type U2OSTet-on cells (Fig 6.1). This indicates that Cdc14B phosphatase
activity is required for this action. Taken together, our data highly suggests that Cdc14B
is also a counterbalancing phosphatase of Cdk2/Cyclin-A to ensure proper centrosome
number in G2 arrested cells triggered by DNA damage.

6.2.2 Cdc14B interacts with B23 and dephosphorylates B23 on T199 in
vitro
Previously in our lab during a search for potential Cdc14A substrates in
mammalian cells, we created a Cdc14A mutant by changing Asp to Ala at position 251,
designated as Cdc14AD251A mutant. This mutant could be used as a “substrate trapping”
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Figure 6.1: Cdc14B phosphatase activity is required to prevent DXR-induced
centriole overduplication. (A) Wild type U2OSTet-ona cell line as well as DOXinducible U2OSTet-ona cell lines carrying the indicated Cdc14B-EGFPs were treated
with 1ug/ml doxyrubisin in the presence of 4µg/ml DOX for 48 hrs. Representative
centrosomes (red) were visualized by anti-γ-tubulin antibody and DNA (blue) by
DAPI. Bar, 5 µM. (B) Percentage of cells with >2 centrosomes were calculated
accordingly. Data shown represent three individual experiments with (+DOX)
induction of the indicated cell lines. At least 300 cells were counted in each
experiment.
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mutant given that it is catalytically inactive and potentially retains wild-type-like binding
affinity toward its substrates. The construction of this Cdc14A mutant was based on its
structure identity in Asp/PTP motif with a protein tyrosine phosphatase (PTP) “substrate
trapping” mutant described previously (Flint et al., 1997; Gray et al., 2003). We took
advantage of this “substrate trapping” Cdc14AD251A mutant as bait for
immunoprecipitation in combination with mass spectrometric analysis (Data not shown)
to isolate potential Cdc14A interacting proteins or substrates. Interestingly, a gel-slice
corresponding to ~ 33kDa band gave rise to the measured masses of three trypsindigested peptides which matched theoretical isotopic masses of protonated tryptic
peptides of nucleophosmin/B23 (NCBI entry 10835063) (Fig 6.2A). Further
immunoprecipitation experiment confirmed this interaction between Cdc14A and B23
(Fig 6.2B). Since Cdc14A and Cdc14B shares high structural and sequence homology
(Gray et al., 2003; Li et al., 1997a), we further tested whether Cdc14B could also
physically interact with B23. We transiently transfected both Myc-tagged Cdc14B and
Flag-tagged B23 into U2OS cells and found that anti-flag antibody also could pull down
Myc-tagged Cdc14B (Fig 6.2A), indicating potential interaction between these two
proteins. As discussed in the introduction section, dissociation of B23 from centrosomes
correlates with the phosphorylation of B23 on Thr199 (Okuda et al., 2000b). Therefore,
it’s interesting to test whether Cdc14B phosphatase can dephosphorylate B23 at Thr199
both in vitro and in vivo based on its potential capability of counterbalancing
Cdk2/Cyclin-E/A activity.
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Figure 6.2: Cdc14A interacts with B23. (A) Coomassie stain of a representative immunoprecipitation experiment
using myc-tagged Cdc14AD251A mutant (lane 1) and WT Cdc14A (lane 2) as a bait in 293T cells. (B) Western
analysis shows B23/Cdc14A co-immunoprecipitation. (Courtesy of Dr. Hyekyung P. Cho)
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Figure 6.3: Cdc14B interacts with B23 and dephosphorylates phospho-Thr-199 of B23 in vitro. (A)
Cdc14B/B23 co-immunoprecipitation. Flag-tagged B23 and myc-tagged Cdc14B were cotransfected into U2OS
cells followed by immunoprecipitation with anti-Flag antibody and then immunoblot with anti-myc antibody. (B) In
vitro dephosphorylation of CyclinE/Cdk2 γ-p32-ATP-labeled B23 by wild-type Cdc14B but not catalytic “dead”
Cdc14BD287A mutant. (C) Upper panel: Dephosphorylation of Cyclin E/Cdk2-phosphorylated B23 by wild-type
Cdc14B but not catalytic “dead” Cdc14BC314S mutant. B23Thr199 phosphorylation was detected by anti-phosphoB23-Thr199 (B23-pThr199, Cell Signaling Inc) antibody. Densitometry analysis showed that in comparison with 15
min rxn, 40% (30min) and 80 % (60min) reduction of phosho-B23 Thr199 was found. Lower panel: Cyclin E/Cdk2phosphorylated B23Thr199A mutant was not detectable by anti-B23-Thr199 antibody showing the specificity of the
phospho-B23-Thr199 antibody. Note for in vitro dephosphorylation experiments, CyclinE/A and Cdk2 were
baculovirus-produced, whereas His-tagged B23 and Cdc14B were all produced in bacteria. (Courtesy of Dr.
Hyekyung P. Cho)
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As an initial step to study the relationship between Cdc14B and B23 in centrosome
duplication control, we tested in vitro whether affinity purified Cdc14B protein could
directly dephosphorylate B23Thr199 phosphorylated by baculovirus produced GSTCdk2/Cyclin-E kinase in a phosphatase assay. First, we showed both in vitro baculovirus
purified GST-Cdk2/Cyclin-E and HA-Cdk2/Cyclin-A successfully phophorylated baterial
puried His-tagged B23 but not the His-B23T199A mutant (Fig 6.3B). Moreover, as
shown in both Fig 6.3B and 6.3C, in vitro purified His-tagged wild type Cdc14B protein
but not the phosphatase dead mutants: His-Cdc14BD287A and His-Cdc14BC314S
respectively (Fig 6.3B and 6.3C), could dephosphorylate affinity-purified prephosphorylated wild type B23 (His-B23WT). In Fig 6.3B we used γ-p32-ATP to label
phosphorylated form of B23Thr199 by Cdk2/Cyclin-E/A and in Fig 6.3C we took
advantage of a commercial antibody specifically recognizes phosphorylated B23Thr199.
Both approaches led to the same conclusion. Before His-tagged Cdc14B was added to the
reaction (0 min), the signals detected by both γ-p32-ATP and anti-Phospho-B23T199
were the highest. However, after addition of wild type His-tagged Cdc14B, the
phosphorylation level on B23Thr199 gradually reduced with time. After 120 min and 60
min respectively, the phosphorylation on B23T199 was hardly detectable (Fig 6.3B & C).
In contrast, when phosphatase dead Cdc14B mutants (His-Cdc14BD287A and HisCdc14BC314S) were used instead, the phosphorylation level on B23T199 after addition
His-Cdc14Bc/s stayed relatively the same even after 120 min (Fig 6.3B and 6.3C). As a
control, we created a B23 mutant His-B23T199A by changing its Thr199 residue to Ala
thereby eliminating its ability to be phosphorylated at this site. And when this HisB23T199A mutant was used, there was no visible bands corresponding to phosphorylated
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form of B23T199 indicating the specificity of anti-Phospho-B23T199 antibody (Fig
6.3C). In conclusion, our data shows Cdc14B physically interacts with B23 and can
dephosplate B23 at Thr199 in vitro.

6.2.3 Cdc14B dephosphorylates B23Thr199 during early S phase
In the next step, we tested the possibility whether Cdc14B could dephosphorylate
B23Thr199 in vivo. And if so, we would be expecting higher level of B23Thr199
phosphorylation in Cdc14B depleted cells. First, asynchronous HeLa cells were
transfected either with siGLO control oligos or Cdc14B siRNA smartpool. 66h posttransfection, cells were lysed and subjected to western analysis probing for
phosphorylated B23Thr199. Unfortunately, under this experiment condition, we didn’t
observe any inceased level of B23 phosphorylation on Thr199 in cells with significant
reduction of Cdc14B expression due to siRNA transfection (Fig 6.4A), suggesting either
B23 may not be targeted by Cdc14B or Cdc14B desphosphorylates B23 in specific cell
cycle stage(s). Since depletion of Cdc14B did not lead to obvious cell cycle defect
(Rodier G, 2008; Wu et al., 2008), we can synchronize HeLa cells depleted of Cdc14B
into different stages of the cell cycle and evaluate its effect on B23Thr199
phosphorylation. Next, we again transiently transfected HeLa cells with siGLO control
oligos or Cdc14B siRNA smartpool oligos, but this time, after 24 h transfection, we
blocked cells at G1/S boundary using double thymidine block. HeLa cells were then
released from the block and cellular protein lysates were prepared at indicated timepoints
after release and levels of B23Thr199 phosphorylation was evaluated by western blot
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Figure 6.4: B23 as a potential substrate of Cdc14B. (A) Asynchoronized Hela cells
were transfected with either siGLO oligo control or Cdc14B smartpool siRNA pool.
7 Cell lysates were subjected to western analysis using antibodies against Cdc14B (top),
Phospho-B23T199 (middle) and β-actin as a loading control (bottom). (B) HeLa cells
transfected with either siGLO oligo control or Cdc14B smartpool siRNA pool. Shown
are cells 3h (S phase) after released from a double thymidine block and analyzed by
western blot using antibodies against Cdc14B (top), Phospho-B23T199 (middle) and
β-actin as a loading control (bottom).
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using a anti-phospho-B23Thr199 antibody. Interestingly, 3h after release when cells were
in early S phase, Cdc14B depleted cells showed a significantly higher B23T199
phosphorylation signal compared with siGLO transfected cells (Fig 6.4B). This result
suggests Cdc14B might regulate B23T199 phosphorylation during early S phase in the
cell cycle when centrosome duplication events occur.

6.2.4 Requirement of B23 for Cdc14B-mediated centrosome duplication
control.
Now we know Cdc14B can both dephosphorylate B23Thr199 in vitro and
potentially in vivo. The next step will be to investigate whether B23 is required for
Cdc14B’s negative role in controlling centrosome duplication. And in chapter four we
have demonstrated that Cdc14B suppressed centrosome amplification caused by
prolonged treatment with hydroxyurea (HU) in U2OS cells. In the current study, we
sought to knock down B23 expression in HU-treated U2OS cells in combination of
overexpressing Cdc14B phosphatase. If B23 is indeed involved in Cdc14B’s role in
centrosome duplication, depletion of B23 will be expected to reverse Cdc14B’s negative
effect in inhibiting centrosome overduplication caused by HU treatment.

To knock down endogenous B23, we first used a vector-based RNAi approach. In search
of the optimal siRNA target sequence to deplete the endogenous B23, we came across an
oligo corresponding to nucleotide position 819-837 relative to the B23 start codon was
most effective in ablating endogenous B23 expression (designated as B23819 siRNA). We
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cloned the B23819 siRNA oligo into pSuper-neo-GFP vector purchased from Oligoengine
and its expression was driven by the H1 promoter. After successful cloning, pSuperB23819 was transfected into U2OSTet-on cells together with pBabe-puro (a kind gift from
Dr. Gerald Evans) and selected for stable clones in a growth medium containing G418
and puromycin. After selection, several stable clones were isolated which constitutively
expressed the B23819 siRNA oligo. One of the clones (N1 clone) were tested for B23
expression, as shown in Fig 6.5A, when compared with wild type U2OSTet-on cells, N1
cells showed significant reduction of B23 expression when probed using a monoclonal
B23 antibody (Sigma).

Next, we transfected N1 cells with a plasmid expressing Cdc14BWT-EGFP and subjected
the transfected cells to 72 h of HU treatment. Surprisingly, compared with control (wild
type U2OSTet-on cells), Cdc14BWT-EGFP positive N1 cells showed similar efficiency of
suppressing of centrosome overduplication when compared with EGFP positive wild type
U2OSTet-on cells (Fig 6.5B). This came as a disspointment since it could mean B23 was
dispensible for Cdc14B’s function to suppress aberrant centrosome re-duplication in HU
treated U2OS cells.
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Figure 6.5: Cdc14B-mediated inhibition of centrosome overduplication does not depend on B23. (A) Western
blot analysis using anti-B23 antibody (Sigma) revealed a significant knockdown of B23 in U2OS cells stably
transfected with pSuper-B23 siRNA (targeting nucleotide position 819-837 relative to the start codon). (B) U2OS
cells or B23siRNA cells were transiently transfected with Cdc14B-GFP expression vector for 24 hrs followed by
hydroxyurea treatment for an additional 48 hrs. Cells were then fixed and stained with anti-Centrin-2 antibody.
Percentage of cells with more than 4 centrioles was calculated from three independent experiments. At least 300
cells were counted in each experiment.
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However, there are several weakness associated with this approach of knocking down
B23. First, since the expression of siRNA oligo is constitutive, U2OSTet-on cells under
selection therefore were constantly having their endogenous B23 mRNA being targeted
for degradation. Since B23 is essential for embryonic development and the maintenance
of genomic stability and B23-/- mice is embryonic lethal, stable clone selection might
have favored cells with the strongest survial potential with minimal levels of B23 present
(Grisendi et al., 2005). In supporing this, we did observe a gradual loss of multipolar cells
during selection (data not shown). These multiplepolar cells might have arised from
centrosome overdupication as also observed in B23-/- / P53-/- MEFs (Grisendi et al., 2005);
Second, the N1 clone didn’t show any increase of centrosome number as expected with
B23 depleted cells, further strengthing the idea that these stably clones generated were
not representive of the most of cells when B23 is knocked down.

Therefore we decided to use an alternative approach. We tested transiently knocking
down endogenous B23 using siRNA oligo pool purchased from Dharmacon. Compared
with control siGLO oligo, when transfected into HeLa cells, Dharmacon B23 siRNA pool
could efficiently knock down endogenous B23 expression as shown in Fig 6.6A. Next,
we transfect this verified B23 siRNA oligo pool into the DOX-inducible U2OSTet-on cell
line stably expressing C-terminal EGFP-tagged Cdc14BWT (Clone 4D). 24 h after
transfection, 2mM of HU were added to the culture medium and cells were incubated for
additional 48h and then fixed for immunostaining with γ-tubulin as a centrosome marker.
As expected, in 4D cells transfected with siGLO oligo control, when induced with DOX,
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Figure 6.6: B23 is a downstream mediator of Cdc14B in suppressing HU-induced centrosome amplification.
(A) Hela cells were transiently transfected siGLO oligos control, siRNA oligo pools targeting endogenous Cdc14B
(Dharmacon Smartpool) or B23 (Dharmacon On-target pool). 60h post transfection, cell lysates were analyzed by
westernblot probing with antibodies against Cdc14B (top), B23 (middle) as well as β-actin (bottom) as a loading
control. (B) Representative images showing γ-tubulin labeled centromes in 4D cells treated HU: uninduced (left),
induced + siGLO (middle), induced + B23siRNA (right). (C) Percentage of cells with > 2 centrosomes were
calculated in each experimental group and data shown represent three individual experiments. At least 100 cells
were counted in each experiment.
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Cdc14BWT-EGFP postive cells showed dramatic reduction of cells with more than two γtubulin spots (~22% as shown in Fig 6.6) compared with cells withouth DOX induction
(~49%), confirming Cdc14B’s negative effect on abberent centrosome duplication. In
cells with B23 being targeted for depletion, when induced, Cdc14BWT-EGFP postive
cells showed ~35% percentage of cells harboring more than two centrosomes,
significantly higher than siGLO control. This indiates that in the HU treated U2OS cells,
B23 is potentially the downstream mediator of Cdc14B in suppressing centrosome
amplification and when B23 expression is transiently knocked down, Cdc14B lost its
ability to suppress centrosome amplification triggered by HU exposure.

6.3 Discussions
Without acquisition of duplication competency to re-duplicate the newly
duplicated centrosomes do not re-duplicate readily (Wong and Stearns, 2003). It’s been
shown that cell cycle arrest in S phase by treatment with either hydroxyurea or
aphidicolin and in late G2 phase by the G2/M checkpoint in response to DNA damage
allow centrosomes to regain the duplication competency, and re-duplication occurs upon
availability of the active Cdk2 (either coupled with Cyclin-E or Cyclin-A) (Hanashiro et
al., 2008). It’s commonly known that Cyclin-E and Cyclin-A are expressed at different
stages during the cell cycle. The activation of Cdk2/Cyclin-E starts in late G1 to early S
phase while Cdk2/Cyclin-A is activated in S phase through the rest of the cell cycle. Thus,
in HU arrested U2OS cells, Cdk2/Cyclin-E is expected to be the major driving force for
centrosome re-duplication. Our data in chapter four demonstrated that Cdc14B
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phosphatase can suppress this centrosome overduplication phenotype, suggesting the
counterbalancing effect between Cdc14B phosphatase and Cdk2/Cyclin-E kinase.In the
current study, we confirmed that DXB-induced G2 arrest could cause centrosome to reduplicate and further demonstrated this unscheduled centrosome duplication could also
be inhibited by overexpression of Cdc14B phosphatase. In cells arrested in G2 due to
DNA damage induced checkpoint, Cdk2 paired with Cyclin-A instead of Cyclin-E is
responsible for the centrosome amplification. Thus, in addition to Cdk2/Cyclin-E,
Cdc14B can also counterbalance Cdk2/Cyclin-A kinase activity at least in the DXB
treated U2OS cells. Although circumstantial, these evidences further strenghthen the
idea that Cdc14B is a negative regulator for centrosome duplication. In addition to its role
in normal centrosome cycle control as we have discussed in chapter four, Cdc14B may
also act as a “guardian” to protect centrosome from being overduplicated in cases when
environmental cues such as drug exposure, radiation cause centrosomes to regain
duplication potentials.

This idea is supported by several previous studies. Sugihara and co-workers showed that
suppression of centrosome amplification after DNA damage depends on p27
accumulation (Sugihara et al., 2006). In their study, it was shown that when cells treated
with DXR, p27 levels gradually increased and Skp2 levels declined. Skp2 (S-phase
kinase associated protein 2, also known as Fbxl1) is one of the best characterized
mammalian F-box proteins and it is an ubiquitin ligase receptor for p27 which targets p27
for degradation (Frescas and Pagano, 2008). During DNA damage induced G2/M
checkpoint (γ-radiation, DXR, etc), Skp2 level is down regulated which results in the
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reduction of p27 ubiquitination thereby allowing the accumulation of p27. Skp2 is
degraded at the M to G1 transition and its level begins to accumulate again at late G1 and
the abundance is maximal during S and G2 phases. Cdc14B has been shown to
specifically dephosphorylate Skp2 on Ser64 and renders it more susceptible to APC/CCdh1
degradation at the M to G1 transition (Rodier G, 2008). Also, it has been implicated that
during the G2 DNA damage response checkpoint, Cdc14B is released from the nucleolus
to the nucleoplasm, activating APC/CCdh1, which in turn, targets Skp2 for proteasomal
degradation (Bassermann et al., 2008). Piece together, Cdc14B may indirectly stabilize
p27 during G2 DNA damage checkpoint that leads to suppression of centrosome
amplification. Indeed, our data support this hypothesis. When excessive Cdc14B
expression was induced, the percentage of DXR treated U2OS cells harboring more than
two centrosomes significantly reduced when compared with uninduced cells. Although
further direct evidence supporting the Cdc14B- APC/CCdh1 -Skp2-p27 pathway in
suppressing centrosome overduplication upon DNA damage in G2 is needed, our
observation combined with previous studies highly suggested Cdc14B might act at
upstream in the DNA damage induced G2 checkpoint to ensure cells have normal copies
of centrosome before enter mitosis.

The counterbalancing effect between Cdc14B phosphatase and Cdk2/Cyclin-E/A
observed in our study, however, was not direct. When treated with HU or DXR,
centrosome tends to overduplicate in U2OS cells. Even it’s been extensively studied that
under these conditions centrosome amplification phenotype was dependent on available
Cdk2s’ activity, it’s not clear whether Cdk2 paired with either Cyclin-E or Cyclin-A were
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the sole factors involved. Therefore, in order to confirm the counterbalancing effects, it’s
better to use simpler systems under which direct functional interaction in the context of
centrosome duplication between Cdc14B and Cdk2/Cyclin-E/A can be assayed. It has
been shown previously that Cyclin-E overexpression (constitutive activation of
CDK2/Cyclin-E) in both mouse and human cells with defective 53 caused centrosome
amplification (Kawamura et al., 2004; Mussman JG, 2000); Also, it’s been reported that
overexpression of Cyclin-A alone but not Cyclin-E triggered centrosome overduplication.
Therefore, the next step is to use these characterized overpression systems to directly
study the effect of Cdc14B phosphatase in counterbalancing these two kinases.

Although Cdc14 contains sequences in addition to its phosphatase domain, so far all of
the Cdc14 known functions in yeast rely on its phosphatase activity (D'Amours and
Amon, 2004). Previous in vitro experiments suggest that mammalian Cdc14A and
Cdc14B may preferentially dephosphorylate proteins phosphorylated by MAPKs and
CDKs (Kaiser et al., 2002b). Genetic and functional evidence on the relationship between
Cdc14A&B and their substrates is lacking. We have identified a potential Cdc14A and
Cdc14B substrate, namely nucleophosmin/B23 through coimmunoprecipitation/ mass
spectrometry and in vitro phosphatase assay. Direct evidence for B23’s role in
centrosome cycle controls came from two studies using B23 knockout mice. Knocking
out B23 caused embryonic lethal indicating B23’s essential role in embryonic
development. Also inactivation of B23 in MEFs led to unrestricted centrosome

duplication and genomic instability (Colombo et al., 2005; Grisendi et al., 2005).
Additonal experimental evidence suggests that B23 controls centrosome duplication at
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G1/S boundary. B23 associates with unduplicated centrosomes in G1 and inhibits
centrosome duplication. Upon phosphorylation by Cdk2/Cyclin-E at Thr199 (threonine of
B23 at position 199) during G1/S transition, B23 dissociates from centrosomes allowing
centrosome duplication to occur though some still remain at mother centrioles of the
parental centriole pairs (Kazuya et al., 2005; Okuda et al., 2000a). From S to early
mitosis, B23 remains separated from centrosomes. Starting from metaphase, B23 reassociates with the centrosomes (Okuda et al., 2000a; Zatsepina et al., 1999). The reassociation of B23 with centrosome requires the dephosphorylated form. Therefore, a
yet-to-be found phosphatase is needed to help remove the phospho group at Thr199 on
B23 in late mitosis. Our data suggests that Cdc14B can be such a candidate phosphatase.
The finding of Cdc14B interacts with B23 and dephosphorylates B23Thr199 in vitro
rasied a possibility that the Cdc14B/B23 connection may be of importance in centrosome
cycle regulation. Further in vivo evidence strenghthened this idea. When HeLa cells
depleted of Cdc14B in each different cell cycle were collected after release from a double
thymidine block and probed with a polyclonal anti-phospho-B23Thr199 antibody, cells at
the G1/S boundary and early mitosis showed a significant increased level of B23Thr199
phophorylation compared with the control siGLO transfected cells. G1/S boundary is the
time when phosphorylation of B23Thr199 occurs, a known Cdk2/Cyclin-E
phosphorylation site involved in centrosome duplication (Tokuyama et al., 2001). In line
with this, our data suggest Cdc14B phosphatase may directly antagonize Cdk2/Cyclin-E
activity in phosphorylating B23Thr199 to maintain a physiological kinase-phosphatase
balance required for new round of centrosome duplication.
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In a separate approach, we have demonstrated in HU treated U2OS cells B23 could be the
downstream mediator of Cdc14B in suppressing centrosome amplification. In this
context, ectopic expression of Cdc14B could’ve shifted the kinase-phosphatase balance
between Cdc14B and Cdk2/Cyclin-E. As a result, there may exisited more
dephosphorylated B23Thr199 thereby causing unscheduled re-associateion of B23 to
centrosomes.

Based on the recognized impact of Cdc14 on cell cycle regulation in yeast and on
mammalian microtubule dynamics and centrosome fidelity, we conclude that a thorough
study of Cdc14 phosphatases in centrosome regulation of mammalian cells must benefit
to our understanding on the basic mechanism of centrosome duplication, potentially
revealing a novel licensing mechanism to control centrosome duplication by the counterregulation between the specific centrosomal kinases and Cdc14B phosphatase. By the
same argument, we believe that an in-depth annotating the molecular mechanism of
Cdc14B-B23 interaction will enable us to delineate potential protein signaling pathway(s)
that regulate the centrosome duplication in coordination with cell cycle progression.

6.4 Summary
Taken together, it’s tempting to propose that there is also kinase-phosphatase
balances between Cdk2/Cyclin-E/A and Cdc14B in the control of centriole duplication.
In HU/APH treated U2OS or CHO cells, Cdk2/Cyclin-E is majorly responsible for the
centriole amplification phenotype observed, and our data in chapter four has shown
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Cdc14B phosphatase activity is required to suppress this phenotype. Further, our data
here suggests this counterbalancing effect may be through their common substrate, B23;
In DRB treated U2OS cells, Cdk2/Cyclin-A was shown to be responsible for centriole
overduplication and our data showed this phenotype could also be inhibited by Cdc14B
phosphatase activity implying, albeit indirectly, a counterbalancing effect between
Cdk2/Cyclin-A and Cdc14B.

6.4 Experimental Procedures
6.4.1 Plasmids and Antibodies
HsCentrin-1 in pEGFP-C1 (Clontech) vector was kindly provided by Dr. Michel
Bornens (Institut curie, Section De Recherche, France). Cdc14BWT and Cdc14BK+C/S were
subcloned into pEGFP-N3 vector (Clontech) fused to a C-terminal EGFP tag whose
expression was driven by the CMV promoter.

Monoclonal antibody against human B23 was purchased from Zymed Laboratories (Cat
No 32-5200). Rabbit polyclonal anti-phospho-B23T199 antibody was purchased from
Abcam (Cat No ab59353). Rabbit polyclonal antibody against human Cdc14B was
bought from Zymed Laboratories (Cat No 34-8900). Goat polyclonal Anti-Centrin-2
antibody was purchased from Santa Cruz Biotechnology, Inc (N-17, Cat No SC-27793R). Monoclonal Anti-γ-tubulin antibody was obtained from Sigma-Aldrich (GTU-88, Cat
No T6557).
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6.4.2 Cell Culture and Transfections
U2OS (ATCC), U2OSTeton (BD Bioscience) and HeLa (ATCC) cells were
cultured under 5% CO2 at 37°C in high-glucose Dulbecco’s Modified Eagle’s medium
(DMEM, Invitrogen), 10% fetal bovine serum (FBS), and antibiotics (100 U penicillin
and 50ug/ml streptomycin sulfate). Chinese hamster ovary (CHO-K1) cells were obtained
from ATCC and cultured in Ham’s F-12 medium supplemented with 10% FBS and
antibiotics.

For transfection, cells were split to 50% to 70% confluency and transfected with Fugene
HD (Roche) using 2ug of DNA and 6ul of Fugene HD reagent respectively per well in
six-well plates.

The doxycyclin-inducible cell lines stably expressing C-terminal EGFP-tagged
Cdc14BWT (Clone 4D) and Cdc14BK+C/S (Clone #2) were maintained in 100ug/ml of
G418 (Invitrogen) and 2ug/ml of puromycin (Sigma-Aldrich). The expressions of both
Cdc14BWT-EGFP and Cdc14BK+C/S-EGFP were induced by the addition of 4ug/ml of
doxycyclin.

6.4.3 Indirect Immunofluorescence
For indirect immunofluorescence, cells grown on glass coverslips were fixed
rapidly for 30 minutes in -20°C 100% methanol, washed in PBS, permeabilized with
PBS/0.5% Triton X-100 for 10 min at room temperature, and followed by blocking with
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antibody dilution solution (1% bovine serum albumin in PBS) for 1 hour at room
temperature. Cells were then incubated either 1 hour at room temperature or overnight at
4°C with primary antibodies, washed three times in PBS, and incubated for 1 hour at
room temperature with secondary antibodies, washed, incubated with 0.1ug/ml of DAPI
in PBS and mounted using PermaFlour Mountant media (Thermo Electron Inc) and
imaging was performed at room temperature.

Primary antibodies were 1:2000 mouse anti-γ-tubulin (GTU-88, Sigma); 1:1500 goat
anti-Centrin-2 (N-17, Santa Cruz Biotechnology, Inc). Secondary antibodies were 1:750
donkey anti-mouse coupled to Alexa 594, 1:750 donkey anti-goat coupled to Alexa 568
(Molecular Probes).

Cells were visualized with a 100 x Plan-Neofluar objective (1.30 oil; ∞/0.17) under an
epi-fluorescence microscope (Axioskop 2, Carl Zeiss Inc). Images were acquired with a
charge-coupled device camera (AxioCam HRC) controlled by Openlab software (version
3.5, Improvision Inc). Image processing was performed using Photoshop CS (V8.0).

6.4.4 RNA interference
For transient siRNA knock down experiments, oligonucleotides targeting human
Cdc14B were obtained from Dharmacon (siGENOME SMARTpool, Cat No M-00347002-0010) which correspond to the flowing sequences:
5’GAUAAUACCAGACCGAUUUUU3’, 5’GAUGCUACAUGGUUAUAUAUU3’,
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5’CAGUAUGGCUUCCUUAAUUUU3’ and 5’CAACUCAUUUAACCUUGAUUU3’;
oligonucleotides targeting human B23 were obtained from Dharmacon (OnTARGETplus SMARTpool, Cat No L-015737-00-0005) which correspond to the flowing
sequences: 5’GUAGAAGACAUUAAAGCAAUU3’,
5’AAUGCAAGCAAGUAUAGAAUU3’, 5’ACAAGAAUCCUUCAAGAAAUU3’ and
5’UAAAGGCCGACAAAGAUUAUU3’. siRNA oligo pools were transiently transfected
into HeLa or U2OS cells with DharmaFECT 1 transfection reagent (Dharmacon, Cat No
T-2001-02). Briefly, cells were seeded at 40%-70% confluency in an antibiotic-free
culture medium and transfected with siRNA oligo pools at a final concentration of
100nM for 60 hours (unless otherwise specified). Negative controls were cells transfected
with 100nM siGLO RISC-Free Control siRNA (Dharmacon, Cat No D-001600-01-20).

To generate B23 knockdown stable cell lines, siRNA oligo that target the sequences 5’GAATTGCTTCCGGATGAC T-3’ (Korgaonkar et al., 2005) (819-837, relative to the
start codon of B23, designated as B23siRNA819) was annealed and cloned into the XhoI
and BglII sites of pSuper.retro.neo+GFP vector (Oligoengine). Stable clones
constitutively expressing B23siRNA819 were established by cotransfection with pBabepuro (a kind gift from Dr. Gerald Evans) into U-2OSTet-on cells and selection in a growth
medium containing 800 μg/ml G418 and 5μg/ml puromycin.

6.4.5 Western Analysis
Cells were first lysed in a buffer containing 1% SDS in Tris-Hcl pH 7.4. Then
6xSDS sample buffer was added and samples were boiled for 10 minutes, votexed and
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cell debris spun down at 15,000 rpm for 5 minutes. An equal amount of proteins were
loaded for SDS-PAGE and transferred onto nitrocellulose membrane (BioRad).
Membranes were then blocked by 5% skim milk dissolved in PBST (0.01% Tween20 in
PBS) for 1 hour at room temperature. After blocking, membranes subjected to incubation
with primary antibody diluted in 3% BSA in PBS for overnight at 4°C. Then membranes
were washed three times with PBST and incubated with horseradish peroxidase
conjugated secondary antibodies (Sigma) for 1 hour at room temperature. Membranes
were washed again and specific signals were detected using enhanced
chemiluminescence reagents (Amersham Pharmacia Biotech).

6.4.8 Cell Synchronization
For HeLa cell synchronization, double thymidine block approach was carried out.
Briefly, cells were cultured in fresh medium containing 2mM thymidine for 19 hours.
After first thymidine block, cells were washed three times with 1xPBS and incubated in
fresh medium for 9 hours to release cells. After releasing, 2mM thymidine was added
again to the culture medium and incubated for another 16 hours. After second block, cells
were washed again and released into the fresh medium, and samples of synchronized
cells were collected and lysed at successive time points.

In a separate approach, HeLa cells were also synchronized with drugs: For G0/G1 block,
HeLa cells were washed and incubated in low serum medium (0.5% FBS in DMEM) for
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48 hours; For S phase arrest, HeLa cells were treated with either 2mM hydroxyurea (HU)
or 10ug/ml aphidicolin (APH) for 48 hours. After incubation, cells blocked at each cell
cyles were lysed and subjected to western analysis.
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